The treatment of pain in India: power and practice by Roques, Clare
 
 
 
 
 
 
 
 
 
Roques, Clare (2018) The treatment of pain in India: power and 
practice. PhD thesis. 
 
 
https://theses.gla.ac.uk/41014/  
 
 
 
Copyright and moral rights for this work are retained by the author  
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge  
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author  
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author  
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses  
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
 
  
The Treatment of Pain in India: 
power and practice  
 
 
 
Dr Clare Roques  
MSc MA MB BChir Cantab FRCA FFPMRCA 
 
 
 
 
Submitted in fulfilment of the requirements of the  
 Degree of Doctor of Philosophy 
 
School of Interdisciplinary Studies, College of Social Sciences 
University of Glasgow 
 
 
January 2018
Abstract 
The World Health Organization describes over 80% of the world’s population as living 
without adequate access to treatment for pain. Improvement initiatives focus largely on the 
field of palliative care and on increasing access to opioid medications. Predominantly, they 
are led from the global North while targeting healthcare provision in the global South. I 
propose that the limited improvement seen from these programmes is in part, attributable 
to their narrow clinical focus and to a lack of understanding of practice at the local level. 
Using India as a single case of study, the aim of this research project is to assess critically 
how medical practitioners, working within and outwith palliative care, treat patients in 
pain.  
My research questions address the practice of pain management and clinicians’ evaluations 
of this care, from the perspective that pain as a medical problem, is a professionally 
constructed phenomenon. In this cross-disciplinary research, I use mixed methods, 
combining qualitative and quantitative data, from interviews and surveys administered to 
clinicians, field observations in India and secondary analysis of a pre-existing oral history 
archive. I draw on theories of the policy process, postcolonialism and social 
constructionism. Through critically evaluating practice, I move beyond more familiar 
descriptions of care delivery and barriers to improvement, to understand how these issues 
are framed, formed and contested.  
The study demonstrates salient features of the Indian healthcare system: scarce resources, 
multiple providers, weak regulation, and the dominant role of the private sector. The 
availability of treatments, including opioids and non-pharmacological therapies, is low and 
variable. The framing of pain as a problem requiring medical treatment is ubiquitous and 
there is consensus regarding the need to improve the delivery of clinical care. There is 
variation, however, in opinions about how this should be achieved, particularly with 
respect to the choice of treatment modality. Power is wielded by clinicians in the form of 
knowledge, and is negotiated with other medical professionals, politicians and patients. 
In conclusion, although Indian clinicians’ descriptions of individual practice recognise the 
unique local factors that impact on the delivery of pain management, their proposed 
strategies for improvement emphasise increasing the provision of medical treatments 
developed in the global North. There is, however, little acknowledgment of the 
assumptions and limitations of this western medical model when used to treat pain in India.
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 Introduction 
Many high profile international bodies, including the World Health Organization describe 
untreated pain as a medical problem demanding increased provision of targeted healthcare 
services. A significant barrier to this is a gross imbalance in access to analgesic opioid 
medications such as morphine, between high and low- and middle-income countries. India 
is an example of a jurisdiction in which poor opioid access persists despite having been the 
focus of local and international initiatives. In general, these programmes appear to have a 
narrow clinical focus and fail to incorporate detailed critical appraisal of local medical 
practice, which, I propose, has contributed to their limited efficacy. It is this gap in the 
knowledge base, specifically related to clinical practice that I seek to address in this work. 
In the thesis I present a cross-disciplinary research project on the medical treatment of 
pain. Using India as a single case of study, I describe through the eyes of clinicians how 
pain management is practised at a local level and explore how this relates to wider issues 
of global healthcare delivery. I incorporate the use of mixed methods and a variety of 
theoretical perspectives, including social constructionism, theories of the policy process, 
and postcolonialism, and draw on my training as both a practising medical specialist and a 
social scientist. The thesis is presented in five chapters: 1-Background, 2-Methodology and 
Methods, 3-Results, 4-Discussion and 5-Conclusions. 
In Chapter 1, I introduce my research questions and describe how pain is conceptualised 
within western medicine. I begin with a historical perspective, explaining how 
technological advances and a burgeoning knowledge base led to the increased use of 
morphine and other techniques of providing analgesia (namely through injections called 
nerve blocks). Through the twentieth century, within western medicine, pain became 
classified into distinct types, acute or short term, chronic or long term and pain associated 
with terminal disease, reflected in the organisation of the profession. In the latter half of 
the century, dedicated pain clinics were set up and the specialty of palliative medicine 
created. I explain how controversy remains regarding both the knowledge base and the 
resulting practice and organisation of pain management within western medicine, and why 
these debates are so political with respect to the use of opioid analgesia.  
The global picture of opioid access is hugely variable, with the majority of the world’s 
population largely living in lower income regions (also known as the global South) unable 
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to access the medications, whilst use in North America is described, albeit 
controversially, as excessive. I demonstrate how the vast majority of work aiming to 
improve pain management at a global level by redressing this imbalance, emanates from 
the field of palliative care and the high-income countries of the global North. 
Consequently, much of this work does not address the treatment of pain outside of the 
palliative care setting or access to treatments other than opioids. Whilst the barriers to 
improving access to pain management both globally and in India are described remarkably 
consistently in the literature as a lack of education, poor medication availability and 
inappropriate policy provision, there is a paucity of critical appraisal of these topics. I 
describe the key published studies in this field and explain how my research adds to this 
knowledge base through in-depth analysis of practice from the perspective of clinicians, 
incorporating the management of all types of pain and treatment modalities in India.  
In the final section of Chapter 1 I describe the theories that underpin my work, namely 
social constructionism, theories from the field of policy studies and postcolonialism. I 
explain how the treatment of pain can be considered to be a socially constructed entity, 
largely created by the medical profession. I consider the implications this professional 
construction has on clinical practice, with particular reference to the power wielded by 
clinicians. I then describe how policy theories, especially when viewed from a social 
constructionist perspective, can facilitate our understanding of the field of study and help 
to frame the results of my project. Crucial to these theories are descriptions of the role 
power plays in fuelling the dynamic stages of the policy process. Finally, I explain how 
postcolonial theory can inform the discussion of the processes when viewed from a wider 
global perspective. Specifically, postcolonial theory aims to critique the power dynamics 
that persist across the world today as a direct result of past European colonial rule.   
In Chapter 2 I begin by explaining how the theoretical perspectives introduced in the 
opening chapter inform my methodology, specifically, my decision to use a combination of 
research methods, namely a survey, semi-structured interviews and the analysis of an oral 
history archive, and incorporating qualitative and quantitative data. I explain the current 
controversies in the literature related to the combining of research methods, and outline the 
strengths and weaknesses of each element. I demonstrate how the use of multiple methods 
is essential to this project, due to the nature of the research questions and ultimately 
because it adds rigour to the results. In the following section of the chapter I set out the 
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details of my research method, describing the processes of defining my research 
questions, creating my research tools (the survey and interview guide), collecting my data 
and analysing the results. 
In Chapter 3 I present the study findings, combining the results from the different data 
sources and types and reporting them under topic headings. I begin by identifying the key 
issue from the results, namely that participants universally conceptualise pain as a medical 
problem. I then describe key findings related to the delivery of healthcare in India relating 
primarily to inadequate resources and diversity of provision. I then move on to topics 
related to the organisation of medicine and the treatment selection made by clinicians. 
Finally, I present data linked to how power is enacted by the medical profession, 
specifically in the form of knowledge and money. 
In Chapter 4, I discuss each set of results presented in Chapter 3. I describe how my results 
confirm other research relating to the provision of healthcare in India particularly with 
respect to the diversity of provision and a lack of resources. I consider how these 
conditions that are particular to the Indian context affect the practice of pain management. 
I discuss how the treatment of pain is professionally constructed and how this leads to 
controversy related to the organisation and practice of clinical medicine. For example, the 
boundaries between the clinical remit of different professional groups are indistinct and the 
relative merits of particular treatment modalities are disputed.  
The professional construction of pain management inevitably leads to concerns over how 
power is wielded by clinicians, and I discuss this concept in detail. I contend that in India 
power is enacted in many forms, most demonstrably as knowledge and money, manifesting 
in many areas of healthcare. For example, clinicians dispute knowledge as they debate the 
most appropriate treatment strategies, and compete for patients’ custom and therefore 
money within the private healthcare system. In order to demonstrate these facets of 
contested power I discuss three specific areas of the policy process namely, agenda setting, 
policy formation and policy implementation. In each of these areas I explain with respect 
to my results how clinicians enact power and the effects this has on the provision of pain 
management to patients. I also discuss how power is negotiated at a global level, and in 
particular how the persistent dominance of the global North can adversely affect the lives 
of the underprivileged majority living in the global South. For example, through the 
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exportation to India, of a western medical model of treating pain that does not 
incorporate a clear acknowledgement of its underlying assumptions and limitations.  
I conclude in Chapter 5 by summarising the key findings from my study and the wider 
implications they have on the provision of pain management at a global level. I discuss the 
current political struggles playing in different regions of the world with respect to the over 
and under use of opioids, and show how this relates to the professional construction of pain 
management. I consider the funding of healthcare and the potential conflicts of interest that 
arise within the medical profession particularly as the demand for pain treatments 
increases. Finally, I describe how important it is for organisations that are directing 
international healthcare improvement initiatives to appreciate the power imbalances that 
persist between the global North and South and crucially to fully acknowledge the 
limitations of western medicine in these contexts. 
 Chapter 1 – BACKGROUND 
1.1 Introduction  
I begin this opening chapter by introducing the aims and research questions of this study. I 
then present an overview of the medical practice of pain management. In Section 1.3, I 
give a brief description of the historical evolution of the treatment of pain within western 
medicine before explaining how pain is currently conceptualised and described within the 
wider context of global healthcare. I elaborate on the current key topics within this field, 
with particular reference to the highly publicised and political issue of the medical use of 
prescription opioid medications. I demonstrate some of the gaps in the current knowledge 
base and the need for cross-disciplinary research.  
In the following section (1.4) I explain and justify my use of India as the location of the 
study, describing the pertinent features of the healthcare system with respect to the 
treatment of pain. I present the key published studies in this field, which largely focus on 
descriptions of the delivery of pain management within the field of palliative care. I 
explain how my research adds to this body of work, by considering individual clinicians’ 
evaluations and normative positions, moving beyond simple descriptions of delivery of 
healthcare to address my research questions.  
In the final section of this chapter (1.5), I describe the theoretical perspectives that 
underpin my cross-disciplinary work, beginning with social constructionism, moving on to 
key aspects of political theory and concluding with a description of postcolonialism.  
1.2 Study Aims and Research Questions 
In a briefing note published in 2012, the World Health Organization (WHO) estimates 
“that 5.5 billion people […] have inadequate access to treatment for moderate to severe 
pain”.1(p1) India serves as an example of one such country, with huge numbers of patients 
described as living without access to pain relief.
2
 Despite numerous initiatives, largely 
targeting improved access to opioid medications for patients receiving palliative care, 
Chapter 1 
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progress has been limited.
3
 I propose that key factors contributing to this limited progress 
are an overly narrow clinical focus and a lack of detailed understanding of practice at the 
local level, resulting in a disconnect between individuals’ practice and improvement 
initiatives driven by international organisations.  
Therefore, the aim of this research project is to assess critically how western medical 
practitioners in India, working within and outwith palliative care, treat patients in pain. The 
specific research questions are:  
1) What types of painful conditions do clinicians treat, what treatments do they offer 
and how are these funded?  
2) How do clinicians think pain ought to be treated, and how do they consider their 
own practice compares to this ideal?  
3) How do clinicians conceptualise the barriers and assets to improving the treatment 
of pain?  
4) What are the opinions and evaluations of clinicians regarding the wider provision 
of pain management across the country?  
5) With respect to pain specialists, how is the medical profession organised and what 
impact does this have on the delivery of care?   
1.3 Pain as a Medical Problem 
1.3.1 The Emergence of Medical Specialties 
The phenomenon of pain existed even before man evolved as a species and found means to 
describe it. Throughout history its complex nature has been subject to multiple, changing 
cultural interpretations.
4
 It has been treated as a religious entity, deeply imbued with 
spiritual meaning, its tolerance considered a virtue.
5
 It has been described in beneficial 
terms when considered a necessary component of rites of passage and initiation.
5
 It has 
been used as a devastating tool to control and inflict suffering during organised torture.
6
 
The advent of modern anaesthesia in the nineteenth century which enabled hitherto 
harrowing procedures, such as limb amputations, to be carried out as painless operations is 
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heralded as one of the greatest medical advances in modern times.
7
 The invention and 
widespread use of anaesthesia marked a shift in focus, away from the description of pain as 
a universal experience demanding cultural interpretation and meaning, towards a 
reductionist model of pain as a physical problem to be fixed by medical intervention.
8
 As 
David Morris writes in his book The Culture of Pain, “Today our culture has willingly, 
almost gratefully, handed over to medicine the job of explaining pain.”5(p19) Although 
opium (a naturally occurring opioid pain killer) had been used medicinally to treat pain for 
centuries,
4
 the industrial production of morphine in 1820 and the advent of the hypodermic 
(or hollow) needle in 1855 significantly increased the medical use of opioids.
9
  
At around the same time the medical profession began to conceptualise pain as falling into 
three different categories: acute or short-lived pain following injury, pain of cancer and 
other terminal disease, and chronic or long-term intractable pain conditions - each 
requiring different treatment strategies.
9
 This classification of pain has remained central to 
the practice of pain management within western medicine and has shaped the organisation 
of pain related specialties.  
In the first half of the twentieth century, fuelled by the awareness of the failure of 
particular chronic pain conditions to respond to treatment with opioid medications, there 
was a growing interest amongst the medical profession, in performing therapeutic medical 
procedures.
10
 The aim of these physical techniques, known as ‘nerve blocks’ was to 
disrupt, either temporarily or permanently, the neural pathways that transmit pain signals to 
the brain. By the second half of the century, however, there was increasing 
acknowledgement of the complex nature of pain and the importance of understanding and 
treating its psychological as well as physical components, a seminal work in this field 
being Melzack and Wall’s Gate Control Theory of Pain.11 This culminated in the first 
multidisciplinary pain clinics being founded in the USA by John Bonica and in the UK by 
Mark Swerdlow during the 1950s and 1960s.
9
 The formation of the International 
Association for the Study of Pain (IASP) and its journal Pain soon followed.
9,12
 Of note, 
pain medicine, a medical specialty dedicated to the treatment of chronic pain, is formally 
recognised in a few countries,
13
 but in many, including the USA and the UK, it is 
considered a sub-specialty of anaesthesia.
14,15
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During the beginning of the twentieth century, concern grew around the risks of 
addiction to opioid medications that were increasingly being prescribed by the medical 
profession.
16
 However, a marked change occurred specifically in the treatment of pain in 
patients suffering with terminal cancer, led in the UK by Cicely Saunders in the late 1950s. 
Her pioneering work, and the creation by other experts working with the World Health 
Organization (WHO) of an opioid based analgesic ladder in the 1980s as part of its Cancer 
Pain Relief Program, led to opioids becoming the mainstay of treatment for the pain of 
terminal cancer.
17,18
 Furthermore, in the same manner as her colleagues working in the 
field of chronic pain who described the psychological components of pain, Cecily 
Saunders also wrote extensively on the need to address patients’ psychological and 
spiritual suffering, coining the term ‘total pain’.19 Saunders founded the first modern 
hospice, dedicated to treating dying patients in London in 1967, a national society for 
clinicians specialising in the field of palliative care was founded in 1985, and since then 
increasing numbers of countries have formally recognised palliative medicine as a medical 
speciality in its own right.
20
 
The treatment of severe acute pain following trauma, surgery and including childbirth, has 
also evolved over the last century, with doctors drawing on similar techniques to those 
used in chronic pain management, such as nerve blocks and epidural injections, and 
advanced systems for delivering opioids.
21
 Since the 1990s, there has been a growth in the 
numbers of specialist acute pain teams within hospitals, largely led by doctors working 
within the specialty of anaesthesia.
22
 Most episodes of acute pain following surgery or 
trauma, however, do not require specialist input from anaesthetists, and are dealt with by 
the clinical team overseeing the patient’s care, such as surgeons.23  
Whilst the structure of professional specialisation that has grown around the treatment of 
pain over the last century partly reflects the western medical classification of pain, there 
have been important changes, particularly within the field of palliative care that complicate 
this picture. Since the early days of the palliative care movement, there has been a close 
association between palliative care and the treatment of patients with cancer,
20
 but over 
time the field has evolved and the remit of the speciality has gradually broadened. The 
most recent definition of palliative care conceptualised by the WHO describes it as 
encompassing all ‘life-threatening illness’.24 Although a definition has indeed been created 
by this organisation, its content is a still matter of debate.
25
 Some have called for a 
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narrower remit, for palliative care to be restricted to use in cancer patients, others have 
called for all patients to be treated within a palliative care model, and others have gone still 
further describing palliative care as a philosophical model to transform healthcare 
systems.
25
 While some members of the medical profession have questioned the need for 
palliative care to be a medical speciality in its own right since its inception,
26
 the current 
trend of broadening the remit of palliative care to encompass more medical conditions and 
to treat patients within this model earlier in the course of their disease, reinforces the ideal 
that all clinicians should adopt the ethos of palliative care.
27
 The trend also leads to an 
increasing overlap between the clinical remit of palliative care and chronic pain specialists.  
Despite the growth of medical specialisations dedicated to the treatment of pain, and 
society’s enthusiastic and increasing reliance on the use of this medical model, it is vital to 
note that pain is not, with the current knowledge base of western medicine, universally 
amenable to elimination.
28
 The word ‘pain’ can indicate a vast range of causal factors 
including physical trauma such as a broken limb, an emotional event such as the death of a 
loved one, or a daily event such as hunger. Even leaving aside the second two examples 
and concentrating on pain that is secondary to some form of physical pathology or 
medically identifiable disease process, pain is an incredibly diverse phenomenon. The 
physical initiators are vastly wide ranging and different types of pain vary in how 
amenable they are to medical treatment. The western medical classification into acute pain, 
pain of terminal disease and chronic pain emphasises this variability. Specifically, acute 
short-lived pain, such as that following surgery or trauma is usually treated effectively 
within western medicine, often using opioid medications.
29
 Similarly pain due to terminal 
diseases, that is, incurable conditions in their final fatal stages, such as (but not limited to) 
advanced cancer, is also frequently amenable to medical treatment and again opioids are a 
key tool in providing analgesia.
30
 Of note, pain of terminal disease, whilst strictly speaking 
not transient, is none the less limited in its timescale due to the nature of the underlying 
disease process resulting in the death of the sufferer. In contrast, pain that is chronic, or 
long-standing and not caused by a terminal condition, examples of which include phantom 
limb pain (following amputation), chronic back pain, diabetic neuropathy (nerve pain) and 
arthritis, is much less amenable to western medical treatment. The vast majority of 
pharmacological therapies, including opioid medications, provide relief only for the 
minority.
31
 While multidisciplinary pain clinics aim to help patients manage their pain, 
total relief or a cure is highly unlikely to be achieved. Indeed implicit in the very definition 
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of chronic pain as a long-standing condition, is its resistance to curative therapy. As 
Arthur Kleinman and colleagues explain, “Chronic pain is an important health issue that 
biomedicine has handled with an astonishing lack of success.”32(p6) 
The conceptualisation of pain as a problem to be fixed within a medical framework 
underpins the early and highly influential work of the WHO carried out the 1980s in 
relation to the treatment of cancer pain.
33
 Mirroring the expanding remit of palliative care, 
the WHO and other high profile organisations, most recently the Lancet,
3
 describe pain of 
multiple aetiologies, as a global health concern of increasing proportion. I focus on these 
descriptions of the current state of medical pain management in the following section. 
1.3.2 The Global Picture of Pain Management 
In the aforementioned briefing note published in 2012, the WHO estimates that 5.5 billion 
people (over 80% of the world’s population) live without access to treatments for moderate 
to severe pain.
1
 The organisation lists examples of painful conditions that are undertreated 
such as terminal cancer, end-stage HIV/AIDS, trauma and surgery, labour and chronic 
illnesses, and it cites the lack of access to opioid analgesics, including morphine as a 
particular obstacle. Due to the illicit use of morphine and other opioid analgesics, these 
medications are controlled under the United Nation’s (UN) Single Convention on Narcotic 
Drugs (SCND)
34
 which is overseen by the International Narcotics Control Board.
35
 
However, despite an acknowledgement in the SCND preamble of the need to allow the use 
of opioids for medical purposes and the inclusion of morphine in the WHO Model List of 
Essential Medicines,
36
 in many countries there is an imbalance with stringent legislation 
resulting in little or no access to their legitimate use. In an attempt to redress this 
imbalance, the WHO has created the Access to Controlled Medications Programme 
(ACMP)
37
 of which the briefing note described above is a part. In this document, the WHO 
also describes access to controlled medications that are simultaneously considered to be 
‘essential’ as a human right quoting another UN document, the International Covenant on 
Economic, Social and Cultural Rights.
38
 This framing of pain and its treatment by different 
organisations, all working under the remit of the UN, is profoundly influential and 
consequently informs much of the work in this field. In the remainder of this section, I 
consider in more detail the published literature relating to the three prominent themes 
Chapter 1 
 
25 
raised by these organisations, namely the description of the need to treat pain within a 
medical framework, the availability of opioid medications and the related politico-legal 
issues. 
Estimates of the scale of the need for improved pain relief emanate from estimates of 
global disease burden,
39
 and include the prevalence of trauma, the need for surgical 
procedures, cancer, HIV/AIDS and indeed all chronic diseases.
40-42
 Several 
epidemiological studies have been carried out to estimate the prevalence of chronic pain 
across the world,
43-49
 and although results vary across countries, a prevalence of around 
20% is common. When considering acute pain following surgery, one of the reasons that 
estimates of prevalence vary is because of the inclusion of estimates of the number of 
patients who could potentially benefit but currently do not have access to surgical 
procedures. These patients are said to account for 11-32% of the global burden of 
disease.
42
 An estimated additional 143 million surgical procedures per year (including 
those needed to treat trauma) would need to be carried out to redress this imbalance.
50
 Up 
to 50% of patients suffer severe pain following surgery and trauma
51
 and an estimated 10% 
of the world’s deaths are due to injuries.52  
The need for pain relief in terminal disease is frequently described in conjunction with a 
need for palliative care.
3,53
 Estimates of the scale of need therefore vary depending on the 
diseases included in this category. Some quote only the incidences of cancer, but 
increasingly all chronic or non-communicable diseases (NCDs) are included. Although not 
all of those suffering from these diseases may be in need of pain management and/or 
palliative care, mapping studies, such as the Global Atlas of Palliative Care at the End of 
Life (a publication by the WHO and the Worldwide Palliative Care Alliance) estimate that 
over 20 million people are in need of pain relief and palliative care, based on NCD 
prevalence.
53
 The 2017 report of the Lancet Commission on Palliative Care and Pain 
Relief, which uses wider inclusion criteria, estimates that over 60 million people 
worldwide, over 50 million of whom are living in low and middle-income countries 
(LMICs), could benefit from palliative care.
3
  
These descriptions of poor availability of pain management on a global level have a 
specific focus on improving access for the vast majority of the world’s population that 
lives in LMICs. In terms of acute and chronic pain not associated with terminal disease 
Chapter 1 
 
26 
there are some examples of initiatives aiming to tackle this problem such as the IASP’s 
Developing Countries Working Group, and their yearly advocacy projects entitled ‘Global 
Year Against Pain’,54,55 and the World Federation of Societies of Anaesthesiologists 
educational projects.
56
 Of note, however, the IASP’s remit is to promote awareness of all 
types of pain including that caused by cancer. Other authors have also called for increased 
efforts to improve acute and chronic pain management in developing countries.
23,40,42,49
 
However, the vast majority of the work in this field has emerged from within the field of 
palliative care with many key programmes originating from organisations specifically 
targeting the treatment of pain in those who are dying of cancer.  
Alongside the WHO, many global organisations focus on improving access to pain relief 
within the context of palliative care, such as: the International Association for Hospice and 
Palliative Care (IAHPC), the Worldwide Palliative Care Alliance (WPCA), the Pain and 
Policy Studies Group (PPSG) at the University of Wisconsin, and the Union for 
International Cancer Control. Both the need for palliative care and current levels of 
provision have been mapped at a global level,
53,57
 and a world ranking index has even been 
produced.
58
 A prominent theme included in this advocacy work is the need to improve 
access to opioid medications. The 2015 Quality of Death Index, produced by the 
Economist Intelligence Unit uses opioid availability as one of its ranking indicators
58
 and 
the problem of opioid availability is highlighted in numerous other international projects 
including the Lancet Commission on Palliative Care and Pain Relief
3
 and the Global 
Opioid Policy Initiative.
59
 Furthermore, it has been noted that the availability of opioid 
medication for cancer pain relief and palliative care, correlates with each country’s Human 
Development Index, although this factor is not the only predictor.
60
 Other so called 
‘barriers’ to improving palliative care at an international level include: a lack of policy as 
well as a lack of financial and material resources, poor awareness amongst the public and 
politicians, insufficient education and training, as well as other psychological, social and 
cultural barriers.
53,61
  
As I noted previously there is far less published work surrounding the evaluation of the 
provision of treatment for pain outside of the remit of palliative care, and consequently less 
discussion of the barriers contributing to this lack of access. Similar categories of barriers 
are, however, described with respect to acute pain management, as are described in 
palliative care, such as: poor access to opioid medications, a lack of policy, scarce 
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resources particularly in rural areas, and inadequate education of patients and 
professionals.
23,49,62
 Despite the expanding remit of palliative care, the treatment of chronic 
pain not related to terminal disease is, in global terms, even less widely researched and 
discussed. Nonetheless, a few authors have described barriers to improving the treatment 
of chronic pain, noting the importance of making available pharmacological treatments 
other than opioids and non-pharmacological therapies; in addition to addressing the 
familiar obstacles identified above, namely the lack of education, low availability of opioid 
medications and scarce resources.
40,49,63,64
  
The increasing overlap in the remit of conditions that specialists working in palliative care 
and chronic pain management are treating, has strongly informed my research, which 
incorporates the critical evaluation of both these areas of practice. This overlap is 
especially pertinent with respect to opioid medications, the medical use of which I discuss 
in detail in the following section.  
1.3.3 Opioid Medications 
In terms of global pain management improvement initiatives, as I outlined above, there is a 
huge focus, particularly from within the field of palliative care on improving access to 
opioid medications. 
The Single Convention on Narcotic Drugs, 1961,
34
 provides guidance for the legislation of 
the use of opioid medications by governments broadly overseen by the International 
Narcotics Control Board (INCB).
65
 Individual countries are obliged to report their yearly 
consumption of such medications to the INCB. Based on this data, the INCB estimates that 
92% of the world’s morphine is consumed in countries where 17% of the world’s 
population lives – essentially in high-income regions such as North America, Western 
Europe, Australia and New Zealand.
66
 Studies have also demonstrated a strong link 
between national levels of opioid consumption and Human Development Index.
60,67,68
 
Despite multiple initiatives to improve this imbalanced access and recent increases in the 
total use of opioids across the world, these increases have largely been due to increased use 
in high-income countries.
68
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The reasons for the low use of opioids in low and middle-income countries has been 
extensively researched and discussed. Despite specific reference in the Single Convention 
preamble of the need to ensure access to controlled substances for medical use, in many 
countries an imbalance has resulted from overly stringent legislation aimed at controlling 
illicit use. Overly complex and restrictive legislation at national or a more local level has 
been cited as a key barrier to access.
68-70
 Over stringent legislation is, however, not the 
only barrier to access. Reduced availability of medications is frequently a problem with 
many countries reporting an absolute absence of certain opioid medications, as well as 
variable supply within pharmacies and healthcare institutions.
69
 Further problems include 
the paucity of resources within the healthcare system and difficulties for individual patients 
purchasing medication.
68,71
 A lack of local financial resources is compounded by the 
reported increased costs of opioid medications in lower income countries.
72
 Finally, there 
are many reports of problems related to a lack of knowledge, leading to clinicians and 
patients being reluctant to prescribe and take opioids due to fears of addiction and physical 
side effects.
68,73
  
These key barriers to opioid access, namely poor availability, inappropriate policy and low 
levels of knowledge, have been described repeatedly since they were initially published in 
the WHO’s document Cancer Pain Relief in 1996.30 Numerous organisations are involved 
in addressing these barriers including several United Nations bodies besides the WHO,
69
 
the European Association for Palliative Care (EAPC), Help the Hospices, Human Rights 
Watch, the IAHPC, the Open Society Foundation, the PPSG, the Union for International 
Cancer Control and the WPCA.
59
 Their work has resulted in many highly publicised 
initiatives such as the Global Opioid Policy Initiative, the Access to Opioid Medication in 
Europe project and the Global Access to Pain Relief Initiative.
59
 These operate alongside a 
plethora of national and local projects, and other initiatives carried out outside of the 
palliative care community. Despite this remarkable body of work which now includes a 
UN Sustainable Development Goal
74
 and a Lancet Commission,
3
 a lack of access to 
opioids remains an immense problem in low and middle-income countries.  
Several issues are notable by their absence in many of these studies. For example, the 
focus on the treatment of acute pain is limited. Although the problem of the under 
treatment of acute pain is highlighted by some authors,
23,40,49,75
 is specifically cited in the 
2012 WHO briefing note
1
 and is the subject of the IASP’s 2017 advocacy initiative, 
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entitled ‘Global Year Against Pain After Surgery’,54 these voices are in the minority. 
This is particularly noteworthy because, as I explained above, acute pain is generally 
considered to be very treatable within a western medical paradigm by using, alongside 
other modalities, opioid medications.
76,77
 Furthermore, the incidence of undertreated acute 
pain is reported to be unacceptably and avoidably high.
1,23,40,49
  
Similarly, there is little attention given to the problem of managing chronic, long-term pain 
that is not associated with terminal disease. I highlight this with particular reference to the 
expanding remit of palliative care because it is associated with another fundamental issue 
that is frequently absent in many of the discussions surrounding increasing access to 
opioids, namely, the contested nature of the use of opioid medications to treat chronic pain 
that is not caused by terminal illness.
78,79
 While a minority of individuals may benefit, 
there is a lack of population-based evidence of long-term effectiveness and indeed 
evidence for the risk of harm, of the use of opioid medications in chronic pain not 
associated with terminal disease.
31,80
 Furthermore, although highly contentious, the widely 
publicised problem of prescription opioid abuse in North America has been, at least in part, 
attributed to over zealous prescribing of opioids to treat chronic pain in patients who are 
not suffering from terminal disease.
81
 Some consider this to be fuelled by calls from within 
the medical community to recognise pain as being ‘the fifth vital sign’, and as such, 
requiring routine measurement and recording by nursing staff, alongside patients’ pulse, 
blood pressure, temperature and respiratory rate.
81
 This perception of many physicians that 
opioids are at risk of being over prescribed has led to the creation of national guidance in 
several countries in an attempt to limit their medical use in chronic pain,
82,83
 and a call 
from the American Medical Association to cease recommending the assessment of pain as 
a vital sign.
82,84
  
While there are concerns among some clinicians that the epidemic of opioid abuse in North 
America will be replicated across the world if availability is increased
81
 this is not a 
universally held opinion. For example, despite the recent rise in prescriptions of opioids in 
the UK, this country has not seen the same rates of addiction and misuse as those of North 
America.
79
 This has been attributed to differences in the culture and structure of their 
healthcare systems.
85
 For example in the UK with its National Health Service one general 
practitioner monitors each patient’s care, by contrast in the USA a similar patient may have 
access to multiple independent prescribers. Furthermore, unlike in the UK, the 
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pharmaceutical industry markets directly to both patients and professionals in the USA 
where different combinations of opioid medication prescriptions are seen.
79
 Even the 
International Narcotics Control Board states that increasing patients’ access to opioids does 
not equate to an increase in abuse.
66
  
When considering this debate in conjunction with the current global initiatives advocating 
for increased access to opioid medications from within a field of palliative care that has an 
expanding remit to treat all patients regardless of their underlying medical conditions, I 
propose that a number of concerns follow. For example, although current guidelines that 
recommend limiting the use of opioids in chronic pain are well publicised amongst 
specialists working in this field it is conceivable that those working in other fields such as 
palliative care will be less familiar with their content. There is therefore the potential for 
some patients with chronic pain not associated with terminal disease, if treated under the 
remit of palliative care, to receive opioid medications that are unlikely to provide them 
with pain relief and have the propensity to cause harm. In countries with low levels of 
healthcare infrastructure and multiple private healthcare providers, the chance of the failure 
of medical professionals to keep in contact with such patients to monitor for side effects or 
problematic use, including diversion of opioids to other individuals, are likely to be high. 
Furthermore, I propose that the failure of many initiatives to discuss the complexities of 
these issues in combination, may contribute to resistance from some medical professionals 
to increase the use of opioid medications where they are likely to be of benefit to patients. 
Since the creation of the first multidisciplinary pain clinics as well as the hospice 
movement in the 1950s, the need to treat pain, regardless of its underlying cause, 
employing a holistic approach has been recognised.
19
 Furthermore, the use of treatments 
besides opioids including interventional techniques such as nerve blocks are specifically 
described as being useful for the treatment of pain in low-resource settings.
75,86-88
 Another 
potential weakness of the focus of global initiatives on opioid treatments is their failure to 
address low availabilities of other treatment modalities, which is especially pertinent when 
considering patients who are suffering from painful conditions that may not respond opioid 
medications. There is a paucity of data relating to the global provision of non-
pharmacological treatment modalities including interventional procedures, although some 
work has been undertaken in relation to non-opioid pain relieving medications
89
 often 
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through initiatives to improve access to the whole of the WHO Model List of Essential 
Medicines.
36,90
 
1.3.4 Politico-legal Perspectives 
A seminal meeting held in Geneva in 2004 marked the beginning of an increasingly 
prominent movement describing pain relief in terms of human rights. Conveners of the 
meeting, entitled a ‘Global Day Against Pain’, sponsored by the IASP, the WHO and 
European Federation of the IASP Chapters, boldly declared through the subtitle that ‘The 
Relief of Pain Should be a Human Right’.51 Key features of this day included highlighting 
the prevalence of chronic pain, its effects on individuals and wider society, the need to 
engage public policy makers, to educate healthcare workers and to discover new 
treatments. In 2008 a declaration from the WPCA and the IAHPC broadened this remit to 
incorporate access to palliative care in their Joint Declaration and Statement of 
Commitment on Palliative Care and Pain Treatment as Human Rights.
91
 There is a 
noteworthy change in language here from talking of ‘pain relief ’ to ‘pain treatment’ (my 
italics), the implication being an acknowledgment that not all pain can be relieved. As well 
as describing the scale of the problem of poorly treated pain, a need for improved 
education, national policy change and access to opioid medication is given particular 
recognition. The declaration also describes the specific legal arguments for describing 
access to pain treatment and palliative care within a human rights framework, quoting two 
key UN declarations, namely the 1948 Universal Declaration of Human Rights
92
 and the 
1966 International Covenant on Economic, Cultural and Social Rights,
38
 that together 
describe the right to health and the right to freedom from torture.  
In 2010, the IASP convened an International Pain Summit with representatives from 
numerous countries and organisations resulting in the publication the Declaration of 
Montreal.
93
 This declaration again describes access to pain management as a human right, 
and includes a description of the need to treat acute pain, pain from terminal disease and 
chronic pain; and to address the issues of education, opioid access and policy reform. Other 
similar declarations urging for access to pain management to be considered a human right 
have followed such as the Lisbon Challenge from the EAPC,
94
 and the Morphine 
Manifesto from Pallium India, the IAHPC and the PPSG.
95
 Access to pain management has 
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also featured as a resolution of the World Medical Association, and has been a feature of 
several UN initiatives including through the Human Rights Council, the UN Commission 
on Narcotics Drugs, a 2016 UN General Assembly Special Session and the WHO.
96
 In 
2009, the American based non-governmental organisation Human Rights Watch also 
championed the cause, by publishing its emotionally provocatively titled report “Please, 
do not make us suffer anymore…”Access to Pain Treatment as a Human Right.97 Although 
little is known of their efficacy, there have been an increasing number of declarations 
across the world since the 1980s, now numbering more than 30, calling for improved 
access to palliative care, within which the most frequently highlighted issues are the need 
for more education, policy change and access to pain relief.
98
  
A detailed critique of the use of a ‘rights based’ approach as an advocacy tool is beyond 
the remit of this thesis, however, I briefly outline two potential themes of debate. Firstly 
the medico-legal implications for professionals treating patients in pain can be 
controversial, particularly in the USA, with clinicians describing a tension between the 
obligations to treat pain and to comply with increasing professional guidance related to 
concerns about over-prescribing of opioid medications.
99
 Secondly, and at a much more 
fundamental level is a critique of the use of human rights per se as a global advocacy tool. 
A prominent theorist here is Stephen Hopgood who argues in his 2013 text The Endtimes 
of Human Rights,
100
 that the Human Rights movement (note the capitalisation) has become 
a western neoliberal tool of moral authority. He argues that although the underlying 
sentiment of an individual declaration that a particular issue should be considered a human 
right may be entirely laudable, embedding such declarations within the largely western 
dominated UN led Human Rights movement can act against local uptake of the 
declaration, particularly in certain situations or political regions. Tied up with this idea is 
the concern that the very action of describing an issue as a Human Right deems the issue to 
be of such moral certainty that it is placed beyond debate. Furthermore, Hopgood argues 
that rather than searching for a one-size-fits-all approach to issues of human rights in the 
form of UN sanctioned global declarations, we should be championing local solutions 
created by local citizens.  
The description of the right to receive medical treatment for painful conditions reinforces 
the argument that pain is a medical problem to be fixed. Despite the shift from the earliest 
descriptions of pain relief being a human right, to access to pain treatment, implying 
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limitations to western medicine’s ability to cure pain; in 2016, the WPCA’s theme for its 
World Hospice and Palliative Care Day was ‘Living and dying in pain: it doesn’t have to 
happen’.101 While, from within the field of palliative care, with a focus on treating pain 
from terminal diseases this advocacy sounds entirely laudable and rational, I argue that the 
generalised wording of the statement could be interpreted as implying that all pain, 
regardless of its cause, can be cured, which demonstrably is not the case. 
Another recurring theme across the medical fields of both palliative care and chronic pain 
management is the framing of each of these areas of healthcare as public health issues. As 
early as 1990, the WHO described the need to improve cancer pain management within the 
field of palliative care as a global, public health concern.
102
 The description by the WHO 
of how access to palliative care can be improved at a global level evolved to become the 
WHO Public Health Strategy for Palliative Care.
103,104
 The final iteration published in 2007 
by Stjernsward and colleagues (Figure 1-1) has become a widely cited model and again 
includes the three key themes of drug availability, education and policy, as well as the need 
to consider implementation strategies. 
 
Figure 1-1 WHO Public Health Model
104 
(Permission to reproduce this diagram has been granted by Elsevier) 
Many others have described palliative care as a public health concern
105-107
 and textbooks 
have been devoted to the topic.
108,109
 Although frequently presented as a common sense, 
logical approach to the increasing prevalence of diseases, the combining of these two 
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spheres of medicine is complex. As I explained in the previous section of this chapter, 
the definition of palliative care is debated and there is a similar lack of clarity on the 
meaning around the term ‘public health’ within the palliative care literature.110 In a recent 
study prompted by these issues, Dempers and Gott identify three key partially overlapping 
public health paradigms that are described within current palliative care literature, namely: 
a WHO model focussing on service provision and integration into national healthcare 
schemes, a health promotion approach, and a population based epidemiological 
approach.
110
 Interestingly, despite the popularity of the WHO model, Dempers and Gott 
show that the health promotion approach which prioritises notions of social capital, 
community empowerment and a de-medicalised approach (my italics) is the most 
prominent paradigm in the literature. 
There is also a call from within the medical profession to consider chronic pain that is not 
associated with terminal disease to be a public health issue,
111
 although this is perhaps less 
prominently championed by high profile organisations than the corresponding descriptions 
of the public health approaches to palliative care. Authors highlight the high prevalence 
rates of chronic pain (of around 20%) as well as the costs to individuals and the wider 
society resulting from the incapacity of sufferers.
111,112
 A key theme highlighted in these 
descriptions is the inherent complexity of this type of pain and the resulting deficiencies of 
the frequently used western, biomedical model which aims to cure causative disease rather 
than to prioritise symptomatic treatment.
40
 Advocates of adopting a public health approach 
describe the need to look beyond increasing the availability of current models of healthcare 
delivery, including specific treatments such as opioid medications, to address the much 
more complex issues of socio-economic disadvantage that are associated with sufferers of 
chronic pain.
111,113
  
Interestingly, mirroring these descriptions of pain as a public health topic are concerns 
surrounding the over use of treatments. Particularly in the USA, the scale of problematic 
misuse of opioid prescription medications has led to this phenomenon also being described 
as a public health issue.
114
 A recurring theme in the descriptions of both the treatment of 
chronic pain and issues related to opioid over use as public health problems is the need to 
address healthcare policy.
111,112,114
  
Chapter 1 
 
35 
When considering global pain management initiatives, a significant amount of policy 
related work has focussed on the detail of modifying national level legislation to improve 
access to opioid medications, a key body of work being that of the PPSG at the University 
of Wisconsin and their policy fellowships.
115-117
 This specific area, however, is an 
exception, with the wider issues around improving access to all aspects of pain 
management and treatments other than opioids being far less well described in terms of 
policy. In particular, despite the extensive literature from the wider field of healthcare 
policy exploring the complexities of policy creation and implementation, there is a paucity 
of cross-disciplinary research.  
In this opening section I outlined the key assumptions in the field of global pain 
management that remain largely unexamined within this literature. Pain is framed as a 
problem that should be treated within a western medical model and access to this medical 
therapy is widely described as a human right. The need to increase awareness and 
education of the concept that pain is medically treatable is an important part of many 
advocacy projects. Education is also aimed at increasing others’ knowledge of the use of 
treatment strategies particularly the use of opioid medications. The majority of advocacy 
work aimed at improving access to pain treatments has originated within the field of 
palliative care. While not surprising perhaps, due to the evocative nature of descriptions of 
patients dying in unnecessary pain, it is also problematic. Patients suffering with acute, 
short-term pain are often not included in these projects. The definition of palliative care is 
becoming more contested due to the speciality’s evolving remit to encompass a widening 
range of medical conditions and to instigate palliative care at an earlier stage of patients’ 
illnesses. The increasing overlap with medical specialties treating patients with chronic 
pain not associated with terminal disease, the frequent failure of medical science to reliably 
and consistently ameliorate this type of pain, and the debates surrounding current 
treatments strategies further complicate efforts to improve pain management at a global 
level. Similarly, the overly narrow, although understandable focus on increasing 
availability of one specific treatment, namely opioids, is problematic due to the highly 
publicised debates surrounding their use in the treatment of chronic pain not associated 
with terminal disease, and the need to address low levels of access to other therapies. 
Finally, altering and implementing healthcare policy are widely cited goals. The 
complexities of policy creation and implementation, however, as well as the contested 
nature of the issues above that inform these processes are rarely acknowledged. I argue that 
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the lack of appreciation of the assumptions being made and the debated nature of each of 
these issues, namely education, clinical treatment and policy, are at least partly responsible 
for the lack of progress. In the following section I discuss how these issues play out in the 
Indian context. 
1.4 The Case of India 
India is an example of a country where pain management is described as particularly 
problematic.
2
 Multiple advocacy projects aiming to improve pain management have been 
led by teams both within and outside the country,
2,118
 it is the site of several WHO 
collaboration projects
119,120
 and has been the subject of a Human Rights Watch 
campaign,
121
 but progress has still been limited. Reflecting the global picture, most 
projects originate from within the palliative care community and largely focus on 
improving access to morphine. Furthermore, within India palliative care is a growing 
medical specialty, and the fields of chronic and acute pain management are expanding, but 
as these specialties find their feet in the competitive market that is the Indian healthcare 
system a unique set of complexities is arising.  
1.4.1 Healthcare in India 
At the time of writing India is classified by the World Bank as a lower-middle-income 
country
122
 with an estimated population of over 1.3 billion, 18% of the world’s total 
population.
123
 The immense size of the country with its vast regional socioeconomic and 
cultural diversity often leads to India being described as a continent rather than a single 
nation. India has a disproportionately high burden of disease for its population
124
 and 
despite recent improvement, rates of malnutrition, maternal and child mortalities and 
infectious diseases remain high.
124,125
 Further adding to the disease burden is a rising life 
expectancy and an increasing prevalence of non-communicable conditions such as heart 
disease, chronic lung disease, diabetes and cancer.
125,126
 India’s health ratings are the 
lowest of the comparable BRIC (Brazil, Russia, India and China) nations
127
 and in some 
measures it is falling behind its neighbours Bangladesh and Nepal, despite recent economic 
growth.
124
 Clearly, the issues related to healthcare delivery in such a context are 
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profoundly complex and a detailed description and analysis are beyond the scope of this 
thesis. I outline, however, some of the salient issues, namely resources in healthcare, 
plurality of service provision and regulation of practitioners.
 
Despite numerous government initiatives to improve healthcare provision in India, 
universal healthcare coverage is far from being realised.
124
 Government provision of health 
services is grossly underfunded, with the latest available figures from the World Bank 
showing public expenditure on health remaining one of the lowest in the world at less than 
1.5% of Gross Domestic Product.
128
 Furthermore, the majority of healthcare is provided by 
the private sector, even to the poor and those living in rural areas.
124,129
 Across the 
population, rates of healthcare insurance are very low, resulting in most individuals paying 
out-of-pocket for treatments
129
 and pushing millions of Indian citizens into poverty each 
year.
124
 Government insurance schemes aimed at addressing this problem have largely 
been targeted to those living in extreme poverty and have shown little impact.
124,130
 The 
scarcity of financial resources within healthcare is echoed in the scarcity of human 
resources, with numbers of trained healthcare staff, including doctors, nurses and midwives 
reported to be around a quarter of that recommended by the WHO.
131
 The lack of 
personnel is further exacerbated by the ‘brain drain’ of trained staff who choose to relocate 
to more affluent countries.
131,132
 Compounding the scarcity of both financial resources and 
personnel is the unequal distribution of these entities across the country and between 
particular groups. The resulting inequities of service provision and outcome are profound 
and have been the subject of multiple studies and improvement initiatives. They include 
discrepancies between socioeconomic status, male and female populations, different castes, 
and between rural and urban areas.
124,133
 Furthermore, each of India’s 29 states and 7 union 
territories, has its own jurisdiction over healthcare leading to gross inequality in the 
provision of healthcare, and reflected in health outcomes across the country.
124,134
 
As well as significant variation in distribution of the limited resources, the actual clinical 
care that is delivered between different institutions varies enormously, with different 
providers in the same city simultaneously delivering corporate funded, state of the art 
interventions which attract increasing numbers of health tourists
135
 while government 
clinics fail to cope with the number of patients attending for the most basic levels of care. 
There is also a huge range of healthcare on offer to patients. Alongside physicians trained 
in western medicine, known as allopathic doctors, large numbers of practitioners offer the 
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non-biomedical therapies of ayurveda, yoga, unani, homeopathy and amchi. Known 
collectively by the acronym AYUSH and often funded by the government, these 
practitioners make up an estimated 9% of the Indian healthcare workforce.
131
 Complicated 
by a weak primary healthcare system
124
 which would ideally help guide patients to the 
most appropriate specialist practitioner, the range of choice of healthcare providers 
presented to society is enormous. 
Across the board, encompassing the fields of allopathic medicine and AYUSH, private and 
government funded institutions, at the levels of service delivery and university training, 
healthcare is weakly regulated.
124,131
 In 2010 the president of the Medical Council of India 
(MCI) was arrested on bribery charges and the very existence of this body, designed to 
uphold high standards of education and training within allopathic medicine, is currently 
under question.
136,137
 Reports of practitioners falsely claiming qualifications, high rates of 
absenteeism, poor quality services, irrational use of investigations and treatments, financial 
kickbacks for referral and other corrupt practices are widespread, and needless to say result 
in low levels of public trust in the medical profession.
124,129,131,133,138
 
1.4.2 Pain Management and Palliative Care in India 
The first western style palliative care institutions were established in India in the 1980s and 
90s, notably the Shanti Avedna Hospice in Mumbai, and the contrasting model of the Pain 
and Palliative Care Society (PPCS) in Calicut, Kerala.
139
 Much of the early work in this 
field was driven by UK based charitable organisations which ran educational programmes 
for Indian clinicians both in India and in the UK.
140
 Services began to expand and numbers 
grow and the Indian Association of Palliative Care (IAPC) was founded in 1994, with 
significant input from Jan Stjernsward, the then Chief of Cancer and Palliative Care at the 
WHO.
141
 The IAPC although initially made up largely of anaesthetists with an interest in 
pain management has always had a strong emphasis on the need to address pain 
management from a multidisciplinary perspective and continues to embrace this 
philosophy. Its membership has grown to well over 1000 members, many of whom are not 
doctors.
142
 Education in palliative care has also grown, culminating in the creation of the 
first MCI approved MD (post graduate medical training) programme in palliative medicine 
at Tata Memorial Hospital in 2012.
143
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In 2008, McDermott and colleagues published a report on the state of palliative care 
services in India as a part of the work of the International Observatory on End of Life Care, 
at Lancaster University, to map the level of palliative care delivery across the world.
118
 The 
study identifies 138 hospice and palliative care institutions in 16 states and union 
territories, leaving 19 with no identifiable services. However, the vast majority of these 
services are located in one region, the southern state of Kerala, with most of the others 
concentrated in urban areas. The PPCS of Kerala, founded in the 1990s has seen 
phenomenal growth over the last quarter century and has evolved into a unique and widely 
celebrated palliative care service. It has been the driving force behind two WHO 
collaboration projects, one based at the Institute of Palliative Medicine in Calicut and the 
other at the Trivandrum Institute for Palliative Sciences led by MR Rajagopal,
141
 and has 
led to the development of the Neighbourhood Networks in Palliative Care (NNPC) 
project.
144
 The NNPC, run by Suresh Kumar, is a community led scheme, where patients 
identified by locally trained volunteers as being in need of care, are referred to medically 
trained practitioners.
144
 Key to this model is the prominent role of the local community in 
channelling medical care through assessment of need. This is in clear contrast to a western 
medical model wherein professionals control and direct care according to clinical 
diagnosis. The NNPC, funded through community donations and government support, now 
runs over 200 clinics, has over 10,000 volunteers, and is estimated to provide care to over 
60% of the state of Kerala. Patients are treated according to their need or suffering, 
regardless of their underlying medical condition.
145
 
Despite the growth of services, increasing interest in the medical speciality of palliative 
care and pockets of outstanding care delivery such as in Kerala, many describe the 
provision of palliative care across the country as grossly inadequate with care only 
reaching an estimated 1% of the population.
141
 A series of projects has aimed to map the 
global delivery of palliative care, classifying countries by their level of service provision, 
ranging from no known service provision (level 1) through to integration into main stream 
healthcare services (level 4).
57,146
 The latest iteration classifies India as 3b with 
‘Generalised palliative care provision; containing pockets of clinical and educational work 
but lacking widespread coverage’.146 Furthermore, the Economist Intelligence Unit’s 2015 
Quality of Death Index, ranks India 67 out of 80 countries surveyed.
58
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At around a similar time to the initiation of palliative care services in India, chronic pain 
clinics were also commencing.
147
 There has been a growth in interest in India over the last 
25 years in the medical profession’s treatment of chronic pain alongside the growth of the 
field of palliative care. It is also important to note, however, that some palliative care 
organisations, a clear example being Kerala’s NNPC programme, treat patients with pain 
and other symptoms that are not associated with terminal disease. This demonstrates the 
practical overlap that occurs at times between these two areas of medical specialisation in 
the Indian context. The Indian Society for Study of Pain (ISSP) was founded in 1984 and 
became recognised as a chapter of the IASP in 1987. Annual conferences have been held 
since its inception and the society now has 13 state chapters and 10 city branches.
148
 In 
contrast to the IAPC, the ISSP has maintained an emphasis on leadership from within 
clinical medicine with at the time of writing, only doctors permitted to be full members of 
the organisation. In contrast to palliative medicine, pain medicine, despite calls from 
specialist practitioners is yet to achieve recognition as a specialty from the MCI in the form 
of a dedicated MD programme.
149
 
The provision of pain management in India outside the remit of palliative care is scarcely 
documented and large-scale mapping projects and rankings such as those described above 
have not been published. However, a recent epidemiological study reports the prevalence 
of chronic pain (of any cause) in India as 13% resulting in significant disability, the 
commonest reported problems being joint pain and headache.
48
 Pain is one of the 
commonest reasons for patients to seek medical advice
150,151
 and according to the Institute 
for Health Metrics and Evaluation, back and neck pain is the second commonest cause of 
disability.
125
 Although official numbers of pain clinics are not documented, provision is 
described as being far below that needed to treat all patients in need, particularly in 
government funded settings and outside large urban conurbations.
152,153
 Short lived acute 
pain such as following surgery or trauma is also described as an undertreated 
problem,
154,155
 with few specialist acute pain services reported to be in operation.
156,157
 
The barriers that contribute to the low level of provision of pain treatments (whether within 
or outside of palliative care) are reported remarkably consistently. These barriers include a 
lack of resources, particularly in rural areas.
118,156,157
 Education is also reported to be a 
fundamental problem. Specifically, there are low levels of understanding regarding the use 
of basic pain treatments,
62,141,158
 and an absence of formalised, coordinated postgraduate 
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programmes and national clinical practice guidelines.
119,159,160
 A need to improve policy 
is also noted but this is mostly described within the context of improving palliative care at 
a national level and even more specifically to improving access to opioid medications.
2,141
 
Despite enormous efforts to create a national policy for the provision of palliative care 
services in India, only fragmented implementation in certain states has occurred.
141
  
Mirroring global initiatives, the vast amount of the work aimed at improving pain 
management in India has focused on improving access to opioid medications in palliative 
care. However, a notable few have described the need to increase opioid availability for the 
treatment of acute pain.
156,157
 The low levels of availability of such medications in India 
have been highlighted in numerous high profile studies and initiatives including the Global 
Opioid Policy Initiative
2
 and the Human Rights Watch report Unbearable Pain: India’s 
Obligation to Ensure Palliative Care.
121
 The problem of low availability of opioids in 
India is made all the more poignant by the country being a key exporter of medicinal 
opioids across the world.
73
 Further complications occur with widespread reported problems 
of poor quality pharmaceutical preparations
161
 as well as complaints about pharmaceutical 
companies encouraging the use of expensive formulations that are in practice put beyond 
use for the majority of the population.
162
  
Other widely described barriers that contribute to the low levels of access to opioids in 
India can be considered under the familiar themes of education and policy. Fears of 
addiction, diversion and other side effects are common amongst the medical profession and 
the public, and many clinicians lack clinical experience in using such medications.
73
 
Legislation surrounding the use of opioids in India is particularly complex and is further 
impacted by different regulations operating in each state and union territory. The Narcotic 
Drugs and Psychotropic Substances (NDPS) Act introduced in the 1980s, with it highly 
bureaucratic policies and associated penalties including prison sentences for breaking its 
rules, is considered to be responsible for the steep decline in opioid consumption seen in 
the 1990s.
2
 The government subsequently permitted a set of simplified rules but many 
states failed to adopt this new ‘model rule’. Following years of advocacy work, the Indian 
government finally approved a modified NDPS Act placing legislation creation with 
central government in 2014.
141
 How this will affect the use of opioids across the country 
remains to be seen.  
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To recap, as is the case across the world, particularly in low and middle-income 
countries, pain in India regardless of its cause is widely described as a medical problem 
that is grossly undertreated. Most of the efforts to increase the provision of pain 
management originate from the palliative care community and focus on increasing 
patients’ access to opioid medications. Palliative medicine and pain medicine are medical 
specialities with a growing number of clinicians and care providers but both are in their 
relative infancy. There are examples of significant overlap in the medical conditions 
treated by chronic pain and palliative care specialists. Barriers to the improvement of pain 
management, alongside poor access to opioids, include a lack of resources, low levels of 
education, and inadequate policy. Many high profile organisations at a global level and 
within India have tried to address these barriers but success has either been limited or 
restricted to isolated examples. The underlying assumptions and limitations of this framing 
of pain as a medical problem, how this relates to barriers to progress, recommended 
improvement strategies, and their associated controversies, are rarely, if ever, discussed in 
the published literature.  
In the following section I describe in more detail the key published studies relating to the 
provision of pain management in India and explain how my research compares, contrasts 
and ultimately enhances the evidence base in this field. 
1.4.3 Key Studies  
As I outlined above the large scale international projects examining data in this field have 
largely focused on the provision of pain treatment within a palliative setting and on the 
availability of opioids. These include, reports from the International Observatory on End of 
Life Care (IOELC) at Lancaster University and Human Rights Watch (HRW), the work of 
the Global Opioid Policy Initiative (GOPI), a series of global mapping projects and the 
Economist Intelligence Unit’s Quality of Death Index. Much smaller scale projects, 
conducted by the IASP and individual researchers, have attempted to describe some of the 
provision of pain management services beyond only the remit of palliative care. Their 
inclusion here, despite their small scale, in stark contrast to the palliative care reports, is a 
reflection of the paucity of research in this field. I now consider these studies in turn, 
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describing the basic methods used, their aims and outcomes, and limitations before 
comparing my own study to those already published. 
All of the palliative care reports listed above, from the IOELC, HRW, GOPI, the Global 
Atlas of Palliative Care at the End of Life and the Quality of Death Index include data and 
descriptions of service provision in India as a part of global projects. In general, they are 
large, multi-centre projects with numerous contributors, authors and high profile funders. 
Furthermore, there is significant overlap in the data used to compile each of these reports 
with much cross referencing of data and use of the same sources. In contrast, the surveys 
published from the IASP and those detailing the provision of acute pain treatment are 
much smaller in scale and ambition, and present only primary survey data. 
The IOELC’s India Country Report118,163 sets out a detailed picture of the provision of 
palliative care, incorporating data from multiple sources including demographic and 
epidemiological, published and grey literature, ethnographic field work and qualitative 
interviews. The report lists, state by state, the number and types of palliative care services 
identified, data of opioid consumption, as well as descriptive passages focusing on the 
perceived barriers to providing care, with particular examples of improvement initiatives. 
Central to this work is the use of oral history interviews from those working in the field of 
palliative care, many of whom are high profile pioneers in the field, but interviews with 
junior nurses and volunteers are also sources of data. It is important to note the emphasis 
given in this report to expert opinion. 
I describe the IOELC’s India Country Report in some detail because, together with the 
other country reports, it forms the basis of several key publications. In 2006, commissioned 
by Help the Hospices, and the National Hospice and Palliative Care Organization, the 
IOELC created a global map of the state of palliative care delivery.
57
 In this map, a 4 level 
classification system is described with each country designated as having a particular level 
of palliative care development ranging from 1- ‘no activity yet identified’, through to 4 – 
‘approaching integration’. This global mapping project has continued with an updated 
dataset (supported by the WPCA) published in 2013.
146
 This latest version of the 
classification system has been further refined to contain 6 categories, with classes 3 and 4 
each subdivided. In this report, India is classed as 3b - having ‘generalised provision’. The 
data has also been incorporated into the 2014 publication Global Atlas of Palliative Care at 
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the End of Life supported by the WHO,
53
 with the key addition of estimates of the global 
need for palliative care derived from disease prevalence rates.  
The Economist Intelligence Unit’s 2015 Quality of Death Index,58 commissioned by the 
Lien Foundation, ranks countries according to their provision of palliative care. Originally 
published in 2010 with 40 countries, the latest version now ranks 80 nations according to 
five categories: ‘palliative and healthcare environment’, ‘human resources’, ‘affordability 
of care’, ‘quality of care’ and ‘community engagement’. It also estimates the need for 
palliative care using estimates of disease burdens and predictions of aging within each 
population. With comparable methodology to the IOELC based maps, the Quality of Death 
Index uses multiple data sources to compile the ranking scores, drawing on published 
research, widely available healthcare data and key informant expert interviews. The index 
leans heavily on the key concepts I outlined above, such as: the idea that pain is a medical 
problem, that education needs to be improved, that there is a need to assess healthcare 
policies in relation to palliative care and that access to opioid medications is considered the 
principal treatment strategy. It is perhaps not surprising therefore that the country ranked 
number one, the UK, is the very country where palliative care first originated, a country 
strongly associated with the model of palliative care that is lauded in the Quality of Death 
Index. Of note, one of the key markers in the quality of care section is the availability of 
opioid medications, which is ranked from 5 – ‘freely available and accessible’ to 0 – 
‘illegal’. Overall, India is ranked as 67 out of 80 countries and whilst there is some detail 
contained in the report including descriptions of successful projects such as those in 
Kerala, recent changes to the narcotics laws and interview extracts from key local experts, 
there is considerably less detail here than in the IOELC’s report, with an emphasis on 
quantitative data and the use of a numerical weighting system to rank care. 
A final report that I want to include in this section although rather different in its structure 
and methodology to those outlined above, but important in its role as an advocacy tool, is 
the HRW Report Unbearable Pain: India’s Obligation to Ensure Palliative Care.121 This 
extensive document published in 2009 describes in emotive terms a picture of grossly 
inadequate palliative care service provision for the vast majority of citizens in India. Not 
surprisingly, given the charity’s name, Human Rights Watch, these deficits in healthcare 
are described in terms of human rights violations, namely the right to health, as well as the 
prohibition of torture and ill treatment. The report includes key recommendations to 
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influential groups including the Indian and state governments, the International Narcotics 
Control Board and the Medical Council of India. Again the report heralds the need to focus 
attention on policy, education and opioid drug availability, all of which are discussed in 
detail with specific recommendations for action. The report combines evidence from 
interviews with patients and key workers in the field of palliative care collected on field 
visits, with other more disparate data retrieved from desk based study. The research 
concentrates on four states and Delhi, chosen due to their varying levels of service 
provision as well as their location. A chapter is dedicated to patients’ stories, with 
contrasting descriptions of personal experiences before and after access to treatment. There 
is a personal and emotive tone throughout the document, with several examples of patients 
in pain and unable to access treatment, describing suicide as their only viable option. 
Added to this are strong human rights declarations calling for urgent political action. In 
this sense, the report is constructed as a partisan advocacy tool rather than as an objective 
measure of the state of clinical care in India.  
The HRW and IOELC reports, and the seminal mapping projects that have followed are 
impressive in their scope and act as valuable tools to inform improvement strategies and as 
advocacy tools. There are, however, limitations to each of these reports, which I outline 
below. 
The use of rankings and categories to stratify levels of development of care delivery as 
used in the Global Atlas of Palliative Care at the End of Life and the Quality of Death 
Index are helpful tools to guide and measure change. They are widely cited, have received 
high profile media attention and serve as important advocacy tools. Despite the breadth and 
depth of data contained in these reports, however, they inevitably have limitations. There 
are simple methodological problems that arise when such descriptions of complex systems 
are reduced to categories or numerical ratings, which are inherently reductionist. This is 
demonstrated by the fact that although several studies have carried out ranking of palliative 
care delivery in European countries the ratings produced have been inconsistent.
164
 
Furthermore, I argue that not only is it impractical to compare such disparate data sets in a 
quantitative fashion but that the concept is flawed at a more fundamental level. The 
description of service delivery at a country level, within a ranking system or as stratified 
categories of development, contains an implicit assumption that there is a single ideal 
trajectory of development that all countries should aspire to and ultimately could attain. As 
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I discuss in more detail with reference to the literature from postcolonial studies in the 
final section of this chapter, the idea that there is one single ideal is likely to be flawed as a 
model for guiding clinical service improvement at a global level. Furthermore, this ideal is 
very strongly informed by a western model of healthcare. Similarly the strong emphasis in 
the HRW report of framing access to treatment in terms of UN defined human rights 
contains a degree of western bias. 
The specific methods of these studies also have limitations and are relatively poorly 
defined in the reports with little reference to, for example, the precise manner in which 
experts are identified and interviewed. There are potential problems here with the degree of 
geographical representation especially in a country as vast as India. With the plurality of 
healthcare delivery I already describe, there are inevitable problems with ensuring 
participants from all groups are represented. Whilst efforts have been made in these studies 
to incorporate a wide range of experts, interviewees and other data sources, it is difficult to 
be sure that all relevant healthcare groups are included. This inclusion of different groups 
is particularly difficult in low resource settings but ironically due to the complexities of 
healthcare delivery it is also likely to be more revealing and important.  
Some authors have also critiqued the use of individual experts due to their bias in 
evaluating services.
164
 Whilst I support the fact that asking individuals to report in detail on 
large geographical regions and sections of healthcare is problematic, for the reasons I 
outlined above, I would question the idea that the bias of experts should or indeed could be 
removed. I would argue that describing the removal of bias of experts is to misunderstand 
the practice of clinical medicine, to conceptualise it as a purely rational scientific process 
rather than the, at least partially, socially or more specifically, professionally constructed 
entity that it is. When considering healthcare delivery and improvement strategies in 
practice, medical expert opinion is western medicine, it is not something that can be 
removed in order to reveal an underlying scientific truth, and therefore it is these opinions 
themselves that should be the object of study rather than being treated as an unwanted 
contaminant of the scientific process. I will return to this issue and the concept of the 
socially constructed nature of medicine in more detail in the final section of this chapter.  
The last key limitation I outline from this group of reports is the lack of clarity in definition 
of the sorts of painful medical conditions that are being treated under the remit of palliative 
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care. The IOELC report and associated maps do not clearly outline whether patients in 
the palliative care services are suffering from cancer, terminal diseases or any chronic 
condition. The diseases included in the estimates of need for palliative care are similarly 
unclear. The HRW report, with a clearly stated remit in its title to focus on palliative care, 
and a note that the paper is focusing on pain from life-limiting illness rather than acute or 
chronic pain not associated with terminal disease, includes a case report of a patient 
suffering with pain following a road traffic accident. As I have already outlined this lack of 
clarity is common, problematic and rarely acknowledged in these papers. Not only is there 
a lack of precision in the definitions of palliative care but also the use of opioids is 
described with little or no discussion of the controversies surrounding their use, 
particularly in the management of chronic pain not associated with terminal disease. For 
example the HRW report states “oral morphine is the drug of choice for chronic 
pain”121(p13)  which is, as I demonstrated earlier, a highly debated statement within western 
medical practice. Furthermore, there is little or no mention of the lack of availability of 
other modes of treatment.  
Each of the reports I described above specifically describes the problematically low 
availability of opioids in India and they all refer to usage data, compulsorily reported by 
each country to the International Narcotics Control Board. The PPSG at the University of 
Wisconsin collates this data into per capita data for each medication, and for each country 
and region.
115
 This extensive data set with multiple, freely available, clearly accessible 
graphical representations is an impressive resource that is widely used as an advocacy tool 
and a means of monitoring change in usage over time. Indeed, the work of the PPSG is 
used in the reports described above. There are, however, limitations with this resource such 
as inaccuracies and time delays in the reporting of data. Furthermore, the data is collected 
for the use of all opioids regardless of their use. The data therefore includes opioids used in 
anaesthesia and drug dependence substitution therapy, as well as in pain management.
165
 
Within pain management the opioids will likely be used to treat acute and chronic pain as 
well as for patients suffering from terminal disease. As I explained above, however, opioid 
consumption and accessibility data is used as a marker of quality of palliative care 
delivery, as in the Quality of Death Index. 
In an attempt to improve the understanding of the use of opioid medications in cancer pain, 
an ambitious study was published in 2013 entitled the Global Opioid Policy Initiative 
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(GOPI).
59
 Following on from a study by the European Society for Medical Oncology and 
the European Association for Palliative Care, to assess the availability, accessibility and 
barriers to the use of opioid medications in Europe, a wider global study was set up as the 
GOPI, with the assistance of the PPSG, the WHO and the Union for International Cancer 
Control. Specifically, the GOPI project sets out to assess the formulary availability, cost 
and actual availability of opioids listed as ‘essential’ by the WHO and the IAHPC, as well 
as barriers to access. Several reports are published by geographical region, but India due to 
its size and complexity earned its own detailed report.
2
 The study used a detailed survey 
tool delivered to two or more field reporters per country or state. Of note, it is not clear in 
the study report exactly how these reporters were identified, their professional role or their 
location of work. The resulting data is presented as a table of formulary availability for 24 
of India’s states, ranging from ‘always’ available to ‘never.’ The familiar barriers of a lack 
of education and appropriate policy are also highlighted. This report and the GOPI as a 
whole provide a clear and extensive picture of opioid availability, but there are inevitably 
limitations with the work. The methodology defined in the published reports in terms of 
details of the participants and their selection is limited in detail. The use of small numbers 
of informants without clear information regarding their professional roles inevitably leads 
to questions of representation of the country as a whole. The aim of the study is to assess 
the use of opioids only for the treatment of cancer pain, consequently, again, the work fails 
to address the issues of opioid use in treating pain from other medical conditions
166
 and 
indeed of the availability of other treatment modalities. 
The studies I have outlined so far focus on the provision of pain treatment, specifically 
opioids, within palliative care or even more specifically for cancer pain. As I demonstrate, 
studies relating to the provision of pain management in India from a more general and 
inclusive perspective are far fewer in number and markedly smaller in scale and ambition. 
There are no widespread mapping projects of service provision for acute pain or chronic 
pain that is not associated with terminal disease, or of treatment availabilities other than 
opioids. There are, however, some small-scale surveys relating to the management of both 
acute and chronic pain, which I discuss in detail below. To be clear, their inclusion in this 
section alongside the global palliative care projects, reflects the lack of attention given to 
these areas of pain management.  
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The IASP carried out a survey, published in 2007, to assess training and education in 
pain management, and the facilities available for delivering care, in developing countries.
62
 
The survey of the IASP members yielded 9 responses from Indian members which were 
reported as pooled data with 8 responses from other countries in the Indian Subcontinent. 
The survey identifies low levels of education in pain management at all stages of medical 
training, from undergraduate to postgraduate. The survey also describes low levels of 
service provision for the treatment of all types of pain including acute, chronic non-cancer 
pain and cancer pain. 100% of the respondents from the Indian subcontinent considered 
pain control to be a problem. The low availability of opioids is also noted although 
interestingly the use of opioids for ‘non-cancer pain’ is also included in the survey, albeit 
in little detail. Again, the barriers are described in terms of education, policy and 
medication access. There are notably low numbers of respondents in the study as a whole, 
for each region and for some questions in particular. Again, as with the previous studies I 
have outlined, the respondents act as key informants, describing the state of pain 
management across their country or region as a whole, as well as describing specifics of 
their own place of work, which for some of the data raises questions of how representative 
it is. Nevertheless, the survey does address the treatment of pain regardless of its cause, 
and the use of opioids beyond palliative care, providing some valuable data in a very 
under-researched field.  
Vijayan Ramani, a pain specialist from Kuala Lumpur, has described some summary 
findings from an ‘informal’ questionnaire within a IASP published article on acute pain 
management in developing countries.
23
 Although the methods and results are only reported 
in very limited detail, data is published from several countries including India describing: 
acute pain as undertreated, low availability of opioids, low levels of education and low 
levels of resources. 
A final survey included here relates to the provision of acute pain management in India. 
Carried out by P N Jain, a past-president of the ISSP, and published in 2015,
156
 the survey 
of anaesthetists identifies low levels of the presence of specialist acute pain management 
teams, low levels of the use of opioids and infrequent availability of clinical protocols. Yet, 
again, the barriers are identified as educational, related to opioid access and inadequate 
resources. The study has a notably low return rate of just 0.04% but with 146 responses 
Chapter 1 
 
50 
and in a field of study that is scarcely represented elsewhere in the published literature it 
is a notable piece of work. 
In this section, I have discussed the key studies, relating to the medical treatment of pain in 
India, outlining their strengths and limitations. I have showed their emphasis on 
conceptualising the treatment of pain as a medical problem and their repeated identification 
of the presence of barriers relating to treatment availability, education and policy, that are 
described as needing to be overcome. I have also demonstrated the markedly different 
degrees of attention that are given to addressing pain management depending on its cause. 
Specifically, the predominance in the literature and the scale of global advocacy projects 
addressing pain related to cancer and palliative care, and their treatment with opioid 
medications.  
The methods I use in my research have been heavily informed by each of the studies and 
their limitations as discussed in this section. I expand on findings and address areas that are 
currently under or not represented in this literature. Specifically, I choose to study 
specialists working in all fields of pain management and in particular to include those 
working outside of palliative care. I also include evaluation of access to treatments other 
than opioids. I use in depth interviews from multiple key informants specifically identified 
to represent different areas of clinical and geographic practice, and incorporate with this 
data from a wider survey of practitioners. When addressing my specific research questions 
(set out in Section 1.2) I focus on asking in detail about the delivery of care at each 
individual’s place of work where knowledge will likely be most clear and accurate. When 
considering the provision of pain management across the whole country, I include critical 
evaluation of participants’ opinions in this field. I move beyond descriptions of the 
existence of barriers, to understand their assumptions and associated controversies by 
examining the evaluations and normative positions of individual clinicians. The 
comparative Table 1-1 summarises the key studies I described in this chapter alongside my 
own research, outlining each study’s scope, aims and methods, and highlighting the 
innovative nature of this project. In the final section of this chapter I outline the theories 
that underpin this work. 
  
Project  Medical Scope Aims Methods 
India Country Report,  
International Observatory on End of Life 
Care, 2008118 
Palliative Care To quantify palliative care services operating in India 
To identify strengths and weaknesses in the state of development  
Publicly available material (published and grey literature) 
Key informant interviews 
Unbearable Pain: India’s Obligation to 
Ensure Palliative Care, 
Human Rights Watch, 2009121 
 
Palliative Care To describe the availability of palliative care services in India 
within a human rights framework 
Field visits 
Selected states (chosen for variability in pall care provision). 
Interviews – stakeholders (patients and professionals) 
Desk research on availability in other states 
Global Opioid Policy Initiative, 
20132 
Cancer Pain To describe the availability, accessibility and barriers to the use of 
opioids for cancer pain in India, and other regions 
Survey to key informants  
Mapping projects,57,146 Global Atlas of 
Palliative Care at the End of Life,  
WPCA & WHO, 201453 
Palliative Care To map of availability of palliative care services, barriers to 
improvement and global need  
Publicly available material (published and grey literature) 
Key informant interviews 
Quality of Death Index, 
Economist Intelligence Unit, 201558 
Palliative Care To describe availability of, quality of and need for palliative care 
Country ranking 
Publicly available material (published and grey literature) 
Key informant interviews 
Education and Training for Pain 
Management in Developing Countries, 
IASP, 200762 
All Pain 
Management  
To assess education, training and facilities for pain management in 
developing countries 
Survey to IASP members  
Informal survey on the status of acute pain 
management, 
Vijayan, 201123 
Acute Pain 
Management 
To assess acute pain provision of services and education/training in 
India and other countries 
Survey – details unclear 
Acute Pain Services in India: A glimpse of 
the current scenario, 
Jain, 2015156 
Acute Pain 
Management 
To assess the presence of acute pain services in India Survey of anaesthetists’ own practice in India 
This study All Pain 
Management 
To critically appraise individual clinicians’ practice of pain 
management, their evaluations and normative positions. 
Key informant interviews, and survey of clinicians treating pain 
in India 
Field visits and oral history archive 
Table 1-1 Comparative Table of Studies Detailing Service Provision of Pain Management and Palliative Care in India
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1.5 Theoretical Perspectives in the Study 
As I demonstrated above, pain is conceptualised by the medical profession as a clinical 
problem to be fixed. Not only is this approach debated both within medicine and across 
society in general, but the nature of best clinical practice within medicine is also the 
subject of controversy. In this section, I explain some of the key ideas relating to the social 
and professional construction of health, illness and medical knowledge, and how they 
relate to the subject at hand. I describe principal aspects of theories relating to power and 
the policy process that have informed this work. I conclude with a description of the 
dominance of western models in relation to improving healthcare at a global level, drawing 
on some of the main themes in postcolonial studies.  
1.5.1 Social Constructionism  
The fundamental concept of social constructionism suggests that reality is created by the 
actions and interpretations of society’s members. As Elder-Vass explains, social 
constructionism argues that “the ways in which we collectively think and communicate 
about the world affect the way the world is”.167(p4) He goes on to explain that a key attribute 
of a socially constructed entity is that, given an alternative set of social circumstances it 
could or indeed would be structured differently. This is in contrast to an objectivist 
perspective wherein entities are considered to exist independently of any socially 
constructed reality. Whilst some argue that these two ontological and their associated 
epistemological positions are incompatible, others describe social constructionists as 
positioned on a spectrum that includes radical and moderate orientations. Radical social 
constructionists argue that reality only exists as a socially created phenomenon but more 
moderate social constructionists, a group in which I include myself, consider the world to 
consist of an underlying reality that is then socially modified.
168
 Roy Bhaskar, through his 
philosophical theory called critical realism,
169
 embraces this concept by conceptualising 
the world as consisting of multiple, ‘laminated’ realities.170 He also describes the 
fundamental importance of understanding the generative mechanisms that create an 
observed phenomenon.
169
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Incorporating a social constructionist view can be used to understand multiple areas of 
healthcare including the meaning of illness within a culture, what constitutes normality or 
abnormality, individuals’ and society’s responses to illness and the creation of medical 
knowledge.
168,171,172
 When considering this research project, although particular entities 
such as healthcare workers, medications and other physical treatments exist as objective 
realities, the manner in which they act or are used is highly dependent on the social context 
in which they operate. Furthermore, critically evaluating the context in which healthcare is 
delivered is particularly pertinent when researching the use of western medicine in non-
western countries, where the sociocultural environment is different to that in which the 
medical technologies were initially devised and implemented.
171
 Furthermore, the 
conceptualisation of entities as being at least in part socially constructed, leads to 
important considerations of the power individual actors hold in society, and the role they 
play in healthcare and wider political processes.
173
 Specifically, with respect to this project, 
a critical evaluation of the power wielded by doctors and their primary role in the 
construction and application of medical knowledge is particularly relevant. As I outline 
below, this role has been the subject of considerable scholarship throughout the twentieth 
century.
174
  
Functionalists, such as Talcott Parsons, describe doctors as highly skilled individuals and 
therefore holders of significant amounts of power through their ownership and application 
of specialist, professional knowledge.
175
 Crucially, they are considered to use this power 
only in a benevolent manner. Deborah Lupton explains how functionalists consider the 
medical profession to be a “moral guardian of society”.174(p4) This is exemplified through 
descriptions of patients as ‘malingerers’ who exaggerate or fabricate illness for personal 
gain. This functionalist approach is criticised, however, for ignoring the potential conflicts 
of interest that arise between doctor and patient, and for placing doctors on an artificially 
high pedestal of morality.
174
  
In contrast to the functionalist approach, authors such as Eliot Freidson, Erving Goffman 
and Ivan Illich describe the negative effects than can result from the power wielded by the 
medical profession. Freidson in his Profession of Medicine: A Study of the Sociology of 
Applied Knowledge,
176
 first published in 1970, describes a ‘professional construction of 
illness’. In doing so, he moves away from considering medicine as a benign, benevolent 
profession, and instead describes doctors as self-serving, and the creators of diseases 
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necessitating medical treatment. He describes in detail how illness is constructed as 
doctors define the boundaries of normality, stating “it is medicine’s view of illness that is 
officially sanctioned and, on occasion administratively imposed on the layman”.176(p206) 
Similarly, in Goffman’s Asylums,177 first published in 1961, he describes how a medical 
model constructed for use in other areas of healthcare is implemented, despite being a poor 
fit, in psychiatric medicine. He explains how diagnostic labelling is used to describe 
behaviour patterns, stating, “in practice these categories become magical ways of making a 
single unity out of the nature of the patient – an entity that is subject to psychiatric 
servicing.”177(p326) In this example, doctors are defining what constitutes a disease, 
prescribing treatment, and in some cases incarcerating patients against their will in medical 
institutions.  
This notion of a professional construction of illness is particularly apt when considering 
chronic pain. Despite this condition’s resistance to medical treatment, there is, through it 
being labelled as an illness, an implication that treatment is required by a physician. As 
declared by Freidson, “The jurisdiction that medicine has established extends far wider 
than its demonstrable capacity to “cure”.”176(p251) He goes on to explain how the profession 
“seeks to discover illness of which laymen may not even be aware.”176(p252) and thereby to 
attract patients. Similarly, Ivan Illich writes, “Man has not only evolved with the ability to 
suffer his pain, but also with the skills to manage it”.178(p144) He goes on to describe the 
many methods used to treat pain before the relatively recent dominance of the medical 
profession, such as massage, acupuncture and opium.  
This perspective, sometimes described as a political economy approach
174
 also moves 
beyond the doctor–patient encounter to incorporate consideration of  the wider societal 
effects of the power wielded by the medical profession. For example, doctors seek to 
influence the political field through their professional organisations.
176
 and in doing so 
increase the amount of economic resource devoted to the delivery of healthcare.
174
 This 
contributes to the so called ‘medicalisation’ of conditions, including pain, that are, 
transformed from being considered a normal part of the human condition into treatable 
illnesses.
179
 This increasing medicalisation seen in recent decades and described with 
respect to many other conditions such as childbirth, sexuality and death,
180
 is attributed to 
multiple factors including the pharmaceutical industry, medical insurance companies, the 
medical profession, governments and the wider society.
179,181
 It is interesting to note at this 
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point, that there remains a call, albeit debated, within the medical profession for chronic 
pain to be classified as a disease,
182,183
 and within several countries, including India, for 
pain medicine to be formally recognised as a medical speciality in its own right.
13,149,184
  
Freidson also talks about the variations in opinion and different schools of thought within 
the medical profession. Whilst he acknowledges that this is to some extent obvious, he also 
states that they “by their very existence, call into question the stability and objectivity of 
the corpus of medical knowledge.”176(p263) It is interesting then to consider this perspective 
alongside the current debates within the field of chronic pain surrounding the definition of 
the condition itself. For example, the very presence of the IASP’s taxonomy185 which 
includes a list of definitions including of the phenomenon of pain itself, and of a dedicated 
working group continually revising and updating the terminology. Within the taxonomy, 
the distinction between acute and chronic pain is noted to be difficult to define with 
precision, beyond the notion that one is short-lived while the other persists. Chronic pain is 
described in a number of ways including: pain that exists beyond the time of tissue healing 
following an injury, pain that exists for a quantified length of time, and pain that is not 
relived with particular treatment strategies.
186
 The authors acknowledge that no one simple 
definition will suit all scenarios. Similarly, despite a WHO initiative to develop clinical 
practice guidelines for the treatment of acute and chronic pain, none have been published 
at the time of writing. There is, however, a description of the degree of difficulty in 
reaching consensus simply on the number of guidelines that should be written.
187
 
Definitions of palliative care are also disputed, vary across the globe and continue to 
evolve.
25
  
The political economy perspective as a model for understanding healthcare is also 
challenged from a social constructionist perspective, perhaps most notably by the French 
philosopher Michel Foucault.
174
 Foucault, in The Birth of the Clinic
188
 first published in 
French in 1963, specifically talks of how medical knowledge is created and then used by 
the medical profession to exert power. For example, he describes how a patient’s 
experience of suffering is transformed into an object of inquiry or examination, “to look in 
order to know, to show in order to teach, is not this a tacit form of violence, all the more 
abusive for its silence, upon a sick body that demands to be comforted, not 
displayed?”188(p102) Crucially, however, he explains how knowledge and the resulting 
power it enables is the product of relationships, and is therefore dynamic and changes with 
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the socio-cultural environment.
174
 When considering clinical medicine, knowledge is 
therefore inextricably linked to the patient’s experience, rather than situated entirely with 
the medical profession. For example, David Armstrong explains how Foucault 
conceptualises the voice of the patient as “an artefact of socio-medical perception.”189(p743) 
This version of reality as presented by the patient is then further reinterpreted by the doctor 
so that the “field and gaze are mutually self-supporting.”189(p743) This analysis is compatible 
with Bhaskar’s critical realism and his laminated conceptualisation of reality.  
I have explained above how the medicalisation of the problem of pain can be considered to 
be a profession construction. However, pain cannot be seen. It is a personal experience of 
the individual sufferer that is therefore inevitably modulated by the social milieu. Only the 
individual experiencing it can appreciate its nature in its entirety. Consequently, when a 
patient is seeking medical advice for the treatment of pain, there is an imperative to 
communicate the precise nature of this symptom to the clinician. Inevitably this exchange 
will result to some degree in the doctor re-interpreting and transforming the symptom, and 
even potentially under estimating a patient’s pain.173 In this sense, in line with Foucault’s 
perspective the treatment of pain is not solely a professional construction, but rather a 
dynamic social relationship influenced by many members of society - a social 
construction. It remains important, however, to acknowledge the particularly potent power 
differential between patient and doctor with the medical description and evaluation of the 
sufferer’s pain ultimately resting in the hands of the clinician. In this research project I am 
specifically considering this perspective of practicing clinicians and therefore focus on the 
professionally constructed aspects of the treatment of pain. However, I also acknowledge 
the influences of other individuals and the wider social context by critically evaluating 
these phenomena from a social constructionist perspective. 
The practical relevance of this theoretical philosophical perspective can be demonstrated 
by considering the process of medical decision-making. Variation in treatment selection 
between doctors is widely reported, and occurs within
190
 and between countries.
191,192
 The 
treatment of pain is no exception, with social and demographic variables reported to affect 
the treatments received by patients.
193,194
 Multiple factors are described as affecting the 
process of medical decision-making including: characteristics of the patient such as age, 
gender and personality; characteristics of the clinician such as specialty training, seniority, 
class and ethnicity; and characteristics of the practice setting such as its funding and 
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size.
192,195-198
 Clinicians therefore draw on knowledge received from multiple sources 
beyond the purely scientific. This includes experiential knowledge from previous clinical 
work, social knowledge from their own cultural background and the knowledge of the 
patient themselves.
199
 My research is specifically focused on the critical appraisal of 
clinicians’ normative positions and evaluative judgements, which are created by, and in 
turn influence, their wider social context. Figure 1-2 summarises these factors that relate to 
medical decision-making, incorporating wider society, the healthcare system and the 
individual actors. 
 
Figure 1-2 Social Context of Medical Decision Making 
A specific example that demonstrates the importance of understanding how clinicians 
construct, interpret and ultimately utilise knowledge is the case of evidence based 
medicine, or EBM. Fuelled by an expansion in medical research, EBM was heralded as a  
‘new paradigm’ within the practice of medicine 25 years ago.200 The idea behind the 
movement is to collate rationally derived data from scientific studies to guide the use of 
medical treatments, thereby improving outcomes for patients by ensuring they receive the 
treatments that are most likely to be effective and reducing harm by cutting the use of 
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ineffective therapies.
201
 EBM has given rise to hugely influential projects such as the 
Cochrane Collaboration, and it informs clinical practice guidance and healthcare policy. 
Since its emergence in the 1990s, however, there has been a critique of the use of EBM in 
clinical practice due to concerns over how appropriate it is to use evidence derived from 
scientifically constructed, artificial scenarios, when treating patients in real life situations 
that are inevitably complex and socially situated.
202,203
 Rather than call for an alternative 
paradigm to EBM, however, there is increasing recognition of the value of incorporating 
the science of EBM with other types of knowledge such as experiential and social
202,204
 
and to use cross disciplinary research to fully appreciate the value of EBM.
203
 Greenhalgh 
explains the need to move away from the notion that knowledge can be simply ‘translated’ 
into practice, and consider a more critical approach incorporating concepts from the social 
sciences such as notions of how knowledge is ‘created’, ‘constructed’ or ‘embodied’.205 
EBM is also widely used to inform healthcare policy.
206
 The policy process which can be, 
albeit simplistically, considered as a series of stages starting with agenda setting, moving 
to policy creation and ending with policy implementation, shares many characteristics with 
the creation and use of scientific knowledge through clinical practice guidelines. 
Appreciating the importance of issues such as the professional construction of knowledge, 
complex social networks and power hierarchies are key to understanding these processes. 
To this end I now turn to describe some of the elements of policy theory that I draw on 
throughout this thesis. 
1.5.2 Policy Theory 
As I demonstrated in the earlier sections of this chapter, the need to address healthcare 
policy in order to improve access to pain management and palliative care is frequently 
cited. The same authors, however, make minimal reference to the extensive literature base 
from policy studies.
53
 Similarly, there is, in general, a lack of detail in descriptions of how 
policies should be amended and implemented, although there are notable exceptions such 
as the work of the PPSG and its International Pain Policy Fellowship programme.
207
  
Clearly, the scope of policy theory is vast with multiple journals, books and indeed entire 
university faculties devoted to the discipline. My aim here is to give an overview of some 
of the complexities of how policies may be created and implemented, and demonstrate 
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why there is the need to appreciate these complexities in order to gain a better 
understanding of the medical treatment of pain within a global setting. There are multiple 
definitions of the term ‘policy’ but for the purposes of this discussion, I will consider 
policy as a set of aims, objectives and strategies set out by figures of responsibility.
208
 
Within the context of the Indian healthcare system therefore this will include many levels 
of authority and responsibility, from local clinical institutions (public or privately funded), 
professional bodies such as the IAPC and ISSP, regulatory organisations such as the 
Medical Council of India, as well as state and national government. Consequently written 
policies will range from national government strategic documents to local clinical practice 
guidance.  
In response to the tendency to focus only on the content of policy, Walt and Gilson
209
 
constructed a framework to aid understanding of the wider role of policy within healthcare. 
They describe four key interrelated elements, namely the policy content, the policy 
process, the policy context and the multiple actors involved. These actors are also 
collectively often described in terms of networks or communities reflecting the numerous 
participants and their dynamic interconnectivity.
210
 Walt and Gilson’s policy triangle209 
demonstrating these interrelated elements is shown in Figure 1-3. To be clear, this is a 
simplistic diagram of a highly complex system, but the aim of the triangle is to guide 
analysis of health policy by ensuring that the key elements of the process are considered.  
 
Figure 1-3 Walt and Gilson's Triangle for Health Policy Analysis
209
 
(Permission to reproduce this diagram has been granted by Oxford University Press) 
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By studying each of these elements and crucially their dynamic interactions, a deeper 
understanding of a particular policy can be gained. So, when considering for example the 
creation of national guidelines for the treatment of pain in India, the content of what should 
be included in the guideline will be affected by the local healthcare context such as the 
availability of medications or equipment, the proximity of rural populations to institutions, 
or the ability to fund treatments. Many actors will be involved in the negotiated process 
that is the writing of the policy. There will be power differentials between different 
clinicians relating to their professional hierarchy both as individuals and as representatives 
of professional societies such as the ISSP or IAPC. They will have different opinions as to 
what constitutes best practice and, as explained in the previous chapter section, they will 
draw on multiple knowledge types beyond the scientific such as social and experiential. 
Other actors may also be involved, directly or indirectly, such as the pharmaceutical 
industry, international non-governmental organisations, politicians and patients. Finally, 
the process of creating the policy needs to be considered, what is the topic of focus and 
why has that been prioritised, who are the authors, how are different opinions of these 
actors negotiated, how will the policy be used and implemented?  
 
Figure 1-4 Stages of the Policy Cycle
 
 
Another useful aid to analysis of the policy process is its conceptualisation as a series of 
stages of a cycle. There are many such frameworks published in the literature such as that 
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described by Barker
211
 which outline the constituent elements of this cycle such as, 
agenda setting, the creation of policy, implementation of policy and evaluation. An 
example of a simplified visual representation of this process is depicted in Figure 1-4.
  
Early descriptions of the process of creating and implementing policy favoured a rational, 
positivist model. Describing decision-making and actions as logical predicable processes. 
Torgersen calls this a time when it was assumed that “knowledge would replace 
politics.”212(p34) The stages approach or policy cycle in Figure 1-4 can indeed be considered 
an example of one such rational model.  
In more recent years, driven in part by a philosophical shift in the social sciences towards 
postpositive and moderate social constructionist perspectives that demand an appreciation 
of the particular social context in which individuals function, multiple alternative theories 
have been proposed.
213-216
 A detailed description of these theories is beyond the scope of 
this thesis but examples include incrementalism, wherein small changes occur repeatedly 
as a response to the complex inputs from the wider political environment
208
 or punctuated 
equilibrium, wherein, particular sets of circumstances can lead to sudden profound changes 
within the policy system.
217
 These newer theories have largely displaced the stages cycle 
approach as a causal theory of the policy process due to the over simplification and 
description of events as linearly ordered.
210,218
 Nonetheless, in the same manner as the 
policy triangle is a useful tool to aid analysis of policy, the stages approach is frequently 
used as a framework to aid discussion. I will indeed follow this by referring to three stages 
of the policy process, namely agenda setting, policy formation and implementation, with 
respect to the particular case of pain management in India. However, it is vital to 
appreciate that these stages are neither distinct nor isolated, nor are they related to each 
other in a predictable chronological fashion. Rather they are interwoven as complex and 
dynamic processes with multiple cycles of feedback and modification. 
Central to any discussion of the policy process, regardless of the particular theoretical 
approach being invoked, is the concept of power - who holds it, how is it negotiated, and 
how is it enacted? Power is ubiquitous within society and can be thought of as the fuel of 
the policy process.
211
 Unequal distributions of power result in one individual or group 
being able to exert control over another. This control can be enacted in multiple ways but 
can be usefully conceptualised within three different dimensions.
208
 Firstly, an individual 
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that has a higher ranking related to a particular attribute such as money, professional 
status, knowledge or physical prowess, when compared to another individual, will be able 
to exert control.
219
 An example would be a senior doctor demanding a medical student to 
carry out a particular task. The second dimension occurs when the holder of power creates 
a structure that inherently removes choice and therefore power from those who are less 
powerful.
220
 An example would be the creation of a political system in which only certain 
groups are allowed to vote in an election. Power is exerted in this fashion within healthcare 
when members of the medical profession take the lead in deciding which diseases will be 
prioritised in advocacy projects or which treatments will be included in clinical practice 
guidelines. The final and most covert form of power enactment occurs when the more 
powerful actors create an environment in which those holding less power are made to 
agree with the distribution of power and the resulting pattern of control.
221
 They become 
unknowingly complicit in maintaining and reinforcing the status quo, and their own 
powerless position. An example would be the marketing of particular medical treatments to 
patients on the sole premise that they will benefit the patient. If during this process, the full 
extent of the likely risks is not fully explained to the patient, it would be only the clinician 
who gains from the interaction either financially or professionally. The patient would be 
unknowingly complicit in this reinforcement of the unequal distribution of power.  
Moving on to consider how these theories of power enactment relate to society as a whole, 
I describe two examples: pluralism and elitism.
211
 From a pluralist perspective everyone 
holds an equal stake in society and is in a position to wield power, for example through the 
process of democratic political elections. The government then acts in response to the 
demands of the electorate. In contrast, elitism dictates that just a few elite members of 
society such as politicians or members of the medical profession hold power. Whilst there 
are criticisms of each of these theories and neither truly represents society
208,211
 both can 
be drawn upon to aid the analysis of the policy process in particular individual 
circumstances.
210
 For example, although the medical profession within Indian society is 
profoundly powerful, patients also exert power when they choose to take their custom to a 
particular practitioner or choose to not take a prescribed medication. It is therefore 
necessary to examine the potential power that all actors in a particular situation may hold 
and to consider all the ways in which power is enacted, the importance of which is made 
clear in the policy triangle of Walt and Gilson (Figure 1-3). 
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In general, there is a paucity of research in low and middle-income countries related to 
the analysis of health policy and much of the work that is done relies on theory and 
frameworks originating from high-income countries.
229
 Nonetheless, whilst acknowledging 
that more work is needed in this area, these frameworks have been used in low and middle-
income countries with a degree of success.
229
 This thesis is not designed to be an analysis 
of policy, but I am aiming to demonstrate, with reference to work from the field of policy 
analysis, that it is important to understand aspects of the policy process in context, rather 
than simply to declare the need to create or change policy. So, with reference to the topic 
of this thesis it is useful to consider the elements of the policy triangle and look at different 
stages of the policy process, its context and the networks of actors involved. I now 
elaborate on each of three stages of the policy process (agenda setting, policy formation 
and implementation) with specific reference to the treatment of pain in India, considering 
the key elements of the policy triangle and the complexities of power distribution. 
Beginning with agenda setting, that is, how or why an issue receives political attention, the 
actors are numerous and include members of the medical profession, patients and their 
families, Indian charitable organisations, professional societies, the pharmaceutical and 
medical devices companies, state and national government, corporate healthcare and 
international organisations such as the WHO, the International Association for the Study of 
Pain, the Worldwide Palliative Care Alliance and Human Rights Watch. Each of these 
actors holds different degrees of power and tools of influence, and each has a different set 
of personal interests. This list of actors is not intended to be exhaustive, but rather 
demonstrates the size and disparate nature of the networks involved.  
When considering the context in which these issues are being raised, the wider political 
environment is highly influential. For example, the structure of jurisdiction in India with 
each state creating its own health policies results in an environment where multiple 
different groups need to be lobbied in turn in order raise an issue such as improving the 
availability of opioids at a national level.  
The actual characteristics of the issue being raised as well as how it is framed, that is, how 
it is conceptualised and publically presented,
230
 are also important.
231
 For example, when 
considering the characteristics of the issue of providing pain relief, an alternative cause 
that is in competition for scarce resources, such as providing universal health coverage, or 
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detecting cancer, may be deemed more worthy. The manner in which the issue is framed, 
however, is also key to whether or not it receives priority. For example, In India, as I 
demonstrated earlier in this chapter, within the field of palliative care, access to pain 
management is often framed as a human right. Low levels of access are described as a 
widespread problem that could potentially be fixed very cheaply within a western medical 
framework through increasing the availability of opioids, if only due effort was directed to 
the cause. As I also explained this medicalisation of pain, however, is only one of several 
frames present within society and more specifically, there are a range of views on what the 
most appropriate treatment strategies are, besides increasing the use of opioid medications. 
Moving on to policy formation, which is again an ill-defined stage in the policy process. A 
variable number of processes may occur during policy formation in which ideas and 
evidence are assessed, and policy is formulated by multiple actors into repeatedly revised 
versions until a degree of consensus is reached.
232
 Due to the relevance to this thesis I will 
consider in a more detail here the specific act of the use of evidence based medicine 
(EBM) in policy formation to create clinical practice guidelines and other evidence based 
policies. 
EBM began to gain popularity within western medicine at the end of the last century
233,234
 
in response to an observed variation in clinical decision making and a burgeoning 
published scientific literature. By compiling data objectively from the increasing number 
of published studies, the aim of the EBM movement is to improve quality and minimise 
costs by treating patients only with the most effective treatments. As I introduced in the 
previous section, while this rational aim is entirely laudable, its simplistic approach is 
becoming increasingly debated and critiqued.
203
 Critics argue that EBM only considers the 
use of treatments in a subset of individuals functioning in specific experimental conditions 
who are not therefore representative of patients in general living as a population in the ‘real 
world’.235 Furthermore, while the aim of EBM is to direct treatment selection for 
clinicians, it fails to take into account other factors that affect this decision making process 
discussed above, such as the characteristics of the patient, the healthcare environment and 
other forms of clinician knowledge whether it be social, political or experiential.
205
  
Moving on from the complexities of using EBM to guide individual patient treatment, 
there is also a significant body of work describing the use of EBM in generating wider-
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reaching clinical practice guidelines. These may be created at a local level within a small 
medical clinic, across a healthcare system such as those published by the UK government 
body the National Institute for Health and Care Excellence, or internationally by the WHO. 
The premise of clinical practice guidelines is to make best use of EBM but the creation of 
each guideline is inherently influenced by characteristics of its authors.
236
 Guideline 
authors have been shown to draw on other types of knowledge besides scientific - such as 
experiential and to be influenced by wider political issues.
237,238
 It therefore follows that far 
from being objectively created tools to streamline rational healthcare delivery, clinical 
practice guidelines should be considered as complex, contested and at least partially 
socially constructed entities.
238
 Furthermore, despite the guideline creation process itself 
frequently being described as involving a particular set of actions or as following set 
criteria, whether this process actually occurs in practice is less certain.
239
 
The use of the results of scientific studies to create public healthcare policy for use at a 
population level shares many similarities to the use of EBM to create clinical practice 
guidelines. For example, some argue that rational scientific quantitative data, the use of 
which is frequently prioritised over qualitative studies, is not a good fit for the complex 
‘messy’ world of the policy process.204 Is has also been noted that what is needed is a 
deeper understanding of how EBM is used to inform policy rather than an increase in the 
scientific base of EBM.
206
 Analysis of the factors involved in the system of incorporation 
of EBM into healthcare policy, including clinical practice guidelines is a complex 
field
238,240
 and a framework to improve our understanding of this process has been created 
by Dobrow and colleagues.
241
 They describe a ‘context-based evidence-based’ conceptual 
framework consisting of three stages - introduction, interpretation and application of 
evidence, each of which is affected by multiple internal and external contextual factors. 
Internal factors include the purpose of the policy, the actors involved and the creation 
process. External factors include the characteristics of the medical condition, qualities of 
the healthcare system and the wider political environment.  
Of note, there are many examples of the content of EBM and its use in the creation of 
clinical practice guidelines, causing conflict between professional groups. For example, 
within the medical profession itself, clinicians can resent the power EBM gives to 
academic colleagues,
242
 and managers who use guidelines to ration treatments may be 
perceived as taking control away from physicians.
243
 A clear example of the political 
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nature of the process of guideline creation occurred recently in the UK, when the 
publication of national guidance on the treatment of back pain, and controversy regarding 
its content, led to the forced resignation of the president of the British Pain Society who 
had helped compile the work.
244
 More specifically there are concerns regarding the 
frequency with which published studies are funded by organisations such as 
pharmaceutical and devices companies that have a financial interest in their results,
203
 and 
in financial conflicts of interest of guideline authors.
203,245
  
The final stage of the policy process I consider here is that of implementation. Again 
theories abound but are largely dominated by the contrasting ideas of processes being 
either top-down or bottom-up.
229
 In a top-down system, compatible with rational theories 
of the policy process, once created, a policy is widely supported across society and is 
seamlessly implemented by compliant able citizens (such as civil servants and healthcare 
professionals), resulting in the desired favourable outcome.
208
 In contrast, a bottom-up 
approach describes the fundamental role that the implementers play and how they are 
ultimately in possession of power. Lipsky’s seminal work in this field where he coins the 
term ‘street-level bureaucrats’246 describes how frontline staff such as doctors and nurses, 
despite being bound by certain rules, do indeed hold a significant degree of autonomy 
when determining their day-to-day practice. Despite Lipsky’s theory being several decades 
old, it is still considered widely relevant within healthcare settings in both high and low-
income environments.
247,248
 That said, neither a top-down nor a bottom-up approach alone 
will provide an adequate explanation for any given policy implementation scenario but by 
referring to elements of both theories a deeper understanding of the complexities will be 
gleaned.
210
  
A final note here with particular reference to this thesis is the need to appreciate the many 
influences that impact the manner in which clinicians enact power as professionals. On the 
one hand, doctors have a high degree of autonomy and resulting power, conferred to them 
through, for example high levels of specialised knowledge that are obfuscating to others. 
Their professional status may also ensure they are held in particularly high regard within 
society.
249
 Conversely, they are also simultaneously bound by a particular combination of 
guidelines and rules from their local employer as well as higher regulating authorities.  
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In this section, I set out the profound and wide reaching influence that both individual 
practitioners and the medical profession as a whole, have on the healthcare policy process - 
at the stages of agenda setting, policy formation and implementation. I now turn my 
attention to consider some of the wider global influences on the practice of pain 
management in India, drawing on theories from postcolonialism. 
1.5.3 Postcolonial Perspectives 
In this section, I demonstrate some examples of how power is distributed unequally 
between different countries or regions of the world with respect to healthcare improvement 
initiatives. I explain how postcolonial theory can inform a more balanced approach to 
research and ultimately practice. 
Numerous high profile organisations working at the global level to improve access to pain 
management are, despite being named as international, in fact western-based organisations: 
examples include the International Association for the Study of Pain based the USA, the 
International Association for Hospice and Palliative Care based in the USA, the 
Worldwide Palliative Care Alliance based in the UK, the World Institute of Pain based in 
the USA and the Union for International Cancer Control based in Switzerland. As I have 
demonstrated, these and many other western based organisation such as the Pain and 
Policy Studies Group at the University of Wisconsin, and Human Rights Watch have been 
profoundly involved in influencing improvement initiatives related to pain management in 
India, particularly relating to improving access to opioids for the treatment of pain within 
palliative care. Furthermore, several European clinicians are described as being pioneers of 
the palliative care movement in India.
141
 Classification systems of the development of 
palliative care such as those included in the Global Atlas of Palliative Care at the End of 
Life and the Quality of Death Index, report western countries with their particular model of 
healthcare as ranking highly. The majority of research publications in this field also 
emanate from the west.
250
 Furthermore, the problems of poor access to pain relief are much 
more prevalent in low and middle-income countries.
60,72
 
At a more general level, I have also explained earlier in this chapter how the description of 
a problem in terms of human rights, an idea frequently coined to describe access to pain 
management, can be considered to originate from a western perspective. A critique has 
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been levelled at the field of global health becoming increasingly medicalised, 
conceptualising health related issues as problems requiring technical western medical 
solutions.
251
 The WHO, considered by some to have an inherent western bias,
252
 clearly 
holds enormous degrees of power in global health, but many other organisations may also 
be wielding power in a less obvious manner such as the pharmaceutical industries and 
charitable organisations. Shiffman describes some of these organisations
253
 and talks in 
particular of two new, very prominent, western based players in this field, the Institute for 
Health Metrics and Evaluation (IHME) and the Lancet, that he describes as rivalling the 
WHO. Although the aims of these organisations maybe laudable, he describes the need to 
question and understand their motivations and remit. For example, the IHME is funded by 
the Gates Foundation which puts considerable power in the hands of this organisation, and 
the Lancet as a world renowned peer reviewed journal may be seen as a purely rational 
unbiased voice and thereby placed beyond critique but will inevitably privilege the views 
of some individuals over others. 
Postcolonial theory is based on the concept that the dominance of European countries that 
controlled vast swaths of the world during the colonial era of the 16
th
 to 20
th
 centuries still 
persists despite the end of direct colonisation. The political and economic power of the 
European countries and those that their descendant populations now preside over such as 
the USA, Canada, Australia and New Zealand, is sustained and reinforced by a structure 
heavily weighted to favour this power differential.
254
 Various terminologies are used to 
describe these two regions, such as ‘western’ and ‘non-western’, ‘first’ and ‘third world’, 
‘developed’ and ‘developing’ or the ‘global North’ and ‘South’. Each of these has their 
own limitations, ‘first’ or ‘third’, and ‘developing’ imply rank and include normative 
connotations about how things ought best to be done, and similar value laden judgements 
are attached to the word ‘western’.255 So although imperfect and indeed geographically 
inaccurate, from herein I will use the terms ‘global North’ to indicate the more wealthy ex-
colonising populations and ‘global South’ to indicate those living in disadvantaged, low 
and middle-income circumstances.
255
 However, due to particularly widespread usage, 
including in the study results, I will continue to use the term ‘western medicine’ to 
describe specific models and techniques of healthcare delivery that have originated in this 
part of the world. 
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Postcolonial theorists describe the actions of the global North as maintaining the unequal 
distribution of wealth between the two regions, for example through economic policies of 
organisations such as the World Bank and the International Monetary Fund,
255
 and similar 
criticisms have been made in the field of global health.
252
 Power is also wielded in other 
ways, however, such as through the dominance of the European powers in the writing of 
history during the colonial era. For example, despite considerable contributions to 
scientific knowledge, including in the field of medicine, from the colonised populations 
these are either not acknowledge at all or only described through the eyes of the colonial 
system.
256
 
A seminal postcolonial text is Dipesh Chakrabarty’s Provincializing Europe: Postcolonial 
Thought and Historical Difference.
257
 In this work, first published in 2000, Chakrabarty 
explains how detrimental the use of the terms ‘developing’ and ‘developed’ are to those 
included under the ‘developing’ umbrella. He talks of how the wording assumes that each 
country will progress along a fixed trajectory of development, one that is already described 
in the histories of the developed nations, that is, the countries of the global North. 
However, he challenges the idea that any one country will follow the same trajectory as 
another. In part, this is due to the structures created by the North, which inherently places 
countries in the South at an economic disadvantage, but also due to the unique nature of 
any country’s path in history. Furthermore, by describing countries as developing they are 
assumed to be striving towards a set of goals and aspirations that are defined by the 
countries of the North. He describes this state as being confined to the waiting room of 
history, aspiring to an ideal that can never be achieved and resulting in feelings of 
inadequacy and failure. He also critiques the idea of simply transferring ideas from the 
North to the South without significant translation. However, he also proposes an 
alternative model of multiple futures, where each individual country progresses along their 
own unique path, and ideas and technologies are translated for use between nations. 
Chakrabarty’s theories are highly relevant to this thesis, indeed the concept of using a 
paradigm where multiple futures exist rather than one single ideal has already been 
described in the academic literature with respect to the field of global palliative care 
development.
258
 Furthermore, in the earlier sections of this chapter I outlined how the 
sociocultural environment affects the conceptualisation of pain, its expression and 
treatment, and of how the particular local context informs all areas of the healthcare policy 
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process. I argue therefore that it is imperative to consider improvement strategies at a 
local level rather than simply extrapolating from work that originates from the global 
North, and indeed that implies there ultimately exists a universal model to suit all. 
1.5.4 Power and Gender 
No description of power would be complete without an acknowledgement of the role of 
gender, although I did not attempt to analyse this dimension in my study. From its 
inception the medical profession has been a male dominated, patriarchal system. As 
Rosemary Pringle writes, feminists often consider the profession to have “snatched healing 
out of the hands of women”222(p1) who had previously owned this role. The first women to 
be added to the British Medical Register was Elizabeth Blackwell in 1849
222
 although 
notably her training had occurred outside of the UK. She was followed by Elizabeth 
Garrett Anderson in 1856 who had forged her own path of training in Britain.
223
 These 
early female pioneers endured great hostility from their male counterparts during this era – 
a struggle tightly linked to the rise of women in other professions and the suffrage 
movement.
222
 As Virginia Woolf wrote of the period, until 1919 marriage had been “the 
one great profession” available to women.224(p13) Of note, discussions of gender do not 
feature in the early sociological writings related to medicine from key authors I have 
discussed such as Freidson and Parsons.
222
 
In India, The particularly strict societal gender segregation that existed in the 19
th
 century 
meant that women were unable to be examined by male physicians. Ironically, in order to 
serve the female population, women were permitted into medical schools in India ahead of 
the UK and before the all male tradition had been established.
225
 However, these early 
recruits were limited in their areas of practice – working only in women and child 
health.
225
 
The number of women entering the medical profession increased enormously over the last 
century.
223
 However, in contrast to the ‘first-wave’ of feminism related to the suffrage 
movement and the presence of women in professions, attention more recently has focused 
on so called ‘second wave’ feminism – related to discussion of professional status.222As 
Pringle writes, “Women clear one set of hurdles only to find they are faced with 
another”.222(p222) Despite a significant rise in the number of women practising medicine, 
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they have tended to work in lower paid specialties and taken on less high-status roles 
when compared to their male colleagues.
226
 This discrepancy is reflected in the persistent 
gender pay gap recently reported in the UK.
227
 Similarly, in India, although the situation is 
noted to be changing, it is compounded by the lower status of women in society in general, 
and women in medicine still work in lower status roles and lower paid fields.
225
 
Furthermore, as I have described elsewhere, women in India persistently have poorer 
access to healthcare than men.
133
 
Interestingly, palliative medicine, especially when compared to surgical specialties, and 
certainly in the UK, is a particularly female dominated specialty.
222,228
 In line with this 
observation, some feminist writers have argued that women are viewed by society as more 
holistic, caring practitioners, when compared to their male counterparts who are more 
attracted to higher status, surgical specialities where problems are cured with technical 
fixes.
222
 It is interesting then to consider how these gender roles might affect the practice 
of pain management in India. If, for example, the masculine stereotype in reflected in the 
technical solutions to pain treatment in the form of interventional procedures, is the rising 
power of the feminine voice (of palliative medicine) a threat to male status?  
1.6 Summary 
I have described in this chapter how pain is widely described by high-profile medical and 
advocacy organisations as a global health problem that ought to be addressed through the 
improved provision of western medical treatments, and the limited impact that many 
improvement projects have had. I have also demonstrated, however, that many elements of 
pain management as practised within western medicine are professionally constructed, and 
how this leads to areas of contention. Examples are seen in the debates surrounding the use 
of opioid medications and the clinical remit of the medical specialty of palliative care. 
Variations in local practice across the world add complexity to this picture. Many research 
projects and high profile initiatives have focused on improving global pain management by 
targeting improved access to opioid medications within the field of palliative care, and 
there is a strong tendency for these projects to be led by the wealthier countries in the 
global North, despite their remit being to improve healthcare in the global South. This 
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leads to a disparity between improvement initiatives and local clinical practice, which I 
argue limits their efficacy. 
I have explained why I chose India as the location for this project in which I am aiming to 
assess local clinical practice. I have demonstrated the need to expand on the current 
evidence base, which is largely descriptive and narrow in its focus. I have described how 
my research project adds to the published literature through appraising medical care that 
lies outside the remit of palliative care and consideration of the use of treatments besides 
opioids. My study is also innovative in nature as I situate a critical evaluation of the 
normative positions and evaluative judgements of clinicians alongside descriptions of 
practice.  
The need to conceptualise illness and healthcare as complex phenomena influenced by and 
inextricable from the socio-cultural environment is well described.
259
 Many have talked of 
the need to look beyond the reductionist models upon which western medicine is based and 
which conceptualise medical science as a quest to discover a universal truth.
260,261
 Despite 
these contributions there remains a paucity of truly cross-disciplinary collaboration in 
healthcare research, demonstrated in the academic literature.
262
 In this chapter, I have 
introduced the theoretical perspectives that inform this research study in its entirety, 
namely social constructionism, policy theory and postcolonialism. By examining the 
professionally constructed nature of medicine, the complexities of the policy process and 
global distributions of power I have described why the treatment of pain at a global level 
and specifically within India should be considered within a cross-disciplinary framework. 
In the following chapter I describe my research methods in detail, demonstrating how 
theories from the fields of social and political science have informed this part of the 
research process.  
 Chapter 2 - METHODOLOGY AND METHODS 
2.1 Introduction 
The overarching aim of this research is to understand how pain is treated in India through 
building up a map or landscape of this field of medical practice from the perspective of 
practitioners themselves. In contrast to the majority of published research related to 
improving pain management at a global level, I seek to incorporate the views of clinicians 
working across all areas of pain management, including and beyond the remit of palliative 
care, and to consider the medical use of a wide range of treatment modalities, including 
and beyond opioid medications. I argue that this terrain, that is in part professionally 
constructed, can only be mapped out with a degree of completeness by using more than 
one research tool and data type.  
I therefore choose to answer my research questions, as laid out in the introductory chapter, 
through the use of multiple methods incorporating both open and closed questions from 
semi-structured interviews and written surveys, created and analysed in conjunction with 
field notes gathered throughout the duration of the study. As I explain in detail in this 
chapter, the vast majority of the data was collected from attendees at two national 
conferences of the professional societies of the Indian Society for Study of Pain (ISSP) and 
the Indian Association of Palliative Care (IAPC). 
In the following section of this chapter (2.2) I explain the methodology of the study, 
beginning with a discussion of the use of mixed methods research and its theoretical 
underpinnings, before considering interviews and surveys as research tools in their own 
right. In Section 2.3, I then detail the specific methods of data collection and analysis used 
in this project.   
2.2 Methodological Considerations 
In the opening chapter, I demonstrated the professionally constructed dimensions of the 
medical treatment of pain, the extension of social constructionism into policy theories and 
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their relevance to this study, and the importance from a postcolonial viewpoint of 
directly seeking the perspective of individuals living in the global South. Therefore, in this 
study, the aim of which is to critically assess the practice of individual clinicians treating 
pain in India, I argue that drawing on multiple theories and the use of multiple methods is 
paramount.  
2.2.1 Combining Research Methods 
The use of more than one method of data collection and analysis has increased over recent 
years within the social sciences
263
 but needless to say this has not occurred without a 
degree of controversy. In this section I outline some of the key topics of debate, the 
potential advantages of using multiple methods and data types, and how and why I have 
chosen to use these techniques. 
Much of the debate in this field has focused on the specific issue of mixing the use of 
quantitative and qualitative data.
264
 Controversies include contention over theoretical ideas 
as well as the practical use of such methods. Traditionally qualitative and quantitative data 
represent opposite ends of the research spectrum and associated philosophical positions. 
Quantitative data is associated with a positivist or postpositivist paradigm,
265
 within which 
researchers seek out an objective answer to a question, albeit with, within the postpositivist 
paradigm, the acknowledgment that a degree of bias is inevitable.
212
 The aim of research is 
to test a pre-defined hypothesis using a deductive process. In contrast, qualitative data 
traditionally belongs within a constructionist worldview wherein there is no such thing as 
an objective truth but only various interpretations of reality. Research within this paradigm 
is inductive, with the aim of discovering new theories and concepts from the data itself.
266
 
Purists therefore argue that the incompatibility of these associated philosophical 
worldviews or ontological and epistemological positions make the use of research 
involving both quantitative and qualitative data untenable.
267
 
However, on a more practical level, the association between data type, and ontological and 
epistemological positions is not absolute. For example, quantitative data such as counting 
the frequency of phrases used in media articles can be used to deepen the understanding of 
a socially constructed phenomenon.
263
 Some argue therefore that although the paradigms 
themselves are incommensurable, within each paradigm multiple methods and data types 
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can still be used. Other proponents working with qualitative and quantitative data, 
consider their approach to be a distinct field called ‘mixed methods research’ or MMR and 
conceptualise it as a methodological movement in its own right.
268
 Some even describe the 
presence of an alternative philosophical paradigm called pragmatism to support the use of 
mixed methods techniques.
269
 Pragmatism as a philosophical model is described in various 
ways but is essentially concerned with actions and their context rather than with 
predetermined situations.
265
 However, others contest the existence of or even the need for 
an alternative MMR paradigm and describe how researchers should instead draw on the 
multiple paradigms already in widespread use.  
Positivism and constructionism themselves are often considered to represent two ends of a 
paradigm spectrum,
266
 upon which others such as postpositivism and critical approaches 
(such as feminism and postcolonialism) are positioned. An argument then follows that 
whilst it may not be feasible to combine the use of strongly positivist and strongly 
constructionist paradigms, it may well be possible and indeed necessary, to draw on 
multiple paradigms that lie in close proximity on the spectrum, for example 
constructionism and critical theory, or positivism and postpositivism.
266
 This mixing of 
methods and paradigms, switching and comparing as the particular research demands, is 
sometimes referred to as the technique of ‘bricolage’.267,270 The ‘bricoleur’, originating in 
this context from the work of the anthropologist Levi-Strauss,
271
 far from being the 
unskilled ‘jack of all trades’ that its name may suggest, is in fact able to tap into multiple 
paradigms and theories thereby working in a fashion more reflective of the complex social 
environment in which we research. Similar to this is a technique called ‘crystallization’, an 
approach to research which also embraces the idea that philosophical paradigms lie on an 
arts-science spectrum.
272
 The approach calls for the use of multiple lenses, or facets of the 
crystal, drawn from artistic representations and scientific approaches in order to enhance 
understanding of our complex social world.
267
  
There are many reasons why multiple methods and data types may be an advantage within 
a research project. In general terms, by using multiple approaches the strengths of each can 
be exploited whilst the weaknesses are offset. Similarly, qualitative data can be used to add 
depth whilst quantitative data can add breadth. More specifically, different tools and data 
may be needed to answer different components of a research question. One method can 
also be used to create the data collection tool for another, such as interview data used to 
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create questions of a survey. Furthermore, two data sets can be compared to each other to 
triangulate or corroborate results and each can be used to add depth or breadth to the 
other.
263
 When considering these practical issues of carrying out research, those from the 
field of MMR call for a clear structure to the integration of each data type. They talk of 
specific designs with their own nomenclature such as ‘convergent parallel’, ‘explanatory 
sequential’ or ‘exploratory sequential’.265 Others criticise this approach as being too fixed 
to the positivist tradition and argue for a more pragmatic approach, that can be closely 
fitted to each individual research project making use of all available data collection 
tools,
267
 akin to the method of bricolage outlined above. 
Ultimately our aim is to seek rigour in the research process and hence maximise the quality 
of the research. I argue that quality will not be enhanced by the choice of a particular tool 
per se, which contains inherent rigour, but rather by using whichever combination of tools 
is most appropriate to the particular research scenario, in a rigorous manner.
273
 The focus 
can then move to issues of validity, reliability and generalisability,
274
 or as these concepts 
are often referred to with respect to qualitative data: truth value, consistency and 
applicability.
275
  
Reliability or consistency, is the degree to which results will be replicated if repeated.
276
 
Although with any socially situated research, the dynamic nature of the processes being 
studied makes it impossible to completely replicate findings,
263
 strategies to increase 
consistency include keeping and making explicit a meticulous log of the entire research 
process and the decisions taken during planning, data collection and analysis; using 
electronic tools to collect data such as audio recordings, and using computer software for 
collation and analysis.
274,275
 Validity or truthfulness, is concerned with the accuracy of the 
research findings.
276
 Whilst acknowledging, that from a constructionist perspective 
multiple versions of reality exist, the truthfulness of the realities presented in the research 
will be enhanced through clear referencing of underlying philosophical positions and 
theory, triangulation or corroboration of findings, inclusion of thick rich descriptions and 
detailed accounts of reflexivity.
275
 Broadly speaking, findings from studies in which 
statistical probability sampling is not employed cannot be definitively applied or results 
generalised at the population level.
263
 However, this is not to say that the results of such 
studies cannot be applied to other scenarios. For example, in a case study, findings can be 
generalised in the sense that they add to our understanding of theory, a concept known as 
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‘theoretical generalisation’.277 Strategies to enhance methodological rigour in this 
dimension include the incorporation of detailed descriptions of the research context.
275
 
2.2.2 The Use of Interviews and Surveys  
Interviews are widely used to collect research data. The method includes a huge range of 
specific data collection methods from unplanned conversations in ethnographies to highly 
structured interview processes eliciting quantitative data.
278
 The process itself can take 
place in many environments such as face to face, by telephone, online or as a written 
exercise.
263
 Needless to say there are pros and cons to each of these techniques, all of 
which can be equally valid depending on the research questions and setting. The 
ethnographic interview allows the participants to direct the content and flow of the 
conversation in a relatively unrestricted manner but the serendipitous nature of this process 
means that large parts of the data may not be directly relevant to the research questions.
278
 
In contrast, a structured interview requires the interviewee to read questions verbatim and 
often offers the participant only certain fixed responses.
279
 Whilst this ensures consistency 
it does not allow for individual expression. Between these two poles lies semi-structured 
interviewing where the interviewee follows an interview guide outlining the topics of 
discussion.
279
 This allows a degree of flexibility for the respondents who answer questions 
in their own words but ensures the key areas of interest in the particular research project 
are covered.
278
  
Semi-structured interviewing elicits qualitative data as thick, rich descriptions of areas of 
interest and is therefore suited for use within an interpretive or constructionist 
framework.
280
 The interviewer can build up a rapport with the research participants 
enabling a depth of understanding of key issues and concepts. This relationship requires 
specific attention be paid to reflexivity to appreciate and understand the inherent bias 
contained within this process.
274
 The subjective, qualitative data that emerges from these 
interviews is analysed to uncover themes, concepts and theories, as opposed to generating 
numerical, quantitative data.
279
 This process is, however, time consuming and relatively 
onerous both for the participants and the researcher which limits in practical terms, the 
number of interviews that are carried out.
278
 The relatively small numbers means that 
research is focused on gaining a deeper understanding of concepts and their context rather 
than revealing numerical data that is statistically representative of populations.
263
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When considering the use of structured questioning, again there are a wide variety of 
methods of delivery, which may be face to face or self-administered.
278
 Due to the 
structured nature of these collection tools, they generally include large samples of 
participants, thereby increasing the generalisability of results and in some cases allowing 
for statistical extrapolation to wider populations.
263
 There can be problems, however, with 
low rates of return of self-completed data collection tools.
281
 If self-administered there will 
be less reactivity or influence of the researcher in the process but the researcher cannot 
prompt or probe the participant if they have a particular query.
278
 Furthermore, it can be 
difficult to ensure the respondents have fully understood each question or indeed have even 
completed a written questionnaire themselves.
278
  
Structured questions may be open or closed and data collection tools may contain a 
mixture of the two. The use of closed questions allows for a standardisation of results, 
which can be analysed and compared quantitatively. Closed questions with fixed category 
answer options, however, force respondents to choose from a list compiled by the 
researcher, which may not adequately describe the respondents’ opinions. In contrast, open 
questions will elicit more nuanced data but require increased effort from the respondent 
and often require more time consuming analysis.
263
  
The word ‘questionnaire’ indicates the use of structured questions (as opposed to semi- or 
un-structured approaches),
278
 but there is variation amongst researchers in the precise 
interpretation of the term. For example, in some instances a questionnaire is simply a 
collected set of questions
263
 whereas in others it is a highly refined, standardised tool 
specifically for use with quantitative data and probability sampling.
282
 In contrast, the term 
‘survey’ whilst also not used entirely consistently263 is generally a more inclusive term, 
encapsulating the use of various data collection methods such as questionnaires or fully 
structured interviews.
278
 To be clear, for pragmatic reasons, which I discuss in more detail 
below, the questionnaire I have used in this study is not a standardised tool and was 
administered to a convenience (rather than a probability) sample. Whilst some researchers 
would therefore deem it to be more appropriately referred to as a survey, where I 
specifically describe my use of the tool and the data collected from it, I will use the term 
‘questionnaire’.  
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It is important to acknowledge that with any of these research methods there is a 
sampling bias in favour of those who are confident and at ease with the specific process of 
data collection and indeed with the use of the spoken or written language.
278
 There is an 
inherent power differential between the researcher, who chooses the topics and methods, 
and the participant who is asked to give up their time and knowledge.
263
 As I explained 
above the collection of interpretive data is by its very nature a product of the characteristics 
of both the participant and researcher. It is therefore imperative that this bias is recorded 
and understood as fully as possible in order to interpret the research findings.
275
 Field notes 
accompanying data collection and reflexive research journals logging the researcher’s 
values, biases and decisions are therefore important parts of the research process.
274
 The 
analysis of this data in conjunction with the raw results from the data collection tools is 
imperative in order to maximise the quality of the research.
263
 
2.2.3 My Use of Multiple Methods 
As I outlined at the beginning of the chapter, the theoretical perspectives that underpin this 
study support my use of multiple research methods. Furthermore, I argue that my specific 
research questions, which include recording the medical conditions clinicians treat and the 
therapeutic modalities they use, and how they evaluate this practice and wider issues of 
healthcare provision across the country, are only answerable by using more than one data 
type. For example, when I ask about the availability of medications and what treatments 
are offered, these are essentially closed questions requiring quantitative analysis. In 
contrast, questions related to individuals’ ideas such as their normative position and 
evaluation, require in depth answers to open questions that are subsequently analysed as 
qualitative data. Similarly, when considering presentation of the results, I have used a 
mixture of both quantitative and qualitative techniques for data from each of the methods 
of collection. For some questions this is the only logical approach such as using graphs to 
show the duration of each interview or the frequency with which participants have 
particular treatments available. In contrast, participants’ views on how pain should be 
conceptualised and regarded by fellow practitioners and government bodies clearly 
requires qualitative analysis, presentation and discussion. I have also added some 
quantitative analysis to some qualitative data to condense some findings for additional 
clarity. Figure 2-1 shows a Venn diagram representation of this use of qualitative and 
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quantitative data. Each contributes alone to answering some specific questions but other 
questions are answered by using both types of data.  
 
Figure 2-1 Representation of my use of Qualitative and Quantitative Data 
Similarly there are specific reasons for choosing to use different data collection tools. For 
example, the question on the availability of specific treatments involved asking about the 
use of 43 different therapies which would have been very cumbersome to ask in an 
interview. Whilst I acknowledge there are limitations with the use of a survey, which I 
address in more depth later, I consider it to be the most appropriate method in this context. 
Likewise, detailed discussion of physicians’ normative positions, personal influences and 
relationships with other society groups are only realistically explored through in depth 
dialogue, such as in interviews.  
As I describe below, the interviews directly informed the creation of my questionnaire. 
Early on in the study I aimed to carry out a survey with the main focus being to increase 
the breadth of responses to the questions asked in the interviews. Having collected a 
significant proportion of the interview data, however, I realised that the survey could be 
used to gain collect more detailed quantitative data regarding treatment availability, not 
simply to add breadth. Furthermore, the actual components of the questions related to 
treatment availability, that is, the specific treatments I asked about, were populated from 
my early analysis of the interview data.  
Not only is the use of both collection tools necessary, I also argue that it increases the 
quality of the data I collected. A few advocates of multiple methods justify its use by 
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suggesting that using more than one technique can offset the inherent weaknesses of 
each method.
283
 However, a more widely cited reason is to exploit the strengths of each 
data type to produce a more complete picture of the phenomenon of study.
263
 With 
reference to this study, the broad aim of the questions in the interviews is to ascertain 
detailed information regarding evaluative judgements of the participants while the surveys 
are largely concerned with data relating to service provision such as treatment availability. 
I did in fact ask both interviewees and survey participants to talk about both the areas of 
service provision and evaluation, albeit in varying detail. This led me to be able to draw 
upon the strengths of each of these methods of data collection. For example, the survey is 
useful to increase the breadth of data relating to evaluation as well as adding depth to 
questions related to treatment availability. Likewise, the interviews add depth to the 
evaluative questions of some of the questions thereby adding the ability to corroborate 
some responses.  
 
Figure 2-2 Representation of the Contribution of each Method of Data Collection to a 
Range of Research Questions 
Mutual corroboration, whereby results from one method are confirmed or not by another 
method, is known as ‘triangulation’ and is described as a tool to enhance the validity of 
research.
263
 While I did not specifically set out to formally triangulate across the 
qualitative and quantitative data in this project, I incorporated a degree of cross checking 
between the questionnaire and interview responses. For example, having inductively 
created a structure of categories and themes from interviews I used these deductively to 
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compare to the relevant responses in the questionnaires. Furthermore, alongside all of the 
methods outlined here I collected detailed field notes which I consider to both inform, and 
to have been informed, by the research process. These notes along with my research 
journal are a crucial part of the reflexive component of this study. Figure 2-2 represents 
how the different methods of data collection I used each have their own strengths but work 
together in a complementary fashion. Whilst Figure 2-1 represents the overlap in the 
questions answered by the qualitative and quantitative data, Figure 2-2 also incorporates 
the idea that the strengths of each data type can be additive. So for a given research 
question, a more complete answer may be acquired by using multiple data types. However, 
for other questions the use of all data types may be either inappropriate or unfeasible. 
In summary, I used multiple methods for several reasons: to create my data collection 
tools, to provide a sense of completeness in answering my overarching research questions, 
to answer the different types of specific questions within this topic and to incorporate a 
wide breadth of participants whilst including in depth analysis of certain areas; each of 
which ultimately enhances the rigor of my research.  
2.3 The Research Process 
2.3.1 Overview 
The process of formulating my research questions, choosing and planning my research 
methods in detail, collecting the data, and collating my findings, began in 2012. This work 
included a literature search, analysing an oral history archive and four trips to India – each 
during the month of February, from 2013 to 2016. I describe this largely inductive process 
in detail below, but in summary, I carried out a planning exercise to assess the feasibility 
of the study in 2013, collected interview data in 2014 and 2015, questionnaire data in 
2015, and presented preliminary findings from the questionnaire data in 2016. During the 
field trips to India as well as attending the ISSP and IAPC conferences, I visited a total of 
14 clinical institutions across the country, in the states of Maharashtra, Karnataka, Odisha, 
West Bengal and Tamil Nadu. These were a mixture of corporate hospitals, independent 
private clinics, charitably funded organisations and government institutions. Throughout 
this process I kept a research journal describing my work and personal reflections, and a 
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detailed technical log of the steps taken within my research process. A summary of these 
field trips and the data collected is shown in Table 2-1.  
Year 
Conference Location Number of 
hospital visits 
Data collected 
ISSP IAPC 
2013 
Nagpur, 
Maharashtra 
Bangalore, 
Karnataka 
4 Planning 
2014 
Navi Mumbai, 
Maharashtra 
Bhubaneswar, 
Odisha 
8 28 interviews 
2015 
Chennai, 
Tamil Nadu 
Hyderabad, 
Andhra Pradesh 
2 
5 interviews 
95 questionnaires 
2016 
Indore, 
Madhya Pradesh 
Pune, 
Maharashtra 
0 
Preliminary results 
presented 
Table 2-1 Chronological Summary of Field Trip Data Collection 
Given the scope of the research questions spanning several academic disciplines and 
multiple fields of medicine, a systematic literature review was not feasible. However, in 
order to ensure I had reviewed the key published texts I undertook online literature 
searches of multiple databases including Embase, CINAHL, Medline, PsychARTICLES, 
Psychology and Behavioral Sciences Collection, PsychINFO, SocINDEX with Full Text 
and Anthropology Plus, using key words including ‘pain and India’ and ‘pain and human 
right’. I also hand searched key journals including The Lancet, WHO Bulletin, Social 
Science and Medicine, Pain, Palliative Medicine, Indian Journal of Palliative Care and 
Indian Journal of Anaesthesia, and relevant grey literature.  
During the research I continually referred to earlier stages of the process, such as reading 
background literature (including updating online searches) and my journal and field notes, 
in order to reflect and refine both my research questions and my findings. For example, at 
the start of my work I was particularly interested in the fact that access to pain relief is 
frequently described as a human right,
93,121
 but as my work progressed this became less 
central to my enquiry. This process is summarised in Figure 2-3. 
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Figure 2-3 Summary of my Research Process 
2.3.2 Data Collection Planning: India Field Trip and the Oral History 
Collection 
My initial interest in this topic of research stemmed from my own career working as a 
consultant in anaesthesia and pain management in the UK’s National Health Service and 
from my experiences of teaching pain management overseas. It was a relatively simple 
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process therefore to establish contact with clinicians who worked or had worked in pain 
management in India through UK colleagues, previous overseas trips and contacts at the 
University of Glasgow. I established that the two major professional societies representing 
the related medical fields of pain management and palliative care, the ISSP and IAPC, 
each hold yearly three day national conferences on consecutive weekends in February. 
Having received encouraging feedback from discussion of my early research plans with 
Indian practitioners I decided to attend the two conferences in February 2013 to establish 
what detailed research was likely to be practical.  
In February 2013 I attended the ISSP conference in the city of Nagpur, Maharashtra and 
the IAPC conference in Bangalore, Karnataka. During the conferences I was able to talk 
extensively with a wide range of professionals including those on the executive 
committees of each of the societies. Those I met were very encouraging about my research 
and offered to both participate in and to facilitate the process. I also visited four hospitals 
in these regions to observe some elements of practice in pain management in the corporate 
and public sectors. Of note at the ISSP meeting I was often the only overseas delegate 
present and my interest in the work of the other conference attendees appeared to be 
particularly novel. This was in contrast to the IAPC conference, which was attended by a 
large number of overseas delegates and faculty, with several representatives from high 
profile international organisations. A field note entry dated 8
th
 February 2013 whilst I was 
attending the IAPC conference reads: 
“At ISSP everyone immediately wanted to know why I was there - they were very 
surprised to see me. Here it's very different.” 
As well as visiting India, during this planning phase I reviewed relevant literature with an 
emphasis on analysing comparable studies focused on the mapping of palliative care and 
pain management services in India, and on opioid availability. I was particularly interested 
in the observation that numerous projects studying the practice of palliative care at a global 
level actually incorporate data related to treating patients in a wide variety of situations, 
crucially, situations that in the UK would not normally be considered to be within the remit 
of palliative care. I also had access to a data set called the Oral History Collection, which I 
was able to analyse in some detail in order to refine my research questions. 
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2.3.2.1 Oral History Collection 
The Oral History Collection (OHC) has been compiled over a number of years from 
several different projects related to researching and documenting the growth and delivery 
of palliative care services across the world. Initially, a relatively small set of interviews 
was collected for the Hospice History Project based at Sheffield University in the 1990s 
detailing the growth of the hospice movement in the UK and culminating in the work A Bit 
of Heaven for the Few.
284
 Subsequently, the scope of the archive was increased to 
incorporate a more international perspective. Following the creation of the International 
Observatory on End of Life Care at Lancaster University in 2003, the archive grew 
considerably, and now consists of 674 separate interviews, from over 700 interviewees, in 
54 countries, spread over 6 continents, with material from subsequent studies still to be 
added. The recording medium of these interviews varies from audiocassettes, minidisc 
recordings and digital sound-files, reflecting the changing technologies of the past two 
decades. Some files also incorporate photographs of the subjects with summary life 
histories to give a more complete record of individuals and their work. Much of this data 
has then been incorporated into a database, charting not only the development of palliative 
care services, but also the creation of the OHC. 
Within the OHC there are 67 interviews from 44 participants listed under the country 
heading of ‘India’, recorded between 2003 and 2005. These were collected by multiple 
interviewers, in various locations such as during national academic conferences and in 
clinical institutions. Consequently, some subjects were interviewed on more than one 
occasion and some interviews involved more than one interviewee. During the first stage 
of analysis of the archive I undertook some basic re-organising of the 67 interviews to 
incorporate a new numbering system specific to this work. I removed duplicates and 
corrected minor inconsistencies in the original database. I read all of the 66 available 
transcripts and wrote brief summary notes of the interview content with comments added 
to indicate areas I thought likely to be relevant to my research questions. I then listened to 
the primary audio data, completed and corrected where necessary the transcripts all of the 
67 interviews and identified 44 that contained data relevant for more detailed analysis. A 
summary of this interview data is included in Appendix 1. 
I then listened and re-listened to the interviews coding and re-coding for themes of interest 
and relevance, modifying the coding structure as I progressed. This coding of interviews 
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yielded data relating to the following themes, each of which specifically informed the 
subsequent questions included in my semi-structured interviews and questionnaires: the 
organisation of pain management as a medical specialty, specifically in relation to which 
medical conditions patients are suffering from, pain management’s relationship to the 
medical specialty of anaesthesia and the effects this has on training, clinical practice and 
other professional responsibilities of practitioners including their personal finances; and 
the clinical practice of pain management specifically related to variations in the use of 
interventional techniques, such as nerve blocks. Inevitably, because this was secondary 
analysis of data, with the interview questions not specifically designed to answer the 
questions set out in my research project, some topics did not yield enough data for analysis 
but their brief presence in the OHC data none the less prompted me to inquire in more 
detail around these topics in my own data collection. These themes include: conflict 
between clinicians especially related to financial issues, other inter-professional tensions, 
perceptions of human rights related issues, motivations for choosing a particular career and 
the roles and aims of the ISSP in comparison to the IAPC. 
Following this OHC analysis and my 2013 fieldtrip to India, I finalised my research 
questions and methods. These included collecting semi-structured audio-recorded 
interviews at the ISSP and IAPC conferences in 2014, and carrying out an online survey to 
the whole of the membership of each society. I gained approval for this work through the 
University of Glasgow’s Ethics Committee of the School of Social Sciences. Although 
neither the ISSP nor the IAPC had a formal ethics committee able to grant approval, I had 
extensive discussions with executive members of both groups and provided them with my 
ethics committee approval letters from the University of Glasgow. They were universally 
encouraging of the work and gave me written approval to conduct my data collection.   
2.3.3 Interview Data Collection 
2.3.3.1 Creation of the Interview Guide 
Having established the plausibility of conducting interviews with ISSP and IAPC 
conference participants, I started the process of refining the wording of the questions in the 
interview guide. For example, I began to appreciate the complexity, variation and plurality 
of the healthcare system in India, which includes corporate run multi-speciality hospitals, 
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over-subscribed government hospitals and numerous unregulated privately run street side 
clinics. In a field note written in India, dated 5th February 2013, I wrote: 
“Up and down the road I am staying on, are numerous clinics, hospitals, diagnostic 
centres - some with operating theatres […] I'm amazed at the number of institutions 
out there (I wonder what regulation exists) and at the level of medical jargon on 
advertising hoardings.” 
I also recognised an even more fundamental issue - that there is a difference of opinion as 
to whether untreated pain is indeed a problem at all. For example, I talked to an 
anaesthetist in a hospital treating patients in pain during and after surgery who explained 
why he did not use morphine. I wrote a field note dated 5
th
 February 2013 saying:  
“He said patients didn't really complain of pain and that giving morphine is very 
problematic because there is lots of bureaucracy/licences needed, risks of addiction 
and diversion, and risk of side effects on the ward due to limited monitoring.” 
This is a crucial issue when interpreting my research because my participants are almost 
inevitably self-selected as individuals who consider untreated pain to be a problem. It is 
highly likely that there is a significant, but as yet un-quantified, cohort of healthcare 
workers, politicians, managers and members of the public who do not consider this to be 
the case and who are not included as participants in this study. 
I also noticed a variation of practice within the medical profession. For example, although 
the anaesthetist in the quotation above described not having morphine available, an 
oncologist working in the same hospital explained that he did in fact use morphine. At the 
ISSP conference I noticed a particular focus on certain modes of pain management namely 
interventional treatments often called nerve blocks. Similarly, some of the participants in 
the OHC interviews talked of their use of these techniques. As I described in the opening 
chapter, however, the vast majority of work in the field of improving access to pain 
treatments at an international level has focused almost exclusively on the availability of 
opioid medications.  
I also began to appreciate the enormous significance of money within the field of 
healthcare in India. Topics included clinicians’ income, patients’ ability to pay for 
treatments and even suggestions of corrupt practice. For example, one participant in an 
OHC interview remarked: 
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“It’s all 100% voluntary. We don’t have any paid work.” (OHC Interview 52) 
In contrast, having been discussing pain management with an Indian doctor, I wrote in my 
PhD journal on 11
th
 June 2012: 
“She commented on how she has noted an increasing number of her Indian colleagues 
are interested in chronic pain as a specialty. She suggested they were wanting 
primarily to learn interventional techniques and that there was potentially money to be 
made in this area.” 
These insights, together with my review of the published literature led to my focus within 
the interview schedule on gathering in depth information from practitioners regarding the 
specific treatments they offered, the medical conditions they treated and details of the 
institutions they worked in. I was particularly interested in understanding their normative 
positions and how these positions were informed. The interview guide used together with a 
plain language statement and consent forms are attached as Appendices 2-5, all of which 
were approved for use by the university ethics committee as explained above. 
2.3.3.2 Interview Participant Sample 
In 2014 I attended the ISSP and IAPC conferences in the cities of Navi Mumbai, 
Maharashtra, and Bhubaneswar, Odisha in order to conduct semi-structured interviews 
with clinicians working in pain management in India. I used purposive sampling to select 
participants to ensure that I included those working in a range of clinical settings. The 
areas I addressed were: funding of the institution (to include private, charity and 
government sectors), medical specialty (to include those working in settings that are not 
labelled as palliative care and as well as those that are), type of medical condition treated 
(to include those treating pain from all causes as well as those treating only certain 
condition such as cancer) and to cover multiple geographical areas of the country. I also 
targeted key informants who have a particular eminence and seniority within the field and I 
used a snowballing technique to identify further potential participants. While I describe 
this technique as purposive, there is also clearly a degree of convenience sampling. I chose 
to collect data at the national conferences due to the ability to meet and interview a large 
number of potential participants in a short period of time. During this first round of data 
collection I recorded 28 interviews.  
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Although I endeavoured to select a range of participants, there are disadvantages to this 
approach of sampling as I was unable to identify practitioners who did not attend the 
conferences, leading to difficulty in assessing the representativeness of my sample. While 
it is likely that a significant number of those with a strong interest in the field will attend 
the yearly national conference, there is a selection bias linked to aspects of the event such 
as the location of the conference, the costs and the education style of the programme, 
which practitioners may not choose to or be unable to engage with. Furthermore, I cannot 
be sure of the nature of the bias of the key gatekeepers to this process who initially 
introduced me to the participants. Membership of the professional societies, let alone 
attendance at the national conference, does not equate with practising pain management in 
India. Many professionals may regard themselves as specialists but for various reasons 
choose to not join the society. Still more are likely to be treating pain but not regarding 
themselves as specialists. 
As had occurred in my visit of 2013, during each of the conferences I was invited to visit 
various hospitals and clinics, sometimes in order to record interviews but also to observe 
practice. In total I visited eight institutions including private independent clinics, corporate 
hospitals, charitably funded hospitals and government run organisations. I took detailed 
field notes during the conferences and these clinical visits to supplement my research data.  
In 2015 I returned to India and again attended the two national conferences this time in the 
cities of Chennai, Tamil Nadu, and Hyderabad, Andhra Pradesh. Again I used purposive 
sampling to identify the key informants who I had not been able to interview in the 
preceding year. I recorded a further five interviews during this time and again was invited 
to visit clinical institutions; on this occasion I attended two. I recruited one participant at 
one of these clinical venues who had not attended the ISSP or IAPC conference but was 
introduced to me by a delegate. 
2.3.3.3 Interview Recording   
During the planning stage of the research I asked clinicians working in India whether they 
thought it most appropriate to conduct the interviews anonymously or with participants’ 
names recorded. The responses I received were not consistent so I opted to give 
participants the choice. The interviews themselves were conducted ‘on the record’ with 
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names, occupations and places of work identified. However, during the consent process I 
gave participants the opportunity to have identifiable details removed from the transcript 
and any resulting publications. I chose this approach due to the nature of the interviews, 
with many participants expected to be high profile individuals, and therefore making it 
potentially difficult to completely conceal every participant's identity. I also stated that if I 
planned to use quotations with explicitly identifiable data I would send these to the 
participant for verification.  
The interviews were recorded in various locations. During the conferences they were 
conducted in closed rooms with only the participant and me present, in public areas with a 
variety of potential delegates able to overhear or interrupt and with more than one actual 
participant present. Of the recordings held outside of the conferences the settings again 
varied with a range of people present. They were carried out in private offices, public areas 
such as the hospital canteen and a busy department, and one during a patient treatment 
session (with consent from the patient). The participants themselves chose each of these 
locations. Sometimes there was added benefit to this open process, for example during one 
interview in a hospital, the participant had arranged for all of their team members to be 
present so that they could ensure wide representation. However, there were also hindrances 
such as background noise and regular interruptions.  
I used a checklist during the data collection to help ensure I stored and filed the data and 
accompanying paperwork. I made each of the recordings on a battery powered portable 
digital audio recorder as MP3 files at a resolution of 128kbps. As soon as practical after the 
recording I downloaded the audio files to a laptop computer and a memory stick where 
they were stored as password protected files. I listened to the files whilst I was still in India 
in order to ensure the data was useable. Each interview was then numbered in 
chronological order of collection and filed with notes related to each individual interview. 
On my return to the UK I emailed all the interview participants to thank them for their 
participation and to confirm their contact details. 
During the period of data collection I added some annotations to the interview schedule of 
some additional prompts that I found useful during the process. The original interview 
guide (version 3a) is shown in Appendix 2, and the annotated guide (version 3b) is 
reproduced in Appendix 3. 
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Prior to the data collection in India, I carried out a pilot interview with a physician 
working in the UK who had previously worked in pain management in India. During this 
interview I trialled the interview schedule, my recording equipment and my interview 
skills. This interview was not used as part of the research data. 
2.3.4 Survey Data Collection 
2.3.4.1 Creation of the Questionnaire 
In order to enhance the interview data and to widen my study sample, I planned to carry 
out an online survey (using the web based tool SurveyMonkey) late in 2014, in order to ask 
questions from the whole of the membership of both the ISSP and the IAPC. The specific 
questions asked were to be informed partly from the interviews collected in 2014. As I 
outlined above I obtained permission to do this via the executive committee members of 
both societies and from the relevant research ethics committee at the University of 
Glasgow.  
On compiling the first drafts of the questionnaire, my initial aim was to discover in 
particular what the individual participants’ views and experiences of delivering pain 
management were rather than how they viewed the picture in their whole country, so that a 
more detailed and nuanced picture could then be created by the analysis of their combined 
responses. The questions, focused on the quality of pain treatment, what improvements 
could be made, what types of painful conditions were treated, what treatments were offered 
and some basic demographic questions. This first draft was sent as a pilot to the following 
sample groups: UK colleagues who had worked in India, Indian pain specialists whom I 
met during my first visit, and known experts in the international field. This was then 
updated several times to create a draft, which was submitted and approved by the 
University of Glasgow ethics committee in October 2013. 
I took this draft out to India with me for my first data collection field trip in February 2014 
where I also obtained feedback and comments from local specialists. As I had originally 
planned, this draft was then updated using data collected from the semi-structured 
interviews taken at the 2014 conferences. For example, on appreciating the wide variety of 
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professions represented at the IAPC conference, including many volunteers, I wrote in 
my field notes dated 15
th
 February 2014: 
“I will have to simplify some of the wording of the questions in the survey – I expect 
that the level of English spoken by IAPC members will be variable. I will also have to 
add a question asking about what the profession is of participants. I am beginning to 
see how the questionnaire will come together from this interview work.” 
More specifically, there were two areas of the questionnaire that I updated considerably 
using information collated from this trip. Firstly, I became aware of the vast array of 
different medical establishments involved in delivering pain treatment. Secondly, I noted 
the considerable variation in treatments offered and decided to dedicate a large proportion 
of the questionnaire to asking about the availability of different therapies. In a field note 
written while observing a workshop held before the ISSP conference on 6
th
 February 2014, 
I wrote: 
“The focus was purely on interventions although several people I spoke to described 
the need to prioritise other treatments such as morphine availability and 
multidisciplinary (in the UK sense of the term) team work (although they noted that 
they were very much in the minority).” 
On my return from the 2014 field trip I listened to all the interviews and took notes 
outlining some basic categories identified by the participants to help to begin compiling the 
survey. These were related specifically to the non-drug treatments available, the drugs 
available and the type of institution in which the participant worked. Much of the 
published debate surrounding the access to opioid medications is markedly tied in with the 
WHO Model List of Essential Medications,
36
 stressing that although certain medications 
and formulations are listed by the WHO as ‘essential’, they are in practice, not available. 
The International Association for Hospice and Palliative Care (IAHPC) also publish a list 
of essential medicines for palliative care
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 which contains a more extensive list of drugs. I 
included medications from both of these lists (opioids and non-opioids) but also added 
medications that are easily available to me in the UK. Similarly, I compiled a list of non-
medical treatments from both the interview responses and from published guidance 
including the Guide to Pain Management in Low-Resource Settings
286
 published by the 
International Association for the Study of Pain, the IAHPC’s List of Essential Practices in 
Palliative Care
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 and UK specific publications. I also used a similar ‘scale of availability’ 
as was used in the Global Opioid Policy Initiative. This work resulted in a draft, which I 
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then piloted again with UK colleagues, Indian clinicians and other specialists in the 
international field. 
I finalised a version of the questionnaire in October 2014, ready to be sent out, via email to 
the membership of both the ISSP and the IAPC. As I began to arrange this final 
distribution phase, however, I was told by the societies that a comprehensive email list of 
members did not actually exist. This called for a sudden change in my plans for this part of 
the data collection. It also reinforced my position in using a mixed methods or bricolage 
approach, making use of the particular tools that are available in a given context. 
The questionnaire therefore evolved into a ‘hard’ paper format, which I planned to 
distribute to as many eligible participants as possible at the 2015 ISSP and IAPC meetings. 
I obtained revised ethics for this change of plan in November 2014 from the University of 
Glasgow and approval from the executive committees of the ISSP and IAPC. The final 
paper version of the questionnaire and its plain language statement are included in 
Appendices 6 and 7. 
Despite my methodical process of creating the questionnaire there are still inherent 
limitations and weaknesses with the tool. The questionnaire contains a mixture of closed 
and open questions. When considering the closed questions, apart from the very straight 
forward opening questions related to profession, location and society membership, I asked 
respondents to choose a category of best fit for their answer. For example, asking: what 
proportion of time participants spend working in pain management, how frequently 
treatments are available and how they evaluate the quality of their service. This forces 
respondents to pick from a list chosen by me rather than one created by them. It does 
however make for easier collation and presentation of the data and a degree of comparison 
with other similar studies. However, these responses lack the thick description of open 
questions. In contrast, the open questions asking for example about how to bring about 
service change provide more complex data, albeit requiring time consuming qualitative 
analysis and presentation.  
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2.3.4.2 Distribution and Collection of the Questionnaires 
I took a small number of printed questionnaires to India in February 2015; due to airline 
luggage weight limits I printed the remainder in India. Although the survey itself was 
anonymous, I numbered each copy so that I could log the number distributed. The first 
conference I attended was the ISSP meeting held in Chennai. I originally tried to add a 
copy of the questionnaire to each delegate’s conference bag, received on registration. 
However, it was not possible for practical reasons to reliably add the survey to each and 
every bag so I opted for the more labour intensive method of handing them out in person. I 
stood by the only entrance to the conference venue and tried to speak to every delegate 
after they had registered, explaining my work and the survey. I distributed as many as 
possible – the only inclusion criteria being that the participant practised pain management 
in India. This method, although extremely labour intensive enabled me to explain my work 
very personally and I suspect improved my rate of inclusion to the study. It meant that I 
met almost all the delegates, many of them familiar faces from previous trips. I asked 
delegates to return their completed questionnaires to a labelled box or in person to me at 
any time during the conference. Invaluably, I was also granted announcements during the 
conference lectures to remind delegates to pick up and complete the questionnaires.  
My second site of data collection was the IAPC conference held in Hyderabad. I used a 
similar strategy of distribution by standing at the entrance to the main lecture theatre and 
attempting to speak to as many delegates as possible. The considerably larger numbers at 
this conference, however, and the relatively high percentage of delegates who did not fit 
my inclusion criteria meant that it was impossible for me to speak to everyone 
individually. Again, I was fortunate enough to have an announcement made during a well-
attended plenary session publicising my study and reminding delegates to complete and 
return the questionnaires. An eminent colleague also generously assisted in distributing the 
questionnaires, which very helpfully increased the number of participants. There was 
nonetheless an inevitable difference in my methods of distribution and explanation at each 
conference.  
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2.3.5 Data Analysis and Presentation 
I analysed elements of the survey and interview data both individually and together. On 
returning to the UK I reviewed all of the completed questionnaires, numbered them from 
1-95 and entered all of the data into a Microsoft Excel spread sheet for further analysis. In 
addition, I uploaded all of the answers to the open questions into the computer assisted 
qualitative data analysis software NVivo. Similarly, I transcribed all of the interview data 
and uploaded each transcript into NVivo.  
2.3.5.1 Quantitative Data 
I analysed the quantitative data from the questionnaires within Excel to produce a number 
of tables, graphs and charts. Most of the closed questions were easily collated and 
presented but as I worked through each question I created a log of my detailed methods, 
such as deviant cases, unclear responses and any assumptions I made. For example, when 
analysing the responses to a question asking what training respondents had received and 
how long it had lasted. I created categories of duration to present this answer graphically. 
Each of these assumptions is detailed in the following results chapter. 
As I explained above, my sampling technique for the survey was largely convenience 
sampling with an added component of purposive sampling. This is therefore not a 
probability sample to be used to infer generalisable findings at a population level derived 
from statistical models. My aim in analysing and presenting this survey data is not to prove 
statistically valid relationships or causation, but to contribute to the map of how pain 
management is practised and to demonstrate some of the complexities and variations in 
practice. In some areas, such as treatment availability this data adds detail, and in others 
such as the description of assets and barriers to healthcare improvement, the data adds 
breadth. 
I presented this preliminary quantitative, survey data at the ISSP and IAPC conferences in 
February 2016 in the cities of Indore, Uttar Pradesh, and Pune, Maharashtra; and at a 
University of Glasgow symposium in December 2015. This allowed me to add validity to 
my research results by discussing these data with participants, other healthcare workers in 
India, and expert peers in the UK and overseas. 
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Although the vast majority of the interview data was qualitative I did analyse and present 
a small amount of data quantitatively. Some of this was straightforward information such 
as the duration and location of the interviews. I also chose to represent the answers to some 
open questions in a quantitative manner as well as analysing them qualitatively. 
Specifically I noted the number and type of institution worked in, the type(s) of medical 
conditions treated and the mode(s) of care given. I chose to do this in addition to 
qualitative analysis to complement the data and add some comparison between the data of 
the questionnaires and the interviews. There are however limitations with this approach 
with an over simplification of complex areas of enquiry. 
2.3.5.2 Qualitative Data 
Having uploaded all of the qualitative data into NVivo I began the process of coding. 
Starting with a selection of interviews I considered to be particularly pertinent, I read 
through the interview transcripts and my field notes and began selecting or coding any 
sections that contained information relevant to my research questions or that were of 
particular interest. I gradually created a set of themes or ‘nodes’; and wrote memos 
connected to the transcripts, to the nodes and to my research diary detailing this process 
chronologically. By reading and re-reading, coding and re-coding, using a process of 
constant comparison to refine the nodes and to identify outliers I built up a hierarchical 
node tree. 
Initially this process was a largely deductive process as I coded for themes related to some 
of the more specific research questions, often those included in both the interviews and 
surveys such as treatment availability and the types of medical condition treated. As I 
explained above, these themes are, broadly speaking, related to how pain management is 
delivered on a day-to-day basis and where possible I analysed and presented this data 
quantitatively. 
In order to elicit more nuanced results, I then began coding data related to participants’ 
evaluation of their work and of the practice of pain management across the country as a 
whole. This process was both deductive and inductive as I worked through some themes 
that were already well described in the literature such as a lack of resources, but also 
created themes for areas that were less well described, such as the existence and function 
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of specific medical specialties. Again, using a method of constant comparison I refined a 
hierarchical node structure related to participants’ evaluations.  
Finally, I created nodes relating to how these evaluations are formed, framed and 
contested. This process was largely an inductive process as the themes emerged as I coded 
and re-coded the data, rather than being defined at the start of the process. For example, 
early on I noticed the high prevalence of the use of the term ‘awareness’ in relation to 
improving the provision of pain management. As I worked with the data I began to see 
awareness as closely linked to ideas of knowledge creation, education and contested 
power. This led to the creation of the nodes reported in the final section of my results 
chapter.  
During this process I created some nodes that turned out to be less relevant and less useful 
as the work progressed. For example, in an attempt to look at the various influences and 
normative positions of participants I coded some data with respect to its chronological 
reference. So I labelled information as ‘past’, ‘present’ and ‘future’; depending on whether 
participants were talking about past influences, what currently happens and what should or 
could happen in the future. While these categories were useful to progress my 
understanding of the data, they did not turn out to be useful as final nodes in themselves to 
be presented.  
Having created this node structure, I analysed the answers to the open questions of the 
questionnaire and my field notes and journal, within NVivo. This process enabled me to 
crosscheck my results by comparing and identifying outliers against my final node trees in 
a deductive process. 
Of note, throughout this data analysis I used the computer software NVivo as a powerful 
system for filing and cross-referencing coded data. It enabled me to collate efficiently and 
to refine my coding process by keeping memos, nodes, and my journal cross-referenced. 
NVivo is not designed to carry out automated computer generated coding
288
 and the actual 
selection and coding of the data was done by hand. Broadly speaking, in the results chapter 
I reported the qualitative data using the nodes I created in NVivo although some of the 
names have been modified or re-ordered to enhance clarity. To ensure completeness and to 
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provide a clear log of my work, where possible, I indicated within NVivo in which 
section of the results chapter each node’s content is reported. 
2.4 Summary 
The aim of my research, to assess critically the practice of medical practitioners working in 
pain management within the healthcare system of India, involves drawing on multiple 
social science theories including social constructionism, theories of the policy process and 
postcolonialism. I have demonstrated in this chapter how these theories directly informed 
my methodological approach of using mixed methods of data collection.  
I have shown that my research questions, which incorporate both the assessment of 
specific details of clinical care delivery as well as the evaluative judgement of individual 
clinicians, demand the use of both quantitative and qualitative data.  
I set out in detail my research methods that include the use of background reading of 
relevant literature, a review of an oral history archive, field notes from four visits to India, 
collection of interviews and surveys with healthcare workers in India, and journal entries; 
highlighting the strategies I employed to seek methodological rigour.  
This research process, summarised in Figure 2-3 and Table 2-1, due to its iterative nature, 
resulted in constant modification of my understanding of the practice of pain management. 
In the early stages of the work, I followed a more inductive approach as new concepts 
emerged, but as I refined my results the process became more deductive and ultimately 
shaped the overall perspective and outcomes of the study.
 Chapter 3 - RESULTS 
3.1 Introduction 
I outlined in the preceding chapters my strategy of using data collected from multiple 
sources in order to build up a detailed, multi-faceted picture of the practice of pain 
management in India. My key motivation for using multiple data sources is to create a 
more in-depth, rounded, and therefore representative depiction of the themes and 
phenomena involved. The results in this chapter are therefore presented in sections 
according to these themes, each of which contain data from multiple sources and combine 
qualitative and quantitative information.  
In the first section (3.2), I present an overview of the primary data collected from 
questionnaires and interviews. In the remainder of the chapter I present key themes arising 
from these data. I begin by introducing the finding about how clinicians describe pain as a 
medical problem (Section 3.3). I then demonstrate the practical implications of this 
professional construction, firstly by presenting data relating to features of the Indian 
healthcare system in Section 3.4, and then by considering the organisation of the medical 
profession and clinicians’ treatment selection in Sections 3.5 and 3.6 respectively. 
In the final sections (3.7-3.9) I move on to present data related to how the participants’ 
evaluations of these phenomena are framed, formed and contested, both locally and within 
a wider global context. In Section 3.7 I present results relating to descriptions of policy and 
governance. In Section 3.8 I consider data on clinicians’ use of knowledge as a tool to 
enact power through their framing of arguments, and by seeking to persuade others to 
modify their thoughts and actions. Finally, in section 3.9 I summarise results describing the 
motivations of the individual participants and the dynamics of how power is contested 
between them and others.  
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3.2 Data Overview 
The questionnaire (Appendix 6) contains a mixture of closed and open questions and is 
divided up in to five sections: questions about the participants (Questions 1-5), questions 
about their place of work (Questions 6-7), questions about the clinical care they provide on 
a daily basis (Question 8-10), questions about treatment availability where they work 
(Questions 11-13) and questions about service quality (Questions 14-17). The audio 
recorded, semi-structured interviews follow an interview guide (Appendices 2 and 3) 
which covers similar topics: introductory questions related to how the participants came to 
work in their current post, questions related to how an ideal pain service would look, more 
specific questions related to the patients and medical conditions they manage and the 
particular treatments that they offer, and ending with questions relating to participants’ 
appraisal of the state of pain management across the country of India as a whole. I also 
collected detailed field notes from each of my fieldtrips to India. Qualitative data from the 
open questions in the questionnaire, the interviews and the field notes were transcribed and 
analysed in NVivo using thematic analysis. Quantitative data, largely from the 
questionnaires, but supplemented with some content analysis data from the interviews was 
analysed in Microsoft Excel spread sheets to produce the tables and graphs presented here. 
3.2.1 Questionnaires 
In February 2015, I attended the national conferences of the Indian Society for Study of 
Pain (ISSP) and of the Indian Association of Palliative Care (IAPC), known as ISSPCON 
and IAPCON respectively, in order to collect survey data from the conference participants. 
I asked only those participants who were currently working in India to complete the forms.  
I have not been able to find out the exact numbers of registrants at the conferences who 
were eligible to take part in the research, however the conference organisers estimated the 
total number of registrants at ISSPCON to be 250, and at IAPCON to be 640 with 140 
known to be from overseas. Overall I distributed 349 questionnaires and received 95 
completed giving a total return rate of 27.2%. At ISSPCON I distributed 159, and received 
40 completed (a return rate of 25.2%). At IAPCON I distributed 190, and received 55 
completed (a return rate of 28.9%). These rates of return are summarised in Figure 3-1. On 
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my return to the UK, I numbered each completed questionnaire from 1-95 and entered 
the responses into a Microsoft Excel spread sheet. 
 
Figure 3-1 Questionnaire Return Rates for each Conference 
The country of India is divided into states and union territories (UTs) and I asked survey 
respondents to name the state in which they work. At the beginning of my research there 
were 35 states and UTs but in 2014 the state of Telangana separated from the state of 
Andhra Pradesh making a total of 36. Because of the timing of this division, I counted the 
two states together. The states in which the respondents work are listed in Table 3-1. Of 
note, the states with the highest numbers of respondents are Andhra Pradesh (including 
Telangana), Kerala, Maharashtra and Tamil Nadu. The ISSP conference was held in the 
city of Chennai, Tamil Nadu, and the IAPC conference in Hyderabad, Telangana, which 
will likely contribute to the relatively high numbers of respondents for each of these states 
and lead to an over-representation from these areas. There are also other states with 
expected high numbers of respondents, notably Maharashtra at ISSPCON and Kerala at 
IAPCON. The state of Maharashtra contains Mumbai – India’s most populous city, 
although the state as a whole ranks second to Uttar Pradesh for total population.
289
 Kerala 
is the state with by far the highest number of palliative care services recorded 
elsewhere.
163,290
 Of note the questionnaire respondents represent only 15 States and UTs 
out of a total of 35. It is not possible to say from this data whether this reflects low levels 
of pain management provision in these unrepresented states.  
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Table 3-1 State or Union Territory (UT) of Questionnaire Participants' Place of Work 
I asked questionnaire participants to indicate whether they are members of the ISSP the 
IAPC or both societies. The results for all participants are presented in Figure 3-2 and for 
each conference separately, in Figures 3-3 and 3-4. Overall more respondents are members 
of the IAPC than the ISSP, and some who are members of the IAPC alone, attended the 
ISSPCON. However no respondents at the IAPC conference are members of only the 
ISSP.  
 
Figure 3-2 Society Membership of all Questionnaire Participants (N=95) 
19 
35 10 
31 
ISSP
IAPC
Both
Neither
State/Union Territory ISSPCON IAPCON Combined 
Andhra Pradesh (incl. Telangana) 1 15 16 
Assam 1 3 4 
Bihar 2 0 2 
Chandigarh (UT) 1 0 1 
Delhi (National Capital Territory) 0 3 3 
Gujarat 0 1 1 
Himachal Pradesh 1 0 1 
Karnataka 4 6 10 
Kerala 5 13 18 
Maharashtra 11 6 17 
Odisha 1 0 1 
Puducherry (UT) 0 1 1 
Tamil Nadu 9 3 12 
Uttar Pradesh 1 2 4 
West Bengal 3 1 3 
Not stated 0 1 1 
Total 40 55 95 
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Figure 3-3 Society Membership of ISSPCON Questionnaire Participants (N=40) 
 
Figure 3-4 Society Membership of IAPCON Questionnaire Participants (N=55) 
In the questionnaire I specifically asked respondents to indicate the proportion of their 
clinical time spent working in pain management. The results are depicted in Figure 3-5.  
 
Figure 3-5 Proportion of Clinical Time Questionnaire Participants Spend Working in Pain 
Management (N=95) 
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Two respondents state that they spend no time working in pain, raising the question of 
whether their results should be included in the analysis of the other questions. However, 
one of these two responds to later questions stating the types of pain conditions they treat, 
implying that they do in fact work in pain management. The other respondent answers 
almost all the remaining questions with either “NA” or leaves them blank. One respondent 
writes in the free text area, “I am not directly involved in patient care”, but they also tick 
the ‘<25%’ as opposed to the ‘none’ box. The inclusion of this <25% option may actually 
mean that others who also tick this option do in fact work in pain management ‘none’ of 
the time. In retrospect the questionnaire may have been clearer if I had included a lower 
cut off to this category. Of the three who tick ‘other’, the following text is written “4 hours 
per week”, “We deal with the psychosocial side of PC – have a support group & Day Care. 
The doctors on the team deal with pain management.” And “All my free time after my 
regular work as a gynaecologist” [sic]. Two of those who leave the tick boxes blank write 
the following free text “When I have free time,” and “Used to work 75-99%. Now more of 
management of the centre.”  
3.2.2 Interview Data  
I collected 28 audio-recorded interviews in 2014 and another 5 in 2015. 10 of these 33 
interview participants are female. The majority of the interviews were recorded at the ISSP 
and IAPC conferences in the cities of Navi Mumbai, Bhubaneswar, Chennai and 
Hyderabad but some participants opted to carry out the interviews at their place of work. 
Table 3-2 shows the state or union territory of the interview participants’ place of work.  
As with the questionnaires, there is a high representation from the states close to where the 
conferences were held, namely Maharashtra and West Bengal (a neighbouring state to 
Odisha). Furthermore, three of the five most populous cities in India – Mumbai, Kolkata 
and Bangalore,
289
 are situated in the states of Maharashtra, West Bengal and Karnataka 
respectively. These are the three states with the most participants in my sample, which may 
simply reflect the higher number of practitioners working in pain management. 
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State/Union Territory  No. of Participants 
Andhra Pradesh (incl. Telangana) 3 
Chandigarh (UT) 1 
Delhi (National Capital Territory) 1 
Gujarat 2 
Karnataka 4 
Kerala 3 
Maharashtra 8 
Odisha 1 
Punjab 1 
Tamil Nadu 3 
Uttar Pradesh 1 
Uttarakhand 1 
West Bengal 4 
Total 33 
Table 3-2 State or Union Territory (UT) of Interview Participants' Place of Work 
The majority of the 33 interviews were recorded with individual participants. However, 
two consecutive recordings were carried out with each participant listening to the other, 
one was carried out with a whole clinical team present and one in front of a (consenting) 
patient. I met all of the participants at the ISSP and IAPC conferences except for one who 
was introduced to me through another conference delegate. I carried out the interviews 
either there and then or during subsequent visits to their place of work. Figures 3-6 and 3-7 
show the numbers of participants met at each conference and where the interviews were 
recorded. 
 
Figure 3-6 Conference Attended by Interview Participants (N=33) 
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Figure 3-7 Location of Interview Recordings (N=33) 
Of note, the preponderance of participants attending the ISSP conference is intentional, 
reflecting my aim of ensuring that participants working in pain management outside of the 
field of palliative care are included in the study. 
The interviews range in length from 16 to 73 minutes giving a total duration of 19 hours 
and 41 minutes of recorded data. Figure 3-8 shows the duration of the interviews arranged 
here in size order with each column representing one interview. 
 
Figure 3-8 Length of Interviews in Minutes (N=33) 
Table 3-3 is the final coding tree of nodes or themes resulting from the combined analysis 
of the qualitative data from the interviews, questionnaires and field notes. Where possible I  
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1st Order 2nd Order 3rd Order 4th Order 5th Order 
Evaluation  
Philosophical position 
(3.3) 
Humanitarian goal 
Patients’ acceptance of pain 
Healthcare system  
Resources (3.4.1) 
Service finances 
Buildings 
Trained personnel 
In-house 
More locations 
Patient finances 
Plurality of healthcare 
(3.4.2) 
Uniform practice 
A medical specialty 
(3.5) 
Conditions treated 
Treatment selection 
(3.6) 
Pharmacological 
Non-pharmacological Ultrasound 
Holistic approach 
Religion and spirituality 
Policy and governance 
(3.7) 
Bureaucracy  
Authority priorities 
Rules of medical organisations 
Knowledge 
exchange (3.8) 
By – strategies  
Higher education 
In-house teaching 
Writing books 
Research to increase knowledge 
Professional bodies  
Patient consultation  
Reputation (word of mouth) 
Marketing  
Public programmes 
Reaching politicians and managers 
For – target audience  
Clinicians 
Lay people 
Managers or government 
Companies  
In order to – 
aims/achievements  
Increase practitioner numbers 
Increase referral number and 
speed 
For the poor or rural 
Improve function of medical specialty 
Improve access to specific treatments 
Increase funding for awareness  
As therapy  
Of – issues/successes  
Pain as a problem Fundamental need 
Pain prevalence 
Denial of terminal cancer 
Negative consequences of untreated pain 
Existence of specialty 
Treatment options 
Personal 
motivation (3.9.1) 
Suffering patients  
Painful experience 
Blocks 
Holistic approach  
A good life 
Autonomy or status  
Colleagues’ attitude 
Pioneers 
Self-taught 
Inspirational teacher or place 
Power contestation 
(3.9.2) 
Top-down 
Competition 
Corruption and trust  
Collaboration 
Global-local 
Money 
Table 3-3 Qualitative Data Coding Tree 
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indicate in this table the chapter section in which the themes (and their subsets) are 
reported. However, some of the topics such as ‘pain as a problem’ or ‘money’ are integral 
to the whole thesis and therefore their reporting is included in many topics and in many 
sections of the chapter, rather than in one discrete location.  
3.3 Pain as a Problem 
All of the interview participants talk of the need to implement changes to improve pain 
management either where they work or in the country as a whole. Before discussing these 
desired changes in more detail I want to comment on the fundamental assumption 
described by participants that pain is a problem to be fixed. This is distinct from 
descriptions related to the prioritisation of the treatment of pain - whether governments and 
managers decide to provide medical pain services, whether a clinician considers a patient’s 
pain to be significant enough to warrant investigation or treatment, or whether a patient 
chooses to spend their money seeking medical advice, all of which I consider in more 
depth later. Here I concentrate on the actual conceptualisation that pain is a problem to be 
tackled within the healthcare system.  
Participants describe the need to treat pain as a fundamental humanitarian goal, their aim 
being to relieve the suffering of others. Some describe this in terms of human rights, for 
example: 
“I very strongly believe the pain relief is a human right.” (Interview 15) 
Furthermore, there is an acknowledgment that potential patients do not share this view that 
pain is a medical problem and are instead very accepting of pain in their lives. One 
participant explains: 
“There’s not exactly a felt need to you know, actually take up pain as a problem.” 
(Interview 16) 
Although this idea that pain is a problem appears to be universally supported by the 
participants, their descriptions of this concept imply that many other individuals do not 
hold this view. All of the interview participants talk of the need to improve pain 
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management across the country, but some of them specifically describe the need to 
spread the idea of the concept that pain is a problem in itself. This is talked of in reference 
to various different groups, including most interestingly the patients themselves but also 
fellow clinicians and other professionals.  
Following on from this presupposition that pain is indeed a problem to be treated 
medically, one of the described barriers to delivery of care is the failure of some members 
of the profession to wholly sign up to this position. For example, participants explain how 
their colleagues talk of pain as an expected symptom of a particular disease, a symptom 
that does not require treatment itself. Their rationale being that by treating the underlying 
disease that is causing the pain, this symptom will also resolve. In this context a degree of 
responsibility for patients tolerating poor pain management is placed with the medical 
profession. For example one participant states: 
“Sometimes the patients also are made to believe if there is surgery or if the cancer is 
growing, I’ll have pain, we have to tolerate.” (Interview 25) 
However, there is also an implication of ignorance within the profession, who are only 
acting as they have been taught to do so. In this context the participants describe a need for 
more education in order to alter the mind-set of clinicians. The participant below describes:  
“We often hear the doctors and nurses telling the patients that, I’m sorry, I wish I 
could do something, but you probably have to bear the pain because it’s a part of your 
disease. So that’s how the attitude is, because they really don’t know about it. I’m sure 
they won’t be callous enough not to try if they knew, but since they’re not taught, 
they’re not aware, then obviously they don’t know.” (Interview 21) 
Moving on to the patients themselves who, in marked contrast to the participants who 
describe pain as a problem, are, at times, described by as being very accepting of the 
presence of pain as an expected part of life. A key theme related to this conceptualisation 
of pain as a medical a problem relates to perceived differences in the Indian population 
when compared to countries in the global North. One participant says: 
“As Indians we, they never express their pain because they think that, you know, 
ageing is normal and pain with ageing is just normal, which you have to live up and 
put up with it.” (Interview 3) 
Chapter 3 
 
111 
This is also related not so much to a fundamental difference between individuals, but to 
societal pressures. For example a doctor talks of the different support available for patients, 
albeit for those living a middle class lifestyle: 
“Abroad you have to do all the work yourself, here we have maids, even the lower 
middle class people have maids. So if you are unable to function there is somebody 
who does the work” (Interview 2) 
This described difference between populations has a particular significance when the 
treatment of pain is discussed. Participants explain that because of the population 
characteristics or societal differences, directly exported western medical treatments are 
unlikely to be the most effective. One interviewee explains: 
“I think we have culturally grown to accept pain more here. So anything that has to be 
done, I think we have to find our own solutions here. So, that I strongly believe in, we 
should not extrapolate what is there from, in the western countries.” (Interview 32) 
However, interestingly participants also talk of how this scenario is changing. Specifically 
within the wealthier and urban communities participants describe a temporal change in 
attitudes as society modernises, for example: 
“Earlier tolerating pain is our culture, they never used to come and complain about the 
pain. That will be there, that’s all ok, pain means ok, if the trauma is there, pain, we 
have to tolerate the pain. That is not there nowadays. Now, now they’re explicitly 
complaining of pain.” (Interview 31) 
A final key point of interest here is that although some participants acknowledge that often 
chronic pain can only be reduced with medical intervention to a certain degree rather than 
eliminated altogether, I only found one clear example of how this limitation of medicine 
may be a problem in its own right. One survey respondent described the answer below as a 
significant barrier to improving their service:  
“Unavailability of an ideal modality to control chronic pain.” (Questionnaire 16) 
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3.4 The Healthcare System 
During the interviews I specifically asked participants about hindrances to improving the 
clinical service they provide, and in the questionnaires I asked them to list the most 
significant barriers and assets to improving their service. When considering the provision 
of pain management within the healthcare system of India, either in participants’ own 
places of work or across the country, the key areas that participants highlight relate to a 
scarcity of resources – both financial and human, and to the presence of multiple types of 
healthcare delivery. The data described in this section, relating to these issues is derived 
from the interviews and questionnaires containing both quantitative and qualitative 
information.  
3.4.1 Resources 
The lack of resources, described by participants, whether absolute, or relative secondary to 
unequal distribution, includes a scarcity of financial wealth and a lack of trained personnel. 
Furthermore, the lack of funding relates both to the organisations providing clinical 
services and to individual patients. I therefore consider each of these themes in turn.  
3.4.1.1 Institutional Funding 
With respect to absolute funding, participants describe problems with the amount or 
quality of physical space available in which to practice. This is noted to be especially 
problematic in the large cities where real estate is at a premium. This results in a relative 
shortage of in-patient beds, in staff having to compete with surgeons to find a time slot in 
the operating theatres to carry out pain relieving procedures and in having to run out-
patient clinics in overcrowded settings. One particularly stark description of these 
pressures is from a doctor working in a government facility: 
“When death happens, we don’t have a place to park the dead body, so it is in the 
middle, and we are doing procedures, on the both side.” (Interview 24) 
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Participants explain how financial constraints also result in many problems for 
delivering specific therapies due to a lack of equipment or specialist trained staff. This can 
result in clinicians modifying their choice of treatments away from the most expensive 
‘gold standard’ options. This is sometimes described in utilitarian terms, maximising the 
number of patients who can be treated. A doctor working in a charitable organisation says: 
“If we try to do better for the individual patient then others will be deprived of care, 
mainly because of limited resources.” (Interview 18) 
It is worth noting in my data sample that although many participants talk of a paucity of 
finances, a number of participants work in institutions they describe as well funded. In 
these institutions although they do not talk of a dearth of absolute funding they do note that 
there are still issues with relative finances in that they need to persuade managers of the 
economic benefits of treating patients’ pain. One participant working in a corporate facility 
says: 
“Well, financially, I don’t think there’s much of limitation from, you know in a 
hospital like where I’m working, it’s just that sometimes the management doesn’t see 
the return of investment on such things.” (Interview 10) 
Even in the government sector a clinician working in Delhi similarly describes high levels 
of absolute funding: 
“Being in the capital of the country I can tell you, there is no dearth of funding, it is 
the lack of willingness on the part of the administration authorities.” (Interview 13) 
3.4.1.2 Patient Finances 
I now move on to consider the finances of the individual patient. When considering the 
qualitative data, participants describe how the finances of patients affect the treatments 
they receive. The explain that having to pay for treatment can cause patients to delay 
seeking medical advice for conditions until they are more advanced and even more 
resistant to treatment, and that it may deter some people from seeking medical help at all. 
One interviewee working in palliative care describes this: 
“Because there’s no insurance, people pay out of pocket and medicines become the 
last important thing, because again health becomes the last important thing where you 
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see people with advanced stages because they don’t want to spend on healthcare, 
they want to spend on everything else before they come into healthcare.” (Interview 
19) 
One pain specialist notes how patients’ ability to pay also affects the actual treatments 
given by doctors: 
“At many times you are forced to you know, change your treatment just because 
something is not available or the patient can’t afford.” (Interview 14) 
This is described as compounded within the field of palliative care, where people are often 
seeking pain relief for a disease such as cancer that they have already spent huge sums of 
money trying to cure. One physician working in pain management explains: 
“When it comes to question of palliation they have already exhausted their funds, they 
spent thousands of money on chemotherapy, surgery, everything, so they want to keep 
it simple.” (Interview 12) 
Participants explain that those services that are specifically targeting improving access to 
pain treatments for the poorer members of the community (often government or charitably 
funded institutions) do not usually offer the more complex or expensive treatments. 
However, in practice even the private institutions do not actually deliver these high-end 
treatments because patients choose not to or are unable to spend such significant sums of 
money. Here a pain doctor talks about using a treatment called spinal cord stimulation: 
“For advanced neuromodulation like spinal cord stimulation, which cost around, in 
Indian rupees it comes to around two-point-five to three lakh [100,000], three-point-
five lakh, which is a huge amount, which is almost at par with the amount which is 
spend on cardiac bypass surgery, when a patient has, so you see how many, you know 
what percentage of the public can afford that huge amount?” (Interview 13) 
Participants talk of the ways in which this situation could be improved – by increasing the 
funding from government, increasing the number of treatments that are funded by insurers 
and by reducing the costs of treatments by working with industry. One pain specialist 
explains how the pharmaceutical industry could be influential: 
“Of course the pharma companies and all these drug companies, they should also have 
subsidised medicines, because in a third world country like ours we have so many 
financial problems, so many obstacles because in many places you get the idea that 
pain is only for the affluent, pain relief is only for the affluent, which is not fair.” 
(Interview 14) 
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Another interviewee focuses on involving companies who manufacture other devices 
such as the spinal cord stimulators talked of earlier: 
“We cannot do many cases because the cost involved is so high. In my twenty, 
twenty-five years of practice I have done not more that four to five procedures. On 
that basis nobody’s going to get convinced to get this treatment. So that’s the reason I 
have been talking to some of the companies to give us those things, we can, we do the 
research in thirty, thirty-five, forty patient then we can present our data to the people 
in India.” (Interview 15) 
Another doctor working in palliative care talks of the need to focus attention on 
finding newer cheaper treatments altogether: 
“Research should be focusing on simpler methods, easier methods to control pain, like 
going into the morphine pump I don’t think the affordability would be zero-point-one 
per cent, you know. We need to look at techniques which can be used simply without 
much set up then pain can be controlled much more better.” (Interview 19) 
As I demonstrate in more detail below (in Section 3.4.2) participants work in a wide range 
of healthcare institutions delivering pain management and employ a variety of financing 
structures. In the questionnaire I asked respondents to indicate the percentage of patients 
they treat who receive all of their treatment free of charge (Question 7). The results are 
demonstrated in the bar chart of Figure 3-9. 
In Figure 3-10 I separate out the results of Question 7 into two sets of columns each 
representing the responses from the different conferences attended. The lighter shaded 
columns depict the responses from those attending ISSPCON and the darker, IAPCON.  
Both graphs demonstrate a wide range of answers with at least one respondent selecting 
each of the options. Of note, however, in Figure 3-9 there are peaks at each end of the 
spectrum, in the 100% and the 1-10% columns. If the results are separated out, however, 
into the respondents from each conference (Figure 3-10) there appears to be a different 
spread, with a peak at 1-10% for those attending ISSPCON and a peak at 100% for those 
attending IAPCON. Although these are not presented here with comparative statistical 
analysis, there is a suggestion of a broad difference in the type of practice between the two 
groups – namely in the degree of charitable work undertaken.  
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Figure 3-9 Proportion of Questionnaire Participants' Patients Receiving Pain Treatments 
Free of Charge (N=95) 
 
Figure 3-10 Proportion of Questionnaire Participants' Patients Receiving Pain Treatments 
Free of Charge, by Conference Attended (N=95) 
3.4.1.3 Trained Personnel 
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dearth of healthcare staff across all areas of healthcare, which means that staffing in 
pain management is not a priority, for example: 
“It is not surprising that pain is suffering, because health, there is no provision for 
health, so where is the question of pain relief?” (Interview 11) 
Specifically within the field of pain management interviewees explain how there are 
insufficient numbers of professionals who are trained in the field. Although many talk of 
how the situation has improved a little over recent years there is a striking difference in the 
availability of services between the urban and rural populations. A doctor working in 
Mumbai describes this: 
“The population of Mumbai itself is about one crore [10 million]. So if, if in a 
population of one crore in city of Mumbai, we have not more than fifteen pain clinic, 
you think the situation in the rural areas, in the district places.” (Interview 15) 
In the questionnaires, a lack of manpower is listed as a specific reason for clinicians not 
being able to expand their services.  
Patients frequently have to travel great distances to access specialist services as explained 
by a doctor working in a regional cancer centre: 
“Actually our cancer patients, which are visiting my department, they are very much 
happy with our service, but what happens, you know, the, ours is the only centre for 
whole of Gujarat, where such services are available, so they have to come, travel a lot, 
from far off places. So I feel that if they have some follow-up at their own place there, 
or district level, then they will be much happy, comfortable.” (Interview 4) 
This lack of services at a geographical level can lead not only to inconvenience for patients 
but also to clinicians modifying their choice of treatments. One participant here is 
explaining why some complex implanted devices requiring on-going medical input are not 
used: 
“What would be the after care? So, due to lack of supportive care, we do not do.” 
(Interview 11) 
The relative lack of doctors means that often there is a severe lack of time available to 
spend with individual patients for example there may be significant overcrowding in out-
patient clinics as described here: 
Chapter 3 
 
118 
“Many a times, the other practitioners, they don’t have sufficient time, they have 
got a huge number of OPD patients, so they are not in a position to give sufficient 
time.” (Interview 6) 
Doctors working in pain management often have other clinical commitments, which they 
consider to impact on the time available to treat each patient. One doctor who also works 
in the specialty of anaesthesia has to deal with patients’ pain after surgery (in the operating 
theatre recovery ward) as well as those in out-patient clinics. This tension is explained 
here:  
“The person who is sitting in the chronic pain has to see the pain management in 
recovery ward also. So, in the afternoon he is tearing between the two.” (Interview 11) 
These demanding working conditions are described as adding to the difficulty of 
recruitment into some posts, which are relatively poorly remunerated further compounding 
the problems of insufficient funds to pay salaries and the lack of training opportunities. 
One doctor working in palliative care explains:   
“We have actually applied for but the response we have got is very poor because 
many people are not willing to come to palliative care. See palliative care doesn’t 
come with incentives. And a country like India, where doctors expect a bit of 
incentive by seeing a patient, giving rounds, in a charitable institute, where you don’t 
get additional payment, if there’s no incentive they don’t feel the urgency.” (Interview 
26) 
However, this particular issue is not specific to those working in palliative care or indeed 
the charitable or government sector where salaries are traditionally lower. Those working 
solely in pain management even in the private sector note that there can be financial 
sacrifices to be made especially when they are setting up an independent practice from 
scratch with a small number of patient referrals and therefore income base.  
The problems of understaffing are not limited to the medical profession. Nurses are also 
noted to be overstretched leading to delays in attending to patients or even omissions in 
administering analgesia. There is also a reported shortfall in allied health professionals and 
administrative staff. One doctor describes how he resolved the problem of not having a 
dedicated radiography technician to work an x-ray machine (c-arm):  
“I have trained even a tea vendor in my hospital in the orienting the c-arm, and this 
imaging, and now he’s working with us.” (Interview 7) 
Chapter 3 
 
119 
Other specialised roles are also not filled partly due to a lack of locally trained staff. 
One palliative care doctor explains how their service relies on overseas help: 
“Whenever the volunteers are available, aromatherapy is available, when the foreign 
volunteers are not there there’s no aromatherapy.” (Interview 17) 
Locally trained volunteers are also often relied upon to deliver pain relief and other clinical 
care most notably within the field of palliative care where patients frequently require round 
the clock care at home during the last few days and weeks of their lives.  
3.4.2 Diversity of Healthcare Provision 
I outlined in Chapter 1, how healthcare in India is provided by a diverse array of 
practitioners operating outside of the umbrella of western or allopathic medicine, and even 
within the field of western medicine or allopathy there are many types of clinical 
institution receiving multiple sources of funding.
131
 In the questionnaire I asked about the 
institutions where participants work, to indicate which sort of institution they work in and 
how it is funded (Question 6). Many respondents tick more than one box, indicating that 
they work in multiple organisations and/or with varied sources of funding. One specific 
limitation of the question format is the difficulty in determining the number of institutions 
each participant works in. For example, if they tick two boxes in one row, such as a 
general hospital with private and charity funding, this could either indicate they work in 
one institution with mixed private and charitable funding, or that they work in two separate 
general hospitals, each with their own single funding type – one private and the other 
corporate. Figure 3-11 shows the type of funding indicated for each institution listed, by 
each respondent, hence the total number of institutions (129) is more than the number of 
respondents (95). 
One respondent does not tick any boxes in the question but writes the free text “I am a 
private freelance consultant, having my own clinic for Pain Management. This not funded. 
Affordable patients pay for their own, if they are not affordable, I am doing this free, 
especially for cancer patients.” This demonstrates another limitation of this type of 
question, namely that respondents feel the fixed categories presented to them are 
inadequate descriptors of their answer. Some respondents do not tick any boxes but they do 
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write the name of an institution in the free text area, these are counted as working in one 
type of institution, although the data isn’t clear enough to be added to the graphical data of 
Figure 3-11. Figure 3-12 demonstrates the numbers of types of institution each 
questionnaire participant works in. 
 
Figure 3-11 Funding of Place(s) of Work of Questionnaire Participants (N=129) 
 
Figure 3-12 Number of Types of Institution Worked in by Questionnaire Participants 
(N=95) 
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The interview participants also talk of working in multiple institutions. While the nature 
of the interview data collection as semi-structured with the use of a guide rather than the 
fixed questions of the written questionnaire leads to some ambiguity, I have been able to 
extract some quantitative data relating to place of work from this source. For example, 
although participants talk about the institutions where they work, I did not consistently ask 
directly how many hospitals they work in or how their practice varies amongst these 
institutions. Furthermore, some participants had recently moved their place of work and 
talk about the institution in which they worked in the past as well as their current post. 
However, I did ask directly about the funding of their place of work. Figures 3-13 and 3-14 
show the number of institutions the interview participants work in and the variation in 
funding types respectively. 
 
Figure 3-13 Number of Institutions Worked in by Interview Participants (N=33) 
 
Figure 3-14 Funding of Place(s) of Work of Interview Participants (N=33) 
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which has a different type of funding. In keeping with the results of the questionnaire, 
several participants work in multiple institutions often funded in various ways. Some 
working primarily in the private sector describe carrying out additional charitable 
activities, others supplementing their income through private work. 
 
Figure 3-15 Type of Clinical Care Delivered by Questionnaire Participants (N=95) 
 
Figure 3-16 Frequency of each Type of Care Given by Questionnaire Participants 
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Leading on from this I asked questionnaire (Question 8) and interview participants 
about the type of clinical care they give on a daily basis and whether this is in-patient, out-
patient or home care. Many questionnaire respondents indicate that they offer more than 
one type of care so the results of this data are presented here in two ways: firstly, in Figure 
3-15, as the number of respondents offering each combination of care type and secondly, 
in Figure 3-16, as the number of respondents offering each type of care. In Figure 3-16, 
therefore, the total number of responses (204) is more than the number of participants (95). 
In addition to the options provided on the questionnaire, one respondent states that they 
provide a “teleclinic”.  
Similarly, where possible I collated quantitative data from the interviews relating to the 
type of clinical care given, depicted in Figure 3-17.  
 
Figure 3-17 Type of Care Delivered by Interview Participants (N=33) 
The plurality of provision in the healthcare system of India is a significant theme in the 
qualitative data. As the results show within the practice of pain management, allopathic 
doctors work in a range of institutional settings. The participants describe how this makes 
choosing a doctor difficult for patients, and how this is compounded by the very low level 
of primary healthcare and presence of family physicians who can help to inform patients’ 
choice. One participant explains how patients will often seek advice from a particular 
individual because they trust them as a person rather than because they think they have the 
most appropriate clinical skills for their particular medical condition.  
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“If I have a problem, I go to a doctor in Mumbai, I know Clare, she’s a good doctor 
so I go to her, with whatever problem I have, because she has treated my mother or 
my father, my sister, so I go to Clare.” (Interview 14) 
Participants also explain how this plurality leads to a great deal of variation in the actual 
practice of medicine, which treatments are provided and how training is structured. For 
example: 
“There is no uniform guideline or protocol for pain management, let me say that. 
People have their own experience and they practise and there is no formal education 
available.” (Interview 4) 
This variation of practice is described as compounded by weak regulation: 
“You can inject ozone, you can inject dextrose, you can inject plasma, there’s no 
regulation. So if Indian Society is strong, they can give guideline. In back pain you do 
this, this procedure. This procedure is not allowed.” (Interview 30) 
One of the noted consequences of the presence of multiple providers is that patients may 
choose to visit several different practitioners who offer the same modality of treatment 
rather than progressing through a structured escalated system of referral to try an 
alternative treatment if one has already failed to provide pain relief. Participants talk of 
how this system causes both a delay in referral and to patients not seeking the help of a 
pain specialist at all. One participant describes these problems: 
“So typically, they go to an orthopaedic surgeon, get written some anti-
inflammatories, they take it for two weeks, it may or may not help, and then they go to 
another orthopaedic surgeon who again writes the anti-inflammatories in a different 
name, so they just keep moving around. And three months later, having, and taken 
anti-inflammatories in different names, and with stomach ulcers all sorts of problems, 
you know they really are stuck in terms of where to go.” (Interview 3) 
This wide array of practitioners is described as leading to issues around competition 
between these individuals, particularly but not exclusively, within the private sector. One 
consequence of this is noted to be reluctance on the part of doctors to refer patients on to 
be treated by their colleagues (competitors). I return to the issue of plurality of healthcare 
provision and competition later (in Section 3.9.2) due to its relation to the concept of 
power. 
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3.5 Medical Specialisation 
In the preceding two sections I presented data explaining how pain is conceptualised as a 
medical problem and of how the medical practice of treating pain occurs in a healthcare 
system with multiple types of provider and where there is competition for scarce resources. 
This leads into the discussion of the professional organisation of clinicians themselves. The 
presence and role of specific subspecialties within healthcare are key themes resulting 
from my data, with participants describing both the importance of the presence of medical 
specialities, and of how they should be organised and function.   
As well as describing the lack of staff trained to manage pain, participants frequently talk 
of the creation and function of pain medicine and/or palliative medicine as medical 
specialties in their own right. As I described in Chapter 1, palliative medicine has only 
recently been recognised as a specialty in its own right with just one MD (postgraduate 
training) programme in operation at the time of my data collection.
143
 In contrast, pain 
medicine is not currently officially recognised by the Medical Council of India as a 
medical specialty or subspecialty in its own right.
149
 Many of the interview participants 
have had preliminary specialty training in anaesthesia and some still spend a proportion of 
their clinical time working in this field. The idea that pain medicine, could also be 
recognised as either a specialty in its own right or as a subspecialty of anaesthesia is 
discussed by the interviewees as one of a number of possible strategies to improve the 
provision of pain services in India. 
The participants talk of several potential consequences of the establishment of a medical 
specialty to justify their position, such as, an increased awareness within the rest of the 
medical profession as well for society as a whole, which I return to later in the section 
related to knowledge exchange (3.8). However, the idea of awareness is very much tied in 
with prioritisation and how important the treatment of pain is perceived to be. One doctor 
explains: 
“I think in terms of solutions, we need more training programmes and things, and 
unless it comes from the top, the Medical Council and the professional regulatory 
bodies say ‘Yes, this is important enough’, so that it becomes a speciality on its own, 
it’s going to be difficult.” (Interview 3) 
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Pain specialists talk of having to divide their time between anaesthesia and pain 
management and some describe how the existence of a medical specialty, with the 
subsequent creation of a separate hospital department and clinical posts, would help to 
alleviate this particular tension, at least in the government sector. 
“I wish to go, you know, purely into pain management but you know, I also have to 
do the operating room work so you know, about forty per cent of my time is for 
operating room, sixty per cent for total for pain management, and I wish to have a 
hundred per cent devotion for pain management which at the moment is not possible 
because of the you know, the university, when you’re appointed by the university you 
know, there is no separate appointment, no separate appointment, because there’s no 
post of professor of pain management, it is actually the professor of anaesthesiology 
who’s doing this extra work.” (Interview 13) 
They talk of how the creation of a specialty could increase both the numbers of 
practitioners working in the field and serve as a force to improve education and training. 
As I showed in the previous section (3.4.2) related to the multiple providers of healthcare, 
education and training is described as poorly coordinated and regulated. This leads to 
many participants calling for the creation of national guidelines to inform and, where 
necessary regulate, day-to-day clinical practice. The participants describe the need to 
coordinate practice both to improve the clinical care for patients and to maintain or 
improve the reputation of the specialty. 
“The trainings are not from the government agencies, and that is creating a little 
disparity in the kind of work being done, because few people who were experienced, 
they start imparting training, there are five, six such pockets, and everybody has 
different way of working. So, the people who are coming out have different ways of 
working. So what is required is a protocolised assessment, to treatment, to post-
procedure follow-up, and understanding the pain rather than the procedures is what is 
required, and it is not there.” (Interview 8) 
That said there are some, albeit voluntary, healthcare accreditation schemes operating at a 
national and international level that incorporate some of these ideals. One doctor working 
in the corporate sector explains:  
“It is run by a management which is internationally, you know, accredited by the JCI, 
so all of our protocols and everything are tested by a central team and, it complies 
with standards which are international accepted.” (Interview 10) 
In general, within my data, the idea that the creation of medical specialities, whose specific 
aim is to provide treatment for patients in pain, is not contested. Furthermore the idea that 
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this specialty organisation with its associated top-down guidelines and regulations will 
lead to improved patient care is also largely undisputed. However, when considering 
exactly how the medical specialities related to pain management should be organised there 
is considerable variation.  
In the questionnaire I asked participants to state their profession (Question 3) by ticking 
one appropriate box from the following list of choices: nurse, pharmacist, social worker, 
psychologist, physiotherapist, volunteer, doctor, other. The results are demonstrated in 
Figure 3-18. 
 
Figure 3-18 Profession of Questionnaire Participants (N=95) 
Three respondents tick more than one box. One ticks both ‘psychologist’ and ‘volunteer’. 
For the purpose of reporting these results I include this respondent as one of two 
psychologists but note that in the rest of the questionnaire this individual writes “NA” 
against many answers including those relating to place of work. They state that they spend 
no time working in pain management and do not give clear answers to the questions related 
to treatment availability. I refer to these results again later. Two respondents tick ‘doctor’ 
and ‘other’. In the associated free text box, one of these states that they have an MBA in 
healthcare management but they also note their medical qualification as “dentist”. The 
other writes “Clin. Dip (Pall Med) Clin. Fellowship (Pall Med)”, which I interpret as 
another medical qualification, rather than as indicative of training in a second profession. 
Both these individuals are counted as doctors. One respondent, a nurse, adds that they are a 
“pain nurse manager” and another that they are “taking care of palliative care training”. 
Others add some specific details of their roles. 
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Figure 3-19 Profession of Questionnaire Participants at ISSPCON (N=40) 
 
Figure 3-20 Profession of Questionnaire Participants at IAPCON (N=55) 
The two pie charts Figures 3-19 and 3-20 demonstrate the profession of questionnaire 
respondents attending each of the two conferences separately. Most notable in these results 
is that all bar one respondent at the ISSPCON are doctors; in contrast at the IAPCON 
almost half of respondents do not identify themselves as doctors. Although those who are 
not members of the ISSP are able to attend ISSPCON, the conference programme is 
largely directed towards the education of doctors’ practice in pain management. 
Furthermore, only doctors are eligible to become full members of the ISSP, as opposed to 
associate members who have no voting rights at the organisation’s annual general meeting. 
This is in contrast to the IAPC whose membership is open to all individuals regardless of 
their professional training, including volunteers. Of note, all of the interview participants 
are doctors but this a specific sampling intention.  
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Figure 3-21 Combinations of Conditions Treated by Questionnaire Participants (N=95) 
 
Figure 3-22 Frequency of Type of Conditions Treated by Questionnaire Participants 
(N=270) 
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and in the interviews what sorts of medical conditions patients they treat are suffering 
from. When considering the questionnaire data, I asked respondents to indicate the range 
of conditions by ticking boxes from the following list of options: ‘cancer pain’, ‘pain 
associated with any terminal disease’, ‘any chronic (long standing) pain conditions 
regardless of the underlying cause’, ‘acute (short term) pain conditions (e.g. trauma, post-
operative)’, ‘labour pain’ or ‘other’. The particular categories for each of the types of 
condition were selecting following the interview work I had carried out in 2014 and from 
my visits to various medical institutions in India. They are categories that were frequently 
referred to by those working in pain management in India. However, there are limitations 
with this approach. The categories selected are based on terminology used in western 
medicine. ‘Acute’ pain refers to pain that is short lived, such as that following trauma or 
surgery. In contrast, ‘chronic’ pain is defined as a long-term condition. ‘Cancer’ pain is 
pain due to a specific disease category, which may be short term or long term and/or 
related to the very final, terminal stages of the patient’s life. Pain of ‘terminal disease’ is 
specific to the end stage of a patient’s life but may be pain from any disease – not 
necessarily cancer. There is clearly overlap between several of these categories. For 
example cancer pain may be terminal, chronic pain may be terminal, patients with terminal 
disease may suffer short-lived pain following trauma, and so on.  
These questionnaire results are presented as graphs in Figures 3-21 and 3-22. Figure 3-21 
demonstrates the combination of conditions treated by each respondent. Figure 3-22 
represents the number of respondents treating each type of condition. The total number of 
responses (270) is therefore larger than the number of participants (95), reflecting the 
multiple options that some respondents tick. Several respondents tick two boxes when one 
could be considered a subset of the other. For example, four respondents select both 
‘cancer pain’ and ‘pain associated with any terminal disease’, and five tick ‘cancer pain’ 
and ‘any chronic (long standing) pain conditions regardless of the underlying cause’. This 
will lead to an over-representation in the graph of Figure 3-22, with some respondents’ 
answers counted in two categories. The highest peaks on the graph of Figure 3-21 are for 
those respondents treating a wide range of long-term conditions but there is also a notable 
spike (n=11) for those treating only cancer pain. 
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Figure 3-23 Combinations of Conditions Treated by Questionnaire Participants, by 
Conference Attended (N=95) 
Figure 3-23 shows the same data as Figure 3-21 but with the added information of the 
conference attended. This demonstrates that all of those participants who are treating only 
cancer pain were at the IAPC conference. Two respondents (at IAPCON) one who has 
ticked ‘cancer’ and, one who has ticked ‘cancer’ and ‘other’, state that they specifically 
treat pain from HIV/AIDS. 
Similarly, when considering the interview data I collated quantitative information 
regarding the types of condition treated by each participant. Figure 3-24 depicts the 
number of participants treating each type of condition and the conferences attended. The 
presentation of the data in Figures 3-23 and 3-24 is particularly pertinent because I have 
specifically set out to research clinicians working not only in palliative care, due to my 
perception that the boundaries in India between pain management and palliative care are 
particularly indistinct. Assuming that those who attend the IAPC conference do indeed 
consider themselves to be working in this specific field, in practice a significant number 
are treating patients suffering from all types of pain, not only pain at the very end of life. 
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Those attending the ISSP conference, assuming these clinicians do not consider 
themselves to be palliative care specialists but specialists in managing all types of pain, 
also usually treat pain caused by any medical condition.  
 
Figure 3-24 Combination of Conditions Treated by Interview Participants, by Conference 
Attended (N=33) 
In the questionnaires I then asked whether or not respondents ideally wanted to treat a 
wider range of conditions (Question 10). The results are presented in Figure 3-25. Of note, 
although the largest portion of respondents (45) wish to treat the same range of conditions, 
a sizeable minority of respondents (36) wish to widen their clinical remit with only one 
indicating that they desire it to be narrower. The one respondent who wishes to treat a 
narrower range of conditions states that they want to treat spinal pain, implying this could 
or should be a sub-specialty area of work. However, some respondents do not appear to 
fully understand the question and tick more than one box, so these are counted as 
‘miscellaneous/unanswered’. One respondent ticks both ‘same’ and ‘narrower’, and they 
also list “spine” as the condition they wish to treat. One respondent does not select any box 
but writes under the section to list the narrower range of conditions “amputation, palliative 
care”, and three others also write in this free text section despite not ticking the box 
indicating that they want to treat a narrower range of conditions. 
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Figure 3-25 Preference for Range of Conditions Treated of Questionnaire Participants 
(N=95) 
 
Figure 3-26 Preference for Range of Conditions Treated and Conditions Treated for 
Questionnaire Participants (N=95) 
I also combined the data from Figures 3-21 and 3-25 as Figure 3-26 to demonstrate the 
range of conditions treated alongside the respondents desire to alter this range. Fourteen 
respondents tick that they treat ‘Any chronic (long standing) pain conditions regardless of 
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the underlying cause’ but then indicate that they want to be able to widen their remit to 
treat all types of chronic pain. One says they want to treat the same range of conditions but 
then write down conditions they would like to treat, and another ticks both ‘same’ and 
‘wider’. Seven respondents indicate that they treat all types of pain but also want to widen 
their remit.  
3.6 Treatment Availability and Selection 
Leading on from the descriptions of how the specialities of the medical profession should 
or could be organised is the issue of what actual treatments individual patients receive. As 
I introduced in Chapter 1, a large amount of research has focused on improving the 
availability of opioid medications. In contrast, in this research, I incorporate the assessment 
of the availability of a wider range of treatment modalities. I also include data relating to 
the different treatment preferences of clinicians. 
The quantitative data presented in this section are derived from the responses to Questions 
11 and 12 of the questionnaire. I asked all respondents to indicate in detail what 
pharmacological and non-pharmacological treatments are available to them. When I 
initially planned this study I aimed only to be questioning doctors, however, due to 
changes in the methods of data collection of the questionnaire, respondents from any 
profession were able to complete the forms. Whilst the inclusion of a range of professions 
is useful to gain information from a breadth of viewpoints, it also presented problems, as 
the questions, particularly those relating to the availability of specific medication 
formulations, require a significant level of specialised knowledge. 
When analysing the results of this section I considered it highly likely that only those who 
had clinical training would be familiar with all of the medications I listed. Indeed, when 
reading the answers from those who were trained as neither doctors nor nurses, 
respondents left a very large proportion of their answers blank. Two indicate that every 
treatment is available all of the time, making them outliers in their answers. Even during 
the data collection itself, respondents verbalised to me that they were unable to answer 
some of these questions. If I was asked in person, I suggested they leave questions blank if 
they felt unable to answer. One participant writes “no idea” alongside the pharmacological 
  
 
Figure 3-27 Pharmacological Treatment Availability for Doctor and Nurse Questionnaire Participants (N=77) (IR = immediate release, SR = slow release, 
O = oral, I = injectable, B = buccal, T = transdermal, S = sublingual, R = rectal, NSAID = non-steroidal anti-inflammatory drug) 
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treatment availability question but does then go on to complete the non-
pharmacological section in more detail. For these reasons I only present the responses for 
treatment availability for those members of the professions that I consider are likely to 
have a sound understanding of the modalities in question. So, for pharmacological 
treatments the responses for doctors and nurses (N=77) are presented, and for the non-
pharmacological treatments the responses of all participants (N=95) are presented. For 
each of the graphs in this section each vertical column represents a particular medication or 
treatment modality divided up into shaded sections representing availability. Each shaded 
block represents the number of respondents that indicate each frequency of availability, 
rated as: ‘never’, ‘occasionally’, ‘usually’ or ‘always’. On occasions respondents tick more 
than one box stating two different availabilities for a particular treatment. In these cases I 
have reported these responses as ‘unclear’ and included them with the ‘blank’ answers in 
the graphs.  
3.6.1 Pharmacological Treatments 
Figure 3-27 shows the availability of all medications for the doctor and nurse questionnaire 
respondents. For ease of comparison, the data from Figure 3-27 is presented again 
separated out into opioids in Figure 3-28, and non-opioid medication in Figure 3-29. Of 
note, there is a stark contrast in the size of the darkly shaded areas indicating ‘always 
available’, between these two graphs.  
I also selected out those medication preparations included in the WHO Model List of 
Essential Medicines.
36
 Some of these, such as ketamine and carbamazepine, are included in 
the WHO list as treatments for other non-painful conditions, however due to their 
widespread use in the management of pain I include them here in Figure 3-30. There are 
still a number of participants indicating low availability of medications particularly in the 
opioid sections on the left hand end of the graph. Only oral paracetamol and oral non-
steroidal anti-inflammatory drugs (NSAIDs) are indicated as available ‘usually’ or 
‘always’ by each respondent who answered.  
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Figure 3-28 Opioid Medication Availability for Doctor and Nurse Questionnaire 
Participants (N=77) (IR = immediate release, SR = slow release, 
O = oral, I = injectable, B = buccal, T = transdermal, S = sublingual) 
 
Figure 3-29 Non-opioid Pharmacological Treatment Availability for Doctor and Nurse 
Questionnaire Participants (N=77) (O = oral, I = injectable, R = rectal, NSAID = non-
steroidal anti-inflammatory drug) 
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Figure 3-30 WHO Model List of Essential Medicines Availability for Doctor and Nurse 
Questionnaire Participants (N=77) (IR = immediate release, SR = slow release, O = oral, 
I = injectable, S = sublingual, R = rectal, NSAID = non-steroidal anti-inflammatory drug) 
Opioid medications are often categorised as strong or weak depending on the degree of 
pain relief they offer. Of the opioid medications included in this survey, codeine and 
tramadol are usually classified as weak with all the others (morphine, oxycodone, fentanyl, 
buprenorphine, methadone and pethidine) as strong. Of these strong opioid medications, in 
my data, injectable morphine has the highest availability. As I noted in Chapter 1, other 
studies often report the availability of medications by country or state, labelling each drug 
with a single availability rating. In contrast, I collected data from many individuals, 
allowing a more nuanced presentation of availability. This is demonstrated in the graph of 
Figure 3-31, showing the availablity of injectable morphine alone, divided up by the state 
where the participant is practising. There is considerable variation shown both between and 
within states.  
Similarly, the medication codeine is reported elsewhere as having a low availability in 
India and of never being available in the state of Bihar.
2
 However, as shown in Figure 3-
32, in this study both respondents from the State of Bihar indicate that codeine is usually or 
always available. This could be a recent change to the availability or it could refect a more 
0
10
20
30
40
50
60
70
80
90
Always Usually Occasionally Never Blank/Unclear
Chapter 3 
 
139 
complex picture with local variations in availability. Note that only one state with more 
than one respondent, in each of Figures 3-31 and 3-32 report a uniform availability. In each 
of these there are only two respondents. Again this implies a complex picture of variable 
medication availability. 
 
Figure 3-31 Injectable Morphine Availability for Doctor and Nurse Questionnaire 
Participants, by State (N=77) (AP = Andhra Pradesh, HP = Himachal Pradesh, TN = 
Tamil Nadu, UP = Uttar Pradesh, WB = West Bengal) 
 
Figure 3-32 Oral Codeine Availability for Doctor and Nurse Questionnaire Participants, 
by State (N=77) (AP = Andhra Pradesh, HP = Himachal Pradesh, TN = Tamil Nadu, UP 
= Uttar Pradesh, WB = West Bengal) 
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Many interview participants specifically comment on the problems of poor availability 
of opioid medications. As I explained, this is already well documented in the literature but 
given its significance, I briefly describe here some of the key themes arising from my data.  
Clinicians, particularly those working in palliative care or treating patients with pain from 
cancer, explain how there are frequently particular bureaucratic challenges to obtaining, 
prescribing and administering morphine – the cheapest and most widely available strong 
opioid. In addition, they talk of the challenges in persuading healthcare workers, 
administrators and patients, that it is relatively safe to use such medications for the 
treatment of pain. Participants note that there are regional differences in availability, both 
between different states, and between urban and rural areas. There are also concerns over 
the quality of some preparations.  
Participants describe problems with obtaining opioids other than morphine. This can be an 
absolute absence of availability in India where certain medications are not approved at all 
for use but also a relative lack where certain medications are prohibitively expensive. One 
such medication is an opioid called fentanyl, which can be administered intravenously or 
via a patch applied to the skin. Despite its relatively high cost, participants note that these 
expensive preparations can be available when cheaper ones are not. Another factor noted 
in my data is that cheaper formulations offer limited profits for pharmaceutical companies 
who therefore do not put efforts into increasing their availability. Furthermore, it is also 
important to note that opioid medications are not only used in palliative care but also to 
treat pain following surgery. One pain specialist succinctly describes several of these 
issues in relation to post-operative pain: 
“We don’t have morphine at all parenteral morphine is not available, we just have 
fentanyl patches and fentanyl, intravenous fentanyl available. But that is also out of 
stock at the moment.” (Interview 14) 
Not only do participants explain that the medications themselves are difficult to get hold of 
but for certain techniques, particularly for the treatment of pain following surgery there is a 
lack of specific equipment such as pumps to infuse the medications. They note this to be 
due to scarce equipment and a lack of desire to fund such treatments. One doctor working 
in palliative care describes a particular method used in his organisation to circumvent one 
such problem: 
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“We taught our families how to put a subcutaneous needle and how to use a 
combination of drugs. Same drug combinations that we would use in a syringe driver 
in the UK, we call it the family driver.” (Interview 20) 
Although the data presented here show that in general there is better absolute availability 
of non-opioid medications when compared to opioids, participants note that some are 
prohibitively expensive in practice. Several participants talk of the need to use medications 
in a modified manner when working with the Indian population who often seem to require 
different doses to those described in the western based literature. One clinician who had 
worked overseas also noted that patients in India were often especially reluctant to take 
medications at all. He describes both these issues: 
“They can be very different when it comes to medications, understanding and 
accepting medicines. So that’s just the sociocultural factors, but even physiologically, 
I would see patients getting drowsy with about 100mg of gabapentin, and extremely 
drowsy, to a point that they’re not able to function.” (Interview 16) 
However, there are also discrepancies in the participants’ descriptions of medication 
availability. One pain specialist working in a large corporate institution says: 
“We have, the opioids that are available in India, we have them here. All the 
medicines that are possibly available in India, in the Indian market, are available here, 
so there are no restrictions per se, for medications.” (Interview 16) 
 
 
Figure 3-33 Preference for Offering a Wider Range of Treatments in all Questionnaire 
Participants (N=95) 
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Figure 3-34 Preference for Offering a Wider Range of Treatments in Doctor and Nurse 
Questionnaire Participants (N=77) 
In the questionnaire I asked in Question 13, whether respondents wish to have a wider 
range of treatments available to them. I present the answer to this question for two separate 
groups. Firstly, for all respondents in Figure 3-33, and secondly for doctors and nurses 
only in Figure 3-34. When combining the answers to Question 13 and the availability of 
pharmacological treatments I include only the responses from doctors and nurses for 
reasons already explained. 
 
Figure 3-35 Opioid Availability in Questionnaire Participants who Answer 'No' to 
Question 13 (N=11) (O = oral, I = injectable, R = rectal, NSAID = non-steroidal anti-
inflammatory drug) 
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Figure 3-36 Non-opioid Pharmacological Treatment Availability in Questionnaire 
Participants who Answer ‘No’ to Question 13 (N=11) (O = oral, I = injectable, R = rectal, 
NSAID = non-steroidal anti-inflammatory drug) 
The majority of respondents do say they would like to see more treatment options available 
but it is also important to acknowledge the group who do not wish to expand their 
treatment availabilities. So, when considering only those who answer ‘no’ to this question, 
I looked at these respondents’ medication availability answers. Figures 3-35 and 3-36 show 
the availability of opioid and non-opioid medications for the eleven doctors and nurses 
answering ‘no’ to Question 13, indicating that they do not wish to offer a wider range of 
treatments. Even in this group, there is still a relatively low availability of some 
medications, notably the strong opioids and rectal preparations of the non-opioids.  
I also analysed those who answer ‘no’ to Question 13 in combination with their responses 
for availability of medications included in the WHO Model List of Essential Medicines 
shown in Figure 3-37 and again there is a low availability of some drugs. These 
respondents are indicating that they do not want a wider range of treatments to be available 
even though they do not have consistent availability of the medications considered to be 
essential by the WHO. This lack of desire to increase the availability of medications, 
particularly strong opioids, is at odds with widely publicised views at both local and global 
levels, stating that availability ought to be improved. 
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Figure 3-37 WHO Model List of Essential Medicines Availability in Questionnaire 
Participants who Answer ‘No’ to Question 13 (N=11) (IR = immediate release, SR = slow 
release, O = oral, I = injectable, S = sublingual, R = rectal, NSAID = non-steroidal anti-
inflammatory drug) 
3.6.2 Non-pharmacological Treatments 
The responses indicating the availability of non-pharmacological treatments for all 
questionnaire participants are represented in Figure 3-38. While there is no non-
pharmacological equivalent of the WHO Model List of Essential Medicines, there are of 
note, low availabilities of several treatments that may well be considered to be core 
components of the provision of pain management, namely the presence of a social worker, 
physiotherapist, psychotherapy, counselling, simple interventions and a multidisciplinary 
team (MDT). One respondent does not tick a particular box in the MDT row but writes 
across that their team is indeed multidisciplinary – suggesting that this response should 
have been ‘always’. 
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Figure 3-38 Non-pharmacological Treatment Availability in Questionnaire Participants 
(N=95) (TENS = transcutaneous electrical nerve stimulation) 
 
Figure 3-39 Multidisciplinary Team Availability in Questionnaire Participants, by 
Conference Attended (N=95) 
I looked at some of these non-pharmacological treatments in more detail, for example, the 
availability of an MDT and interventions, both simple and complex. Figure 3-39 shows the 
availability of an MDT for the attendees at each conference. Of note only 20 out of 40 
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(50%) ISSPCON respondents and 36 out of 55 (65%) ISSP respondents have an MDT 
available always or usually. 
 
Figure 3-40 Simple Intervention Availability in Questionnaire Participants, by Conference 
Attended (N=95) 
 
Figure 3-41 Complex Intervention Availability in Questionnaire Participants, by 
Conference Attended (N=95) 
The term ‘intervention’ is used here in a specific, western biomedical context with a lot of 
implied meaning. I use the term to indicate a treatment typically involving a physically 
invasive process such as an injection to numb a nerve, an epidural injection, or even an 
operation to insert a pump or electrical device into a patient. These are then considered 
together as a set of treatments, separate from pharmacological or psychological modalities. 
Following my interviews (both formal and informal) I decided to subdivide interventions 
in to ‘simple’ and ‘complex’. The availabilities of these two categories of treatment, 
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further subdivided by the conference attended, are shown in Figures 3-40 and 3-41. Of 
note, in contrast to the IAPCON attendees, almost all the respondents at the ISSPCON are 
able to use simple interventions ‘always’ or ‘usually’. 
Furthermore, when returning to the data from questionnaire Question 13, relating to 
preference for widening the range of available treatments, Figure 3-42 shows the 
availability of non-pharmacological treatments for the 20 respondents who answer ‘no’ to 
this question. To be clear, all respondents are included in this analysis, not just doctors and 
nurses. Again treatments that are often considered to be core components for pain 
management, such as the presence of a multidisciplinary team or simple interventions are 
not consistently available. 
 
Figure 3-42 Non-pharmacological Treatment Availability in Questionnaire Participants 
who Answer 'No' to Question 13 (N=20) (TENS = transcutaneous electrical nerve 
stimulation) 
The interview respondents also highlight this variation in treatment preference particularly 
with respect to interventional procedures such as nerve blocks. One of the reasons for this 
variation is described as being due to differences in training. Anaesthetists, who provide 
analgesia after surgery, often carry out the more simple interventional techniques, and 
indeed that is often the first contact with pain management that many pain specialists 
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describe in the course of their careers. One palliative care specialist who had originally 
trained in anaesthesia notes how treatment choices vary between clinicians: 
“I think one problem is that either palliative care physicians manage only with 
pharmacological agents and interventional pain therapists do only interventions, and 
this I think is a huge problem. Interventional, I mean pain management has to be 
comprehensive.” (Interview 18) 
Some describe how the absence of other treatment options, namely the low availability of 
opioids, has led them to focus on the use of nerve blocks. Others talk of the need to only 
use blocks as a last resort when pharmacological routes have failed. In these situations 
some doctors have the expertise and facilities to perform these treatments, others have to 
call on the assistance of other colleagues sometimes requiring referral to other institutions. 
Some doctors explain how with time they have reduced the number of interventions that 
they feel is necessary. One doctor working in palliative care who originally trained in 
anaesthesia describes how his practice has changed over the years: 
“Used to do a lot of interventions, I mean injections in the past, but when we start 
getting more confident about the medication we, now only very little, one per cent, 
less than one per cent of patient. There was a time initially when at least fifteen to 
twenty per cent of patient had this interventional thing, so this has come down 
enormously.” (Interview 22) 
Some acknowledge that it may be helpful to increase the number of blocks they perform 
but that the low number of patients that would potentially benefit does not justify the 
relatively high outlay of costs (for both personnel and equipment) that would be necessary 
to offer such a service. One pain specialist working in a cancer hospital explains: 
“But interventional, still I am not very much unsatisfied with that because the only ten 
to twenty per cent of the cancer patient needs intervention, it is not must.” (Interview 
4) 
Another doctor working in palliative care talks about acquiring more equipment (referred 
to here as an image intensifier, used for taking x-rays): 
“The issue about the image intensifier, it is a logistic issue. We do not have that kind 
of money and if we had more money maybe that would not be the priority because we 
have to prioritise so many things.” (Interview 18) 
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As I noted in the earlier section relating to a lack of available space, some doctors 
describe a constraint to performing blocks as the need to share facilities, namely operating 
theatres and x-ray equipment with other specialists such as surgeons. X-ray equipment is 
used to improve the efficacy and safety of these interventional procedures but other 
imaging techniques including ultrasound can also be used. Interestingly one interviewee 
talks of the particular hindrances to the use of ultrasound in India where strict legislation is 
present in an attempt to reduce the amount of gender selection of foetuses.  
“You need special permission because the increasing misuse of ultrasound for sex 
determination, which is, which I don’t blame the government for setting, putting up 
these stringent rules and sanctions but still I feel that there should be accounting for 
the people who are not in any way connected with that part of it.” (Interview 14) 
As I talked about in the previous sections related to patient finances and the number of 
trained personnel, participants describe a particular problem with being able to offer more 
complex interventional treatments such as implantable devices. Whether or not this is 
actually described as a problem by clinicians does however vary, with some specialists not 
even entertaining the idea that implanting these devices should be a priority in the Indian 
scenario. Participants also note that other non-pharmacological treatments such as 
physiotherapy or psychology may not be funded or as I explained above, there may not be 
enough adequately trained specialists available. Even pain specialists working in the 
private sector note that they would like to be able to offer a wider variety of treatments. 
This lack of availability of trained professionals is compounded by some patients’ 
reluctance to engage with some of the non-medical treatments. A pain specialist working 
in a corporate hospital describes this: 
“I lack a psychologist, because, not enough trained psychologists around, especially 
when it comes to pain patients. I don’t have an occupational therapist, so, I would say 
I lack in those two areas where I don’t have people, and I would also be wanting to 
run a pain management programme, but because of these things lacking, and also 
probably patients also not being very willing to kind of come forward for such 
programmes in India, that’s probably where I’m lacking.” (Interview 10) 
One final point, which is rather more controversial with respect to the use of interventions, 
is that of the income earned by clinicians when carrying out this work. One pain specialist 
explains that there is a potential conflict of interest if doctors are paid for each procedure 
they carry out:  
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“Blocks really are effective in some cases but nowadays anywhere you go that 
they’ll say, give a block, trigger point, and this, that. And some of the patients are not 
happy, we are not explaining the real indications and contraindications of selection of 
patients and that’s giving a bad name to the pain clinicians.” (Interview 25) 
Although a holistic approach to treating patients would not be considered by some as a 
treatment in its own right participants working in all areas of pain management refer to it 
extensively, and there is considerable overlap between holistic care and the idea that 
treatment is best offered by a multidisciplinary team. A holistic approach is often talked 
about within the context of palliative care where pain is described as a ‘total’ phenomenon 
involving physical, social, psychological and spiritual dimensions.  
Although many participants consider a team approach to be an essential component of a 
pain management clinic they also frequently talk of the particular difficulties in 
implementing multidisciplinary strategies such as a lack of prioritisation of funding, 
patients’ unwillingness to engage in such treatments and finding the necessary specialists 
who are motivated to work in such a team. These issues seem to run across the different 
treatment sectors although ironically, with the large volunteer base in the charitably funded 
palliative care organisations, patients can sometimes receive more holistic care than in 
private clinics. One pain specialist working in the private sector explains: 
“The ideal service would be, you know, where you provide support to the patient 
from, from every angle possible, that’s the ideal thing, which is not, which is not, you 
know, it’s not even close to, you know, fulfilment in India.” (Interview 3) 
In contrast, a pain specialist working in palliative care in a government funded hospital 
explains how her service functions: 
“Once they come is we have time, why is they are very happy is most of the times, 
most of the people, they speak to them, they are given a lot of importance. So they 
feel, that, ok, if you go to this department you are, you are taken care of by many 
people. Not only a doctor, nurse also speaks to them, social worker speaks to them, 
pharmacist speaks to them, clinic psychologist speaks to them, volunteers, there quite 
a few volunteers.” (Interview 31) 
Furthermore, as I alluded to earlier, seeking the involvement of other medical specialists 
can bring about issues of competition as one pain specialist describes: 
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“If a spine surgeon comes and becomes part of the group then we stop getting 
referrals from the other spine surgeons who think that, you know, their patients would 
go away, so this is sort of a typical sort of an Indian scenario where they don’t want to 
lose the patients.” (Interview 3) 
The importance of including spiritual and religious elements to therapy is not referred to 
either frequently or consistently, although a few interview participants do speak on the 
subject and highlight the fundamental importance of incorporating this dimension to 
patients’ care, which is often neglected. For example: 
“So this spirituality somewhere I think gives them some strength, which you know in 
hospitals also we need to have some place where we can offer this to patients.” 
(Interview 2) 
Of note, one interview participant explains that the complexities of offering spiritual 
guidance in a country of such religious diversity. These issues are addressed for the 
individual patient by staff who prefer to facilitate access to the requested religious or 
spiritual professionals rather than providing it as a part of in-house clinical therapy: 
“We do not foresee in the future also, a specialised spiritual counsellor, because India 
is a multi-religious country and the world over, by and large, spiritual counselling is 
too closely associated with religion and we have to handle it right.” (Interview 18) 
3.6.3 Service Quality 
In the final section of the questionnaire I asked respondents about the quality of the service 
they offer. In Question 14, I asked participants to rate the quality of the care provided in 
the organisation in which they work as ‘excellent’, ‘good’, ‘acceptable’, ‘poor’ or ‘very 
poor’. Figure 3-43 shows these responses for each of the 95 participants. It is interesting to 
note that only eight participants rate their service as ‘poor’ or ‘very poor’ despite the low 
availability of many treatment options as demonstrated above.  
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Figure 3-43 Quality of Service Rated by Interview Participants (N=95) 
I then combined the answers to Question 14, rating quality, with the answers from earlier 
questions relating to the range of conditions participants would ideally like to be able to 
treat (Question 10) and the range of treatments they would like to offer (Question 13). The 
responses are demonstrated below in Figures 3-44 and 3-45. For these two graphs the two 
respondents who do not rate the quality of their service are omitted giving a total of 93 
responses.  
 
Figure 3-44 Quality of Service Rated by Interview Participants and Desire to Treat a 
Different Range of Conditions (N=93) 
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Figure 3-45 Quality of Service Rated by Interview Participants and Desire to Offer a 
Wider Range of Treatments (N=93) 
Only those who rate their service as ‘poor’ or ‘very poor’ consistently say they want to 
have a wider range of treatments available.   
3.7 Policy and Governance 
Alongside participants’ descriptions of the problems or barriers related to providing good 
quality wide reaching pain management, such as: scarce resources, plurality of healthcare 
provision, variations in clinical practice, the lack of recognition of pain related medical 
specialties and limitations in treatment availabilities; they also explain some of the possible 
solutions. Many of these relate to improved governance and altering either the use of or the 
content of policies. In this context, I interpret the term ‘policy’ as being any initiative 
relating to the organised creation and implementation of rules or guidance by those with 
responsibility, whether they be from local managers, professional groups or the 
Government of India itself. Policies in some contexts, however, are also noted by 
participants to be barriers.  
Tying in with the previous section on treatment availability, I briefly describe the noted 
problems or barriers of bureaucracy and policy related to opioid medications. The laws in 
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India governing the procurement and use of opioid medications are complex and 
stringent, and vary from state to state.
2
 Participants refer to these complex laws, which aim 
to balance the prevention of illicit use of these potentially addictive substances whilst 
ensuring their availability for legitimate medical use, and note some of the recent 
amendments to simplification of this legislation. Many participants talk of the difficulty 
they have in obtaining adequate supplies of opioids for their patients. For example, one 
doctor working in palliative care explains: 
“The strictness for morphine is there all over India, but it is specially so in Punjab. For 
getting morphine I have to send a form on a prescribed format, each and every patient 
individually, to Delhi. And somebody has to get that morphine from Delhi. So I don’t 
have morphine in Punjab. It’s very difficult for me.” (Interview 21) 
Bureaucracy is not only a problem for the acquisition of opioid medications. Participants, 
particularly those working in the government sector, explain how difficult it is to procure 
new equipment: 
“Then there are steps and it will reach to the chief after ten to fifteen steps, it will take 
three months, then he will find something else, will again write, and it will come 
down like following those steps again, this is the main problem in India in the 
government hospitals, are those tables, those steps, and those red tapes, we call them.” 
(Interview 7) 
Continuing on the theme of local management, participants also talk of problems in 
persuading managers to prioritise the treatment of pain, across all types of institution 
including those with private, charity and government funding. For example one pain 
specialist working in a corporate hospital explains: 
 “Because this is not something which earns money for the corporate hospital. It 
doesn’t earn money. So, that is a barrier, the management not realising the importance 
of good pain relief.” (Interview 2) 
A pain consultant working in a government institution in Delhi describes his efforts to 
improve the provision of palliative care services: 
“I have subscribed and made a request to the authorities about the hospice and 
palliative care to be brought in to the, under the government of Delhi, but somehow 
government is taking time.” (Interview 13) 
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These previous examples relate to the frequently described perception of top-down 
control exerted by managers and politicians, a concept I return to at the end of this chapter. 
There is a notable exception to this, however, in the description of a service operating 
where the local community provides funding. In this example, the community or end-users 
largely set the priorities of the service in a bottom-up fashion, as one of the clinicians 
explains: 
 “If we are asking the community to support then the agenda also should include what 
community wants. If we say that we need all your money but then I will decide which 
patient to give, that’s not right actually.” (Interview 33) 
Bureaucracy is often spoken of as a barrier and a hindrance to progress but participants do 
give positive examples of how rules and regulations may be favourable. For example one 
of the voluntary accreditation organisations (NABH) has stipulated the presence of a pain 
clinic as a requirement. One pain specialist explains how this has affected the number of 
clinics: 
 “Now because of NABH and it being compulsory for having a pain clinic in the 
hospital, even those who have passed out earlier are now aware that there is something 
called a pain clinic.” (Interview 2) 
Some also express a desire for more regulation from various groups. They note that if 
insurance companies agree to fund certain treatments then the delivery of these particular 
therapies will be significantly facilitated. They also explain how the two national 
organisations, the ISSP and IAPC can improve the delivery of pain management with 
advocacy work to improve awareness, coordination of education initiatives, encouraging 
cooperation, uniform practice and training of clinicians within the specialties, organising 
research, and lobbying government to change policy. For example one participant 
describes their evaluation of the IAPC’s recent work: 
“I think IAPC is doing a great job, they are involved in almost every part. They are 
doing work for policy change, they are working for education and awareness, they’re 
working for better communication skills and they are working for inclusion of 
palliative medicine in undergraduate and postgraduate syllabus.” (Interview 21) 
At a government level the participants also talk of the constructive way in which new 
policy can be used to improve rather than hinder pain management. They talk of the 
endorsement from the Medical Council of India (MCI) in establishing formal postgraduate 
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training programmes, such as the MD in palliative care at Tata Memorial Hospital, 
Mumbai and its role in lobbying for the compulsory inclusion of pain management in the 
undergraduate curriculums. Clinicians also talk of the role the government and the MCI 
can take in ensuring pain management practice and training is more regulated and uniform, 
by meeting specific nationally defined standards. A pain specialist explains how training 
could be improved: 
“I think we have to standardise, MCI should play a major role, Medical Council of 
India. They should standardise training, there should be competency-based training 
introduced. The people will get through when they complete their whole set of things 
to be done, and then only will they be allowed to give the exam.” (Interview 27) 
3.8 Knowledge Exchange 
The participants’ descriptions of pain management in India – of how pain should be 
considered a medical problem, the importance of specialisation within the medical 
profession, the need to increase the allocation of resources and to improve treatment 
availability, are all linked together by the pivotal theme of ‘knowledge exchange’ 
frequently referred to in the data as ‘awareness’. Throughout the interview narratives, the 
questionnaires and my field notes the concept of the need to alter the opinions and actions 
of others through education and awareness initiatives is striking in its prevalence. So 
ubiquitous and fundamental is this theme that I have subdivided the reporting of these 
results into sections relating to the strategies used to influence the different target 
audiences such as clinicians, patients and managers; and the different aims of and topics 
used to frame the knowledge exchanged in these initiatives.  
3.8.1 Knowledge Exchange Strategies Aimed at Healthcare Professionals 
The descriptions interview participants give of awareness programmes for their fellow 
professionals include initiatives they call ‘education’ or ‘training’, the aim being to change 
practice by increasing knowledge. In this section I present both questionnaire and 
interview results relating to these themes. 
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In the questionnaires I asked participants to indicate the length and type of training they 
had received in pain management and I asked the doctors to list their formal medical 
qualifications (Questions 3 and 4). Of the 69 participants who identify themselves as 
doctors, 21 list MBBS (the basic allopathic medical degree) as a qualification. Two 
respondents list degrees in dentistry. Many respondents also have a higher degree, 
requiring MBBS training, despite not actually writing that they have obtained this 
qualification. Broadly speaking these Indian higher degrees fit into two categories: MD or 
MS (doctor of medicine or master of surgery) programmes, and diplomas. Of the 69 
doctors, 45 have at least one of these higher degrees from various medical specialities, 
shown in Figure 3-46. Some respondents write their specialty out in full, for others I 
assumed it from their degree acronym e.g. DA indicating diploma in anaesthesia. Clearly 
the most common specialty of training is anaesthesia. Of the 31 that list a higher degree in 
this specialty – one states their specialty as “anaesthesia and pain medicine”, one as 
“anaesthesia, pain”, one as “anaesthesiology, pain relief”, and one as “anaesthesia, pain 
and palliative care”. Of the 6 ‘unspecified’ two list UK qualifications in anaesthesia. 
Similarly, although, I did not ask directly about the specialty of training, every interview 
participant either volunteers or implies this in some way. The clear majority (25 out of 33) 
trained in the specialty of anaesthesia, with the others training in pharmacology, general 
medicine, surgery and physical rehabilitation.  
 
Figure 3-46 Specialty of Training of Medically Trained Questionnaire Participants with a 
Higher Degree (N=45) (ENT = ear, nose and throat, Rad/RadOnc = radiotherapy or 
radiation oncology, GM/FM = general medicine or family medicine, Pall Med = palliative 
medicine, O&G = obstetrics and gynaecology) 
In addition to these Indian qualifications, the following higher degrees from overseas are 
also listed by questionnaire respondents: three higher degrees in anaesthesia (from the UK 
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and Ireland) one of whom also has a higher pain qualification from the UK, one lists a 
diploma in paediatrics from Ireland and two list diplomas in palliative care (from Cardiff 
and Perth, Australia). Of the 17 with no higher degree noted (either Indian or overseas) the 
following specialties are indicated: anaesthesia - 9, ear nose and throat (ENT) - 1, 
palliative medicine - 3, not stated - 4.  
Many medical degrees and qualifications are listed often simply as acronyms or 
abbreviations leading to uncertainty in some cases as to what qualifications the individual 
has actually been awarded. For example “PGD” or “MMSc” in pain medicine, which 
without knowing where these were awarded I cannot classify them. Similarly others write 
simply “anaesthesia graduate” or “trained in Cardiff”. Other listed qualifications are in 
related fields such as ayurvedic medicine, behavioural medicine and management studies. 
Where appropriate, other qualifications, not formally accredited by the MCI or the 
National Board of Examinations are presented with the following data relating to pain 
training.   
 
Figure 3-47 Training in Pain Management of Questionnaire Participants, by Profession 
(N=95) 
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Figure 3-48 Length of Training in Pain Management in Questionnaire Respondents who 
Received Training (N=45) 
In Question 4 I asked all questionnaire respondents, if they had any formal training in pain 
management. In total 69 state that they have had formal training. The training of members 
of each profession is summarised in Figure 3-47, which demonstrates that most of the 
nurses, doctors and physiotherapists have received formal training. In the second part of 
the question I asked participants to describe this training and state how long it lasted for. 
This was a free text section but for the purposes of presentation I summarise the length of 
training into discrete categories. 45 respondents indicate how long their training has been, 
shown in Figure 3-48. 
As I noted in the previous section, several doctors list a particular pain or palliative care 
training course in their answers and these are often described as fellowships or certificate 
courses. Some specific course names are listed relatively frequently. Six doctors say they 
have done a Basic Certificate Course in Palliative Medicine or BCCPM, three note training 
on a Post Doctoral Certificate Course (PDCC) and six have the qualification FIPP - Fellow 
of Interventional Pain Practice from an organisation called the World Institute of Pain. Of 
note, one respondent says that they have the FIPP qualification but also that they have had 
no training. 
The strategies that interview participants describe to increase awareness amongst 
healthcare workers cover many areas of practice, multiple professional groups and various 
stages of training. The professional groups noted to be involved are doctors, nurses and 
allied healthcare professionals, and each of these groups can receive education throughout 
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their careers. The participants talk about education frequently as they explain both their 
own career trajectories and suggestions for how pain management can be improved.  
Participants often speak of education as one way to overcome many of the problems 
described in the previous sections such as improving the quality of treatments given to 
individual patients, increasing the referral rates to specialised physicians and increasing the 
popularity of working in pain management. The importance of educating all healthcare 
workers, not simply doctors, is stressed. 
Many of the educational initiatives described occur within each participant’s own 
institution. One pain specialist explains how he has emphasised the importance of ensuring 
all ward staff in a hospital have a degree of knowledge as to how to assess and treat pain: 
“A year or two ago when I came in, pain scores were not absolutely there except for 
operated patients, so and, so now that thing’s changed drastically. So if you, I would, 
just in about six months time, after being sticking to it, and having the, the, the senior 
nurses, top down, going about it, we would get calls from the wards, with nurses 
saying, ‘There’s a patient who’s in pain, he says it’s six out of ten.’ So I don’t even 
need to ask about it, so it’s a good thing you know. So that, and I saw that change.” 
(Interview 16) 
Exposure to pain management is often described as inadequate with little or no teaching 
occurring for undergraduate medical students. Some participants describe teaching 
initiatives they are involved in for students, as well as emphasising the need to include pain 
teaching in the undergraduate curriculum and to educate doctors at an early stage in their 
careers. One participant explains: 
“I think education work, the main thing is to educate the junior doctors, because once 
somebody becomes a specialist, or once somebody reaches a certain phase in career, 
it’s difficult to teach them new things. So, somebody who is just passing out of 
medical college or you know, a houseman, at that stage it would be good to, kind of, 
teach them the importance of pain and I think that’s where probably the education 
should come in.” (Interview 10)  
Participants talk of the need for this inclusion in the curriculum to be mandatory. One 
doctor explains: 
“We are working with the Medical Council of India to include pain management as a 
post-doctoral certificate course, so after doing MD of anaesthesia the young graduates 
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can take that fellowship. And that should be, according to me, at every medical 
college in India.” (Interview 15) 
The need to ensure all doctors have at least a basic training in pain management to prepare 
them for their careers, particularly when working in the poorly resourced rural areas of the 
country is described here: 
“Basic knowledge has to start with the undergraduates who are going to work in the 
rural areas, because after undergraduation MBBS, when you finish, you have the, 
government has put up a commitment that they have to work in the rural areas for one 
year. So when they go there, these are the doctors who are going to face like people 
who come with regular pain, like they have back pain, they have other pains, if they 
can identify what type and everything, and they give the correct medications, I think 
at least they can solve half of the problem.” (Interview 24) 
The need to continue education of all professionals even at a later stage in their career is 
also noted with some participants running some very successful, widespread introductory 
courses in general pain management and specifically in palliative care. Others talk of how 
helpful it can be to speak to medical professionals from other specialties when they hold 
their own regular educational meetings.  
With regards to more specialist training, several participants who have been practising for 
quite a few years explain that they had negligible access to pain training in India at the start 
of their careers, and had resorted to seeking out their own training, often overseas. One 
specialist explains how he taught other colleagues: 
“I used to do ten SMS to ten friend who told me that they’re interested and tell me if 
you are doing anything.” (Interview 30) 
As I explained above, specialist training remains relatively uncoordinated with only one 
formal MD programme (in palliative medicine) running at the time of this data collection. 
However, many participants describe specialist training courses they run themselves, of 
varying length and content. Participants also talk of writing textbooks and running 
specialist, national pain management conferences.  
As I described already many participants are running training courses themselves both 
within their own institutions and across the country. Some are aimed at providing a basic 
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training in pain management for all clinicians, others at the provision of specialist care. 
The need for uniformity of training, led by the government is described here: 
“The best thing that can happen is the Government of India takes it up as a project to 
implement pain management as a training in the department of anaesthetics. And 
through that, the child who comes out, knows what is rational, what is evidence based, 
how it has to be done, and the protocols are all set, and standardised textbooks are 
approved by the government.” (Interview 8) 
I specifically asked interview participants about research in pain management. Within the 
context of awareness, research can be thought of as a tool to increase the knowledge base 
of the participants who go on to exchange this knowledge with others. Although it is 
widely acknowledged by participants that more audit and research would be beneficial, 
interviewees explain that often very little is undertaken due to a lack of time, funding and 
expertise. One participant explains: 
“I’m talking from my own practice, and I want to do research and, but I don’t know 
how to go about it.” (Interview 14) 
When considering the specific topics that should be the focus of research projects, 
several interviewees talk of the need for more research based on the Indian population 
in order to see which treatments are effective. A pain specialist describes one scenario: 
“All the drugs which we’re using has been tried and tested in the western population, 
we don’t really know whether these drugs suit the Indians, or whether it actually 
works well or worse than any others, we don’t really understand those things.” 
(Interview 3) 
Another important point participants make is that research can serve to reinforce the 
current selection of certain treatments but can also cause some treatments to not be offered 
when studies demonstrate their ineffectiveness. 
The professional societies the ISSP and IAPC are often referred to by participants as 
having a role or potential role in increasing awareness. Whilst acknowledging the 
initiatives of these groups already underway, participants explain that the societies could 
increase their work by increasing training and research for clinicians, and providing a 
unique forum for collaboration and networking, as well as running programmes aimed at 
other groups. Participants also explain that the societies could advocate for specific goals 
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such as the inclusion of pain management in the undergraduate curriculum, improving 
access to opioid medications (mostly this is related to the work of the IAPC) and to 
improve uniformity of specialist practice by standardising training and establishing 
national guidelines (mostly referring to the work of the ISSP). 
3.8.2 Knowledge Exchange Strategies Aimed at Patients and Wider Society 
The need to increase awareness in patients and their relatives and friends is a key theme, 
and frequently cited. For example, participants explain that better research originating in 
India will not only improve treatment selection by clinicians but will also serve to persuade 
those who are funding therapies of their effectiveness, whether they are patients, managers 
or insurance companies. A participant explains the current situation where local research 
evidence is lacking: 
“Whatever data we have is a foreign data. As you know the medical scenario in the 
western world and the medical scenario in our country is a totally different. Though 
there are some patients who can afford these treatments, but they don’t get convinced 
the moment I discuss with them, they say, ‘Doctor, what is your experience?’” 
(Interview 15) 
A number of strategies are described as used to inform patients more directly. For 
example, at the simplest level, patients’ understanding of pain and its treatment will occur 
during a doctor patient consultation. The participants talk about taking the time to do this 
as a specific feature of the management of pain, especially as patients often feel they have 
received rather dismissive treatment from other healthcare professionals. For example one 
specialist explains: 
“So they’re very happy and they acknowledge that we spend time with them, and 
they’re very happy that we give them an understanding of what pain is about.” 
(Interview 10) 
Some even refer to this increased awareness or knowledge exchange as having therapeutic 
value in itself: 
“If you visit the pain clinic you will realise that much of what happens there is 
listening to them. The talking part or prescribing or managing part is only a little.” 
(Interview 32) 
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As I explained above, patients in India frequently choose for themselves which 
practitioner to seek advice from and therefore often rely on reputation and word of mouth 
to select their clinician. Some describe this in more explicit terms using the word 
‘marketing’. So, although not strictly speaking a strategy from doctors to persuade patients 
to attend their clinic, reputation is noted to influence patients’ choice of where and indeed 
whether to seek medical input. One interviewee explains this process: 
“I have to show results and I have to build up my own network, it comes to that. So in 
my community I have to show that I have treated so many patients and I am good and 
I do this kind of work.” (Interview 14) 
Considering society as a whole, not just those who are currently suffering with pain, 
participants describe the role of public awareness programmes. These are noted to take 
various formats such as written articles in the press, television and radio interviews, open 
discussion forums, health camps and work with other community organisations such as the 
Rotary Club. Several participants say that this particular area of work could be carried out 
by the national societies, the ISSP and IAPC. A pain specialist talks about how their 
patients are persuaded to seek treatment: 
“I think education in the community is very important, very important, pain awareness 
programmes, a lot more about how damaging pain can be to you physically as well as 
emotionally and mentally, is very important. So, we have our pain pamphlets in both 
the hospitals which educate people on the harmful effects of pain.” (Interview2) 
Another participant talks here about running a pain camp together with another local 
organisation: 
“We approach the organisation, they help us in creating awareness about that camp, 
they gather the people and pain physician and team goes to that particular area, where 
sixty, seventy, a hundred patients come. We see them at a time and advise them about 
their treatment, and give them guidance.” (Interview 4) 
3.8.3 Knowledge Exchange Strategies Aimed at Other Professionals  
I described above how participants explain that one of the roles of the ISSP and the IAPC 
may take, can be to persuade mangers, politicians and industry of the need to prioritise 
pain management. Similarly, participants explain that clinical research and indeed public 
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awareness campaigns can be used to persuade funders to ensure particular treatments 
are made available.  
Within an individual organisation, participants note that managers decide which services to 
prioritise, how many staff to employ and which treatments will be made available. 
Politicians are described as affecting local service delivery by creating central policy to 
promote pain management and access to specific treatments (such as opioid medication). 
At the national level politicians are also noted to play a role in regulating training and 
clinical practice. The need to persuade managers to fund particular treatments is described 
as problematic in the private as well as the government sectors. One participant here 
explains the ironic situation of having to persuade mangers to provide a cheaper treatment 
option, in this case an epidural injection: 
“If you are doing some simple epidural the patients might not be needing surgery, but 
that will be reducing the hospital’s income.” (Interview 28) 
Participants also talk of the need to influence private companies operating in healthcare in 
terms of awareness. For example, pharmaceutical and medical devices companies set the 
price of their wares and participants talk of negotiating these in order to increase 
affordability for their patients. Health insurance companies decide on which treatments to 
fund for particular conditions and participants explain how they need to be persuaded of 
the benefits.  
3.8.4 Framing and Aims of Knowledge Exchange  
In Section 3.3 I showed how participants conceptualise pain as a medical problem. This 
framing of pain as a treatable problem is key to participants’ descriptions of the aims of 
exchanging knowledge. These aims ultimately relate to improving the quality and coverage 
of pain management service provision. For example, participants explain how improved 
knowledge could lead to increased practitioner numbers and ultimately to increased 
numbers of patients being referred in a timely manner to specialists. For example: 
“Patients will not come forward to accept the services, unless they are aware of the 
benefits. So education has to come at all levels, awareness has to come at all levels, 
and visibility of the services that are there, that has to be there.” (Interview 21) 
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Similarly: 
“We have reached out in terms of talking about our services and therefore they 
referred to us. So we, our referral, sort of base, has increased from the hospitals.” 
(Interview 23) 
The framing of pain as a medical problem links to participants’ descriptions of the value of 
the associated medical specialities, the specific treatments that patients receive and the 
funding of this care. I describe the results relating to each of these issues in turn.  
3.8.4.1 Pain as a Problem to be Treated 
The need to persuade others of the fact that pain is a medical problem is described by 
participants as fundamentally important to improving pain management. In order to 
convince other agents that this is indeed the case, participants sometimes talk of the need 
to treat pain in humanitarian terms, describing the treatment of pain as a human right.  
Participants also describe the scale of the prevalence of pain, despite acknowledging scare 
amounts of data. They explain how this prevalence can have significant detrimental effects 
on society as well as the individual sufferer, not least in financial terms, due to loss of 
earnings and increased healthcare costs. One interviewee explains, 
“We have to impress upon the Medical Council and the professional regulatory 
bodies, through learned societies like the Indian Society for the Study of Pain, the 
Indian Society of Anaesthesiologists, and we are in the process of involving as many 
societies as possible, to tell them, ‘See this is a problem in our country, it’s a big 
public health burden, though you don’t realise because we do not have the studies to 
show how many billions of rupees you are losing out.” (Interview 3) 
As I explained, participants talk of the need to increase awareness that pain is a treatable 
problem within the patient population, in order to persuade them to seek medical advice. 
Some describe an additional dimension related to this in some patients with terminal 
cancer who are in a degree of denial regarding their devastating prognosis. This denial may 
be compounded or indeed initiated by the family choosing to not tell the patient of their 
diagnosis. For some of these patients, persuading them to come forward to receive pain 
treatment, particularly under the umbrella of palliative care, would also involve candid and 
potentially distressing, discussion of their disease. One interviewee explains this, 
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 “Very few cancer patients come to us. Because here again the patients don’t want 
to hear they are terminal and there’s no treatment available. Many of the terminal 
patients are not told by the relatives that they are beyond cure.” (Interview 2) 
3.8.4.2 The Value of a Medical Specialty 
As well as describing the need to increase awareness of the concept that pain is a problem, 
participants also talk of the need to improve awareness of the medical specialties 
themselves that deal with the treatment of pain. They also explain that the medical 
speciality itself will function better if it is regarded as a higher profile area of medical 
practice, for example through more coordinated education, training and regulation. In 
doing so they justify their very existence as new and emerging areas of practice. At the 
simplest level participants explain that the aim of increasing awareness of the existence of 
the specialties is to increase the number of referrals, either from other clinicians or from 
patients approaching pain specialists themselves. This can be particularly problematic in 
poor or rural populations. One participant explains: 
“Eight times out of ten, nine times out of ten, they don’t know a pain doctor existed 
until they came to our hospital.” (Interview 16) 
There is also an added importance given to the declaration and widespread awareness of 
the existence of pain management or palliative care specialties at a more political and 
strategic level. Participants argue that if a specialty is formally recognised by governmental 
organisations then more structured training can follow. In the current scenario specialist 
training is uncoordinated across the country and participants explain that in general, 
knowledge of pain management strategies amongst all doctors is inadequate. An increased 
awareness would therefore improve pain management both at a specialist level and 
amongst all healthcare professionals at a more basic level. One interviewee explains: 
“Doctors won’t come forward for education and training unless they are aware, and 
patients will not come forward to accept the services, unless they are aware of the 
benefits.” (Interview 21) 
Participants also explain that another particularly important consequence of better 
awareness of the existence of specialties of pain management would be an increase in 
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popularity of the specialty, resulting in more clinicians choosing to pursue a career in 
pain management. One participant describes this: 
“Then at the same time physicians will also start thinking, yes, this is a new area, so I 
can be there, that’ll be my identity.” (Interview 7) 
3.8.4.3 Treatment Options 
Participants talk of how little knowledge both professionals and wider society members 
have of specific treatment options in pain management. They explain how this can lead to 
inadequate or poor quality treatment selection by healthcare staff. For example, with 
respect to opioid medications:  
“Because of lack of knowledge on opioids, lot of them think when you talk about 
morphine and other things, they’re afraid or scared from what the other physicians or 
their family also knows.” (Interview 19) 
At a managerial level, participants explain that a lack of understanding of specific 
treatment options can lead to a lack of prioritisation of funding and implementation 
strategies. At a political level, they talk of how there may be policies that restrict access to 
certain treatments. Within the specialty of palliative care there is a particular concern about 
how a lack of awareness of opioid medications within all of these groups leads to a lack of 
patient access to these drugs. One doctor explains: 
“If the policy maker’s not educated, morphine will not be available, and if morphine is 
not available, the doctors can’t work. So I think, this should be simultaneous, the, the 
awareness of the policy makers and awareness of the doctors.” (Interview 25) 
A need to increase the availability of other treatment modalities, however, is also talked 
about within the context of awareness. One participant explains here how other doctors 
often do not know of the range of appropriate treatments available for different types of 
pain: 
“What is chronic pain? How to treat? What is, what is the difference between 
musculoskeletal and neuropathic? Because many a times they treat neuropathic also 
like a musculoskeletal pain. So this difference is mandatory, they should know. 
“(Interview 5) 
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Participants talk about how specific non-pharmacological methods of treatment are not 
known about and of how multi-modal or holistic care could be employed more frequently. 
For example: 
 “Many times we advise patient, when patient is affording, he can, he has his 
insurance, but his surgeons says, oh don’t go for it, because he’s not aware about this 
procedure, the technique.” (Interview 30) 
Another pain specialist talks here about the need to understand the complexity of pain 
management: 
“It took me a while to emphasise that it is not just half an hour thing, pain relief is 
much more demanding and more intense and comprehensive, modality, it’s not just 
giving a block, you know.” (Interview 14) 
From a patient’s perspective, participants note that the degree of self-funding of healthcare 
means that patients themselves need to be persuaded of the potential benefits of particular 
treatments. One pain specialist talks here about the difficulties in referring patients for 
treatment by a psychologist: 
“Some of them refuse, some of them agree, and some of them are undecided so, the, 
the acceptance is pretty low in India, compared to other countries, being sort of, seen 
by a psychologist, because there is still that stigma attached there’s a mental health 
issue when you get referred to the psychologist.” (Interview 3) 
When considering what improvements participants think patients themselves would like to 
see within pain management, participants often explain that a lack of awareness amongst 
patients meant they are almost unable to evaluate the quality of care they are receiving. 
One specialist explains. 
“It’s difficult what they would like, because they don’t know what we are doing.” 
(Interview 8) 
Furthermore, some participants explain that improving this awareness amongst patients 
would increase their access to treatments, as they will begin to demand specific treatments 
from a more informed position. This is explained here by a participant: 
“Once they realise the potential to make them better, to make them useful to the 
society, then they will be in a position to push our cause, so we don’t have to go and 
make the big noise at the top.” (Interview 3) 
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Another related point, regarding treatment and educating patients is the concept that a 
dialogue between the doctor and patient regarding pain, how it occurs and affects 
individuals, can actually be seen as a therapeutic intervention in itself. One participant 
says: 
“Many times people are happy just, with just the fact that somebody listened to them.” 
(Interview 32) 
3.8.4.4 Finances 
Many of the areas I talked about above such as increasing practitioner numbers and 
treatment availability, particularly with respect to influencing managers and politicians, are 
related to acquiring increased monetary resources. Some participants also talk of the 
specific need to have increased funding specifically in order to adequately carry out work 
to improve awareness. This can include lobbying medical device manufacturers to help 
fund research that will act to persuade patients of the benefits of specific treatments, as 
described here: 
“I have been in constant discussion with the medical companies, especially these 
expensive equipment companies, that you give us, provide us some equipment so we 
do research in our India. So we present the Indian data to the people. Whatever data 
we have is a foreign data. As you know the medical scenario in the Western World 
and the medical scenario in our country is a totally different. Though there are some 
patients who can afford these treatments, but they don’t get convinced the moment I 
discuss with them.” (Interview 15) 
One participant working in palliative care explains that because they give so much of their 
care free of cost they have no income spare to spend on awareness work: 
“I think that if we have a proper funds we can actually propagate the information of 
palliative care to all the different parts.” (Interview 26) 
Finally, some participants explain that increased awareness will be self-perpetuating with 
increased knowledge levels leading to more funding to further improve education, research 
and publicity. 
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3.9 Motivation and Contested Power 
In this final results section I explore how the evaluative judgments presented in the earlier 
sections, relating to the quality of pain management in India, the descriptions of barriers 
and solutions to overcoming these problems, are formed. I examine the influences 
participants describe as informing their career progression and daily practice. I then look at 
how participants negotiate power, primarily through exchanging knowledge, with members 
of their own profession and many other groups in society when advocating for change.  
3.9.1 Motivation 
At the start of the interviews I asked participants to describe how they came to be working 
in their chosen speciality and location. During their answers presented here respondents 
describe their underlying motivations for dedicating their professional lives to treating 
patients in pain. The themes that arise relate to witnessing suffering, feeling personally 
drawn to the daily clinical work, and specific personal relationships.  
3.9.1.1 Witnessing Suffering 
Participants talk of seeing the suffering of patients, relatives, friends or even in themselves 
and feeling compelled to try to rectify these problems. One anaesthetist explains: 
“Seeing the agony of the patients, mainly the cancer patients. And I thought I have to 
do something, anaesthesia is not going to help them.” (Interview 5) 
Others talk of the scale of the problem of untreated pain, estimating the prevalence in the 
population, often compounded by patients presenting with very advanced disease. One 
doctor working in a cancer hospital describes how this prompted his career choice: 
“I researched and found out that about seventy to eighty per cent of the patients of 
advanced cancer suffer from unbearable pain. So I understood that apart from 
chemotherapy, radiation therapy, or surgery, whatever you offer, one has to take care 
of pain because it is one of the most commonest symptoms of advanced cancer. So, 
that’s how I decided to explore more about pain, the different pathophysiology of pain 
and learn more about pain, and hence after that I have taken some training and 
become a pain physician.” (Interview 26) 
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Some participants talk in more detail about aspects of the care of patients that they 
consider to be inadequate, which can be linked to the plural healthcare system described 
earlier. They explain how patients often seek consultations from many different physicians 
before finding a pain specialist who has the necessary expertise, and of how they entered 
the field in order to help to rectify this. One pain specialist explains: 
“The chronic pain patients move from pillar to post, and the amount of time and 
energy and attention given to these patients is quite less. So I felt, why not enter into 
the field? And do the best possible to give them relief because most of the chronic 
pain patients they move from pillar to post.” (Interview 8) 
Some stipulate specific conditions that they are interested in treating such as cancer pain or 
in the case below, the pain of childbirth.  
“I saw the women suffering so much with labour pain, I thought that it is, it maybe the 
right of the women to give them the, at least, you know, offer them the analgesia.” 
(Interview 9) 
These examples all refer to the state of pain management in India at a fairly general level, 
participants also talk on a much more personal level about untreated pain. Some have 
suffered a painful condition themselves, others talk of how they have witnessed the 
suffering of loved ones, and view this as a particularly formative episode in their lives. One 
doctor working in palliative care explains:  
“That is how I decided that this is what I have to do. Because I was not getting my 
peace of mind back after their death, it was just troubling me and I, I would struggle 
that what is the answer to the end of life? Like, people should not die like this, this is 
not the end should be. And this is how I came into palliative care.” (Interview 17) 
3.9.1.2 Specific Treatment Strategies 
Some participants explain how the technical aspect of performing interventional 
techniques such as nerve blocks is a part of their medical practice they are particularly 
drawn to.  
“I passed my anaesthesia MD in 1982, I immediately started my private practice in 
anaesthesia but when we’re doing our residency, myself and my colleagues were very 
much interested in giving different blocks for anaesthesia purpose, and in my private 
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practice I learned that I can give these block for my patients, I started doing some 
more.” (Interview 6) 
In contrast to this, some describe how the ideal of a holistic approach, rather than a focus 
on one specific treatment modality makes pain management particularly attractive to them. 
One pain specialist explains: 
“The multidisciplinary aspects of pain interest me in terms of looking at the 
psychology of pain, or even the philosophy of pain as well as the social side.” 
(Interview 3)  
3.9.1.3 Personal Drive 
Interviewees sometimes talk of a deep driving force inspiring them to work in pain 
management but also of how this balances some of the difficulties encountered 
when they chose this particular career path. One such difficulty is sacrificing a 
higher personal income, particularly if they choose to work in the government or 
charitable sectors. One participant who has chosen to work in palliative care 
explains: 
“I love my subject, pharmacology, I am a pharmacologist, but this is more, this is 
more rewarding and more peace giving to me, palliative care.” (Interview 17) 
Here a pain specialist working primarily in the government sector explains his 
move from working as an anaesthetist in the private sector: 
“I felt, I am doing nothing. It was a boring job, and the patients are also not, they do 
not know me, and I also, so this is unethical, this is unethical what I felt, so I stopped 
going there. Suddenly, people thought I am a fool, but, but I am happy, I am happy 
with my conscience.” (Interview 7) 
Another interesting motivator sometimes described is that of personal autonomy. Those 
who have originally trained in anaesthesia explain how they often feel very much at the 
beck and call of surgeons who essentially dictate when they require input from an 
anaesthetist. Within the private sector the surgeons also control the monetary fee paid to 
the anaesthetist, resulting in a power differential some find to be personally troublesome. 
In contrast, working as a pain specialist in their own right ensures they have a higher 
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degree of ‘ownership’ of their patients, resulting in more autonomy and a feeling of 
higher status. One pain specialist explains:  
“Anaesthesiologists in India, they have their identity crisis. That’s a, that I must say, 
but it may be everywhere in the world, I do not know, but it is more in India, because 
they’re dependent on the surgeon, and where, and he is a team member of the surgeon, 
like an assistant. So, the surgeons also behave like that, and because in the private 
clinics, the surgeon have a just discussion on the kind of budget of the operation, say 
for example 60,000 Indian rupees, and so he is thinking, to take 25,000 for himself, 
and 25,000 or for the hospital, and the medicines, so there’ll be only 5 to 10, 6,000 
will be left for the assistants and anaesthetist.” (Interview 7) 
Another pain specialist explains how this feeling of low status can be much more 
fundamental than simply a dissatisfaction with income: 
“Even if you save the life of patient, the patient is always thankful to the surgeon and 
not to the anaesthetist.” (Interview 15) 
Of note, this feeling of dissatisfaction with status is not talked about as a reason for 
choosing to work in the specific area of palliative care. 
3.9.1.4 Relationships 
Relationships with colleagues are described as both motivators and hurdles, for example, 
the need to tolerate the negative attitudes of colleagues. This can be simply in their 
derision of the decision to take up a career in pain management, which is often related to a 
reduction in income. Pain specialists also describe difficulties in their daily practice with 
their medical colleagues not appearing to value their clinical work. One pain specialist 
describes this early on in his career: 
“It was not always pleasant, there would be a lot of hostility because I, I have a very 
respected senior colleague of mine, he said so, ‘What do you mean pain? Everybody 
does pain. What do you mean? What you, what are you doing? Why don’t you do 
anaesthetics, you know? We need anaesthetists, why don’t you do anaesthesia?’ That 
sort of very dismissive.” (Interview 16) 
This dismissive attitude is sometimes described as arising from a degree of ignorance of 
pain management strategies and the work of pain specialists. However, some also describe 
how, albeit slowly and in relatively few cases, this is changing over time with an improved 
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understanding of the specialty, as well as an increasing respect when colleagues see 
how patients can benefit from specialist pain management. 
“Initially when we started people were looking at us with, especially oncologists, 
looking at us with little bit suspicion. But now they realise that this is a good service, 
and actually they, they even realise that somebody who is registered with us is likely 
to, likely to complete the therapy, curative therapy, the likelihood is more with 
somebody who has already been supported emotionally and physically.” (Interview 
22) 
One pain specialist talks of how this improved appreciation of their work has now 
led to increased referral from previously sceptical colleagues: 
“You’ll be surprised that those doctors who was criticising me are now my patient. I 
injected them, their back, their you know, one orthopaedic surgeon who was 
criticising me a lot, his wife is my patient.” (Interview 28) 
Linked to this description of overcoming a degree of hostility from within the medical 
profession is a description of career paths that are in some way pioneering. Participants 
describe how they needed to persuade many different groups that pain management was a 
worthwhile enterprise – colleagues, managers and ultimately patients.  
“I would remember the, say five years ago I would be knocking at a lot of people’s 
doors asking for you know, my services to be offered to them, that I can do something 
in pain, I can do something in pain.” (Interview 16) 
Those who have now established careers in pain management, describe how training 
opportunities within India were almost non-existent for them. This necessitated self-
learning and searching out individual teachers, often resulting in periods of training 
overseas. For example: 
“I don’t have any formal training as a pain physician but I learnt by myself, reading, 
doing the mistakes, and learning from the mistakes. And in the process I attended 
many international conferences, I visited also Sloan Kettering, for about one month as 
a pain scholar, on a pain scholarship.” (Interview 15) 
Several participants talk of how one specific teacher often based in a country in the global 
North, was particularly influential in their early career. However, there are also 
descriptions of how the number of locally trained clinicians fulfilling the roles of teachers 
and mentors has increased somewhat over recent years, and they are now therefore able to 
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deliver education more appropriate to the Indian setting. One pain specialist working in 
palliative care explains: 
“Earlier in all our conferences we used to call external faculty, now I think our people 
also are well equipped and well skilled, or well experienced in palliative care, and we 
started tailoring for our needs.” (Interview 31) 
3.9.2 Power Contestation 
Throughout the data, participants talk of contesting power in various forms and with 
multiple groups, mostly in relation to descriptions of how the delivery of pain management 
can be improved. Most prominently, power is described as being negotiated in terms of 
knowledge and money. For example, increasing the knowledge of others in order to 
persuade them to act in a particular manner is described as a fundamental aim of increasing 
awareness, which in turn is associated with the aim of increasing financial resources. In the 
private sector, increasing patient referrals directly increases income, to the hospital and/or 
to the clinician, depending on the salary structure of the individual institution. Some 
organisations will pay a fixed salary regardless of the number of patient referrals received 
by an individual; others will be paid per patient and procedure. In other organisations, 
participants talk of the need to increase awareness amongst wider society, managers and 
politicians in order to increase funding to the institution itself as opposed to generating 
income from patients’ individual fees, using this funding to improve facilities or subsidise 
patient charges. However, even in these situations where the clinician is receiving a fixed 
salary there is a potential indirect personal gain from increased service funding, with 
improved working conditions, job security and profile. Power is contested therefore 
between and within various groups. These relationships take various forms and I describe 
them below under the following headings: top-down/bottom-up, collaborative-competitive, 
and global-local. 
3.9.2.1 Top-down and Bottom-up 
I described in the preceding section how participants call for more awareness and therefore 
funding from groups that are perceived to be in more powerful positions than the 
participants. Classically, these groups are hospital managers and politicians. Participants 
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describe the role of these powerful individuals both as a hindrance, and as a potential 
asset. For example, politicians are held responsible for creating policy leading to poor 
availability of opioid medications but government institutions are hailed as crucial to 
implementing standardised training and practice. Similarly, managers are viewed as being 
able to both prevent and facilitate the prioritisation of pain services or research within a 
hospital. Other examples from my data include accreditation authorities that declare the 
presence of a pain clinic as ‘essential’ or insurance companies that agree to fund particular 
treatments. 
The national organisations, the ISSP and IAPC, and indeed others such as the Indian 
Society of Anaesthesiologists can also be considered as top-down groups. Although the 
members of these societies are of course clinicians themselves, the collective groups can 
be viewed as more powerful entities than their individual members. These societies lack 
the authority of government bodies but are described by participants as being potentially 
powerful advocates for advancing the profile and standards of pain management, almost 
acting as a stepping-stone to the higher level of government. 
Clinicians themselves are often viewed as being in a powerful position, deciding which 
treatments to offer and to whom. However, as I explained already, participants describe 
how patients have to choose their own medical professionals, consent to treatment and 
often pay directly for their healthcare, demonstrating how they and their relatives hold a 
degree of power. Some participants talk of the need to engage patients and wider society in 
order to improve pain management from the ‘bottom-up’. However, I argue that 
participants are actually often talking of top-down control when interacting with patients 
and wider society. For example, when participants talk of increasing awareness within the 
patient group, clinicians are talking about aiming to persuade patients that they will indeed 
benefit from the treatments the clinicians deem to be appropriate.  
One notable exception to this top-down exchange is an initiative where local community 
members who take the lead in directing the aims of the service fund this programme. A 
participant working for this group explains how the service evolved from treating, almost 
exclusively, patients with cancer, to seeing those with any medical condition:  
“We had a lot of debate within our clinic and then we said this is what we should do. 
If we are asking the community to support, then the agenda also should include what 
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community wants. If we say that we need all your money but then I will decide 
which patient to give, that’s not right actually, and for the community the common 
denominator is suffering. Ok, you may be having cancer, you may be having HIV, or 
you may be having stroke, and for me as a doctor I can differentiate, but for the 
villager diagnosis is secondary to that. But all they can see is that those are three 
people suffering.” (Interview 33) 
3.9.2.2 Competition and Collaboration 
Power is also contested within the group of healthcare professionals themselves. Above, I 
explained how the participants talk of increasing awareness and knowledge through 
education strategies targeted at their colleagues. There is a degree of competition within 
the medical profession, described by participants, particularly in the private health sector 
where clinicians are vying for the custom of patients. For example, a surgeon may be 
reluctant to refer a patient to a pain specialist, as they may fear that the patient may not 
return to them again for further input. However, of note in the government or charitable 
sector, although participants talk of the need to increase awareness partly so that patients 
seek out treatment, these services are also at times described as being over-subscribed.  
Some participants also describe a reluctance to refer to other professionals due to a desire 
not to admit defeat. One doctor explains. 
“There’s a kind of ego problem let me tell you, the surgeons, the orthopaedicians, you 
know, they think once they have failed then only they will refer.” (Interview 13) 
Participants also note that this competition can play out by clinicians choosing treatments 
in order to make income despite them not being the most appropriate option. For example, 
here a participant describes the presence of ‘block shops’, that is, clinics where nerve 
blocks are carried out: 
“Block shops, that’s, again, it is, it is pushed by the corporates. There is good money 
in it, and you know nerve blocks are not very effective in all cases, you know the 
limitations of blocks, so that should not be there.” (Interview 25) 
Furthermore, this can breed mistrust of the medical profession in general, with patients not 
sure of the motivations of individual doctors. One participant explains:    
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“They don’t trust the healthcare system, they think the healthcare system, every 
single person is out there to make money not in their own interest, so they don’t trust 
it, that becomes a problem.” (Interview 19) 
Importantly, there are also many examples of collaborative work. Clinicians frequently talk 
of the need to refer to their colleagues to provide expertise in a particular area. For 
example, palliative care specialists who do not have the necessary training or equipment 
ask colleagues in anaesthesia to perform nerve blocks if pharmacological treatments have 
not worked. Anaesthetists also refer to specialist palliative care teams and many 
participants describe holistic patient care delivered by multidisciplinary teams. There is 
however, a call from many participants for more collaboration both clinically on a day-to-
day basis, in other work such as advocacy through membership of the national professional 
societies, and on education and research projects. Interestingly, one participant specifically 
notes the need for more collaboration between groups working in palliative care and those 
working in pain management without expertise in this field: 
“I think one problem is that either palliative care physicians manage only with 
pharmacological agents and interventional pain therapists do only interventions, and 
this I think is a huge problem. Interventional, I mean pain management has to be 
comprehensive.  
So, how can that be improved?  
By more dialogue between pain management people and palliative care people, and a 
joined look at where we are. Which is not easy, but it is necessary.” (Interview 18) 
3.9.2.3 Global-local Interactions 
Many participants talk of how overseas practice influences their daily work. There are 
numerous examples in both the interviews and the questionnaires of participants receiving 
training either overseas or from colleagues who are based outside of India, usually but not 
exclusively, in countries of the global North such as the UK, USA and Australia. Some 
participants note how this has started to change as more training opportunities become 
available in India, following the growth of the practice of pain management. Similarly, 
they explain how the teaching faculty at education meetings is increasingly made up of 
Indian clinicians. A few participants describe how they in turn are now teaching abroad, 
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receive overseas students to train in their organisations, and run international 
educational conferences. 
Participants explain that the majority of research and guidelines available to inform their 
treatment selections originate from countries in the global North. They describe, therefore, 
how there is a specific need for more Indian based research into understanding how 
therapies originating in the global North can be effectively implemented in India, or indeed 
if they are likely to be effective at all. One participant says: 
“Whatever data we have is a foreign data. As you know the medical scenario in the 
western world and the medical scenario in our country is a totally different.” 
(Interview 15) 
Participants describe how western medical treatments are inadequately understood in the 
Indian context and require translation rather than being directly transferred. In some cases 
participants talk about a change as simple as a dose reduction of a medication but they also 
talk of how some treatments are likely to require much more modification to work in the 
different sociocultural environment of India. One participant gives an example here: 
“They don’t like western medicines, because they feel that sometimes, they will be 
more, they will accept complementary and alternative medicine and something that’s 
indigenous, they relate better to it. Even if it doesn’t work for them, they’d still be 
more, they’d be happier with it than taking a medicine because there’re a lot of 
negative connotations about medicines. The commonest thing is pain killers are bad.” 
(Interview 16)  
As I described at the beginning of Section 3.3, some participants describe the huge 
variation between populations in how people perceive and tolerate pain. A pain specialist 
explains: 
“A lot of ideas about pain and how we perceive it, depends on our social background, 
our environment.” (Interview 14) 
Some participants describe receiving support in various forms from international 
organisations such as the WHO or the International Association for the Study of Pain, and 
indeed many describe using WHO published guidance in their clinical practice. However, 
participants also call for more collaboration from these high profile and therefore powerful 
groups, suggesting they provide more top-down support for local Indian initiatives such as 
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education programmes and the modification of resources such as guidelines and patient 
information media for local use. A few participants clearly state they would welcome more 
direct financial support from wealthier countries and others describe how they have 
already benefitted from overseas money and volunteers working at their institutions.  
3.10 Summary 
In this results chapter I presented a combination of quantitative and qualitative data from a 
range of sources, in order to build up a picture of how pain management is practiced in 
India and of how clinicians evaluate this work. The data derives from participants working 
in several regions of the country and in many types of institutions, with various funding 
arrangements. The results demonstrate features of the Indian healthcare system that are 
perceived as directly affecting the practice of pain management - such as the paucity of 
resources, a multiplicity of healthcare providers, weak regulation, and a lack of uniform 
practice. Within this system the treatment of pain is seen to be given very low priority.  
The results demonstrate that the overall need to improve access to pain therapies within the 
healthcare system is relatively undisputed by the participants who highlight the low levels 
of availability of opioids as well as many other medications and treatment modalities. They 
also show that availability patterns vary across the country, as do participants’ views on 
which therapies should be the focus of improvement strategies. There is variation amongst 
the participants in their desire to increase the availability of specific treatments, as 
advocated by high profile international organisations including the WHO. 
Similarly, the participants describe with a degree of consensus the need to improve the 
treatment of pain across the country through formalised specialist training in pain 
management. However, views about the specific form that this specialisation should take, 
particularly with respect to the organisation of the medical profession and its specialities of 
palliative and pain medicine are less uniform. 
However, the most prominent theme arising from the data is the overwhelming agreement 
amongst the participants that pain is a problem to be fixed by the medical profession. 
Participants consistently note a lack of awareness amongst others regarding the need to 
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consider pain to be a medically fixable problem. They also describe the need to raise the 
profile of the treatment of pain within healthcare. Low levels of awareness are manifested 
in multiple ways, from patients not considering pain to be a problem requiring medical 
intervention, through clinicians not understanding the range of available treatments, to 
managers and politicians not prioritising pain management within the healthcare system. 
Participants talk of the need to implement strategies to improve awareness for patients, 
society, healthcare colleagues, managers and politicians. This process of altering the 
awareness of a particular issue amongst other individuals can be considered to be a 
demonstration of the use of knowledge as power. The results reveal how power is 
negotiated by the medical profession in several forms including as knowledge and money; 
and in multiple locations at local and global levels.  
In the following chapter I discuss these results in detail with particular reference to the 
conceptualisation of pain as a medical problem, the organisation of the medical profession 
and treatment selection. I examine the debates that surround these issues and consider the 
implications these have for the delivery of healthcare.
 Chapter 4 - DISCUSSION 
4.1 Introduction 
In the preceding results chapter I built up a picture, largely from the perspective of 
practising clinicians, of how pain is treated in India. The data includes descriptions of the 
Indian healthcare system, details of how individuals practise pain management and their 
views on how pain ought to be treated.  
In this chapter, I discuss these results, beginning in Section 4.2 with an overview of data 
relating to descriptions of the healthcare system in India. I give particular emphasis to 
those features that strongly influence the delivery of pain management, namely scarce 
resources and the diversity of healthcare provision. These features of the healthcare system 
can be considered to be the backdrop to the discussions presented in subsequent sections 
(4.3 - 4.5) relating to the professionally constructed phenomena identified in this study. In 
Section 4.3 I discuss the medicalisation of the treatment of pain, describing how pain is 
conceptualised as a medical problem to be fixed and the impact this has on the organisation 
of the medical profession. An important dimension of this medical model is the use of 
specific treatments by individual clinicians, and in Section 4.4 I discuss these different 
therapy modalities and their selection. I begin with pharmacological treatments, moving on 
to non-pharmacological therapies and end by discussing the variations seen in treatment 
selection. When considering these topics of treatment selection and the organisation of 
medical specialities dedicated to the treatment of pain, multiple points of view exist within 
the medical profession and across wider society. In Section 4.5 I discuss how these 
individual views are negotiated, considering how clinicians enact their professional power 
both within India and at a global level. I structure this section with reference to theories of 
the policy process introduced in Chapter 1, discussing in turn agenda setting, policy 
formation and policy implementation. 
Throughout the chapter I highlight the unique contribution this study makes to the current 
body of knowledge, demonstrating the practical relevance of my findings and the 
importance of taking a cross-disciplinary approach in order to fully appreciate how pain is 
treated within a society. Finally, in section (4.6) I discuss the limitations of the data and 
reflect on how my personal perspective influences the study findings.  
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4.2 Healthcare in India  
India is a huge country with a population of over a billion people spread over 36 
administrative states and union territories, making the task of providing health care an 
immensely complex and indeed highly political process.
124
 While it is therefore difficult to 
generalise, there are some characteristics of the Indian healthcare system highlighted by 
my study findings that are particularly noteworthy and relevant to the provision of pain 
management, namely the distribution of scarce resources, and the diversity of healthcare 
provision.  
4.2.1 Resources 
As I described in the opening chapter, healthcare generally in India, and specifically the 
provision of pain management, is widely reported to be grossly under funded and over 
subscribed. Low levels of trained personnel mirror the lack of financial resource. The 
results of this study, presented in Section 3.4.1, clearly confirm this lack of resource, with 
participants describing how they lack the facilities, equipment and staff to provide 
adequate pain relief to patients. They show that not only are there scarce financial and 
human resources within individual healthcare facilities but also low numbers of facilities in 
existence across the country, painting a picture of a system unable to provide high quality 
care to all of those who require it. 
The low levels of palliative care provision in India are already well described in the 
published literature. They are highlighted again in the recently published report from the 
Lancet Commission on Palliative Care and Pain Relief,
3
 which describes inadequate access 
to pain relief across the global South. This report continues the trend of so many other 
global initiatives in focusing on the highly emotive issue of pain relief associated with care 
at the end of life and the specific problems related to accessing opioid analgesia. The 
authors describe the gap in access levels between those living in poor and well-resourced 
environments as an ‘abyss’, replacing the less dramatic term ‘divide’ which is used in 
earlier descriptions of their work.
41
 However, the results of my study take this description 
of access further by demonstrating this lack of resource for the treatment of pain across 
multiple clinical areas including those often considered to be beyond the remit of palliative 
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care, namely in the treatment of chronic pain not associated with terminal disease and 
acute, short-term pain. My study also demonstrates low levels of access to many other 
treatment modalities, besides opioids. I argue that the broad approach I have taken is 
particularly pertinent because the management of acute short-term pain, that is largely 
amenable to treatment with opioid medications, is frequently overshadowed by highly 
emotive descriptions of the need to improve access for those suffering with terminal 
disease. My approach is also relevant due to the expanding remit of palliative care to 
encompass the treatment of an ever-widening range of diseases. I return to each of these 
topics later in this chapter.   
Not only is access to healthcare in India under resourced, it is also described in the 
published literature as being inequitable across different strata of society, for example, in 
relation to caste, gender, wealth and geographical location.
124,133
 Unequal access to 
treatment is confirmed in my study particularly with reference to wealth and geographical 
location. These two variables often overlap with the poor population living in rural areas 
being disadvantaged by living a long distance from institutions and being unable to afford 
to travel, as well as to pay for their treatment. The results of the study also demonstrate, 
however, the unequal distribution of pain services across different regions of India, with 
participants reporting large variations in the number of pain management facilities even 
between different urban areas.  
As I have described, private healthcare in India is prolific, with the majority of health 
services provided by this sector. However, palliative care services in India are frequently 
provided by the charitable sector meaning that many reports into problems of access to 
pain treatment fail to encompass detailed analysis of care delivered in the private sector, 
particularly in large corporate facilities. I explicitly set out to redress this imbalance by 
including the views of those working in these areas and indeed my results show that 
clinicians consider there to be a relative lack of resource allocated to the treatment of pain 
regardless of the type of institution being discussed. My results confirm the already well 
described difficulty faced by those working in the government and charity sectors, who are 
faced with the stark reality of allocating resources in an environment where life saving or 
disease curing treatments are not available.  
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It is particularly interesting to note, however, that even in the corporate sector this 
relative lack of funding is described as problematic. In these hospitals that enjoy high 
levels of absolute funding and offer similar services to those provided in the global 
North,
291
 participants explain that the treatment of pain is often afforded only very low 
priority. This is demonstrated by descriptions of fellow clinicians not knowing how to treat 
pain and even being unaware of the very existence of pain specialists, and also in managers 
who are unwilling to fund pain services. The treatment of pain is viewed across the 
healthcare system as a low priority when compared to the provision of disease curing 
therapies.  
The descriptions I included so far relate to the scarcity of resources allocated to the 
treatment of pain from the perspective of delivery – that is, the supply side of healthcare. 
This research also highlights factors on the demand side that serve to further reduce access 
to pain treatments. For example, patients themselves frequently do not prioritise the 
treatment of pain and are unable or unwilling to fund this aspect of their care. Other studies 
have shown that despite the costs involved many patients even from the poorest sections of 
society favour the private sector, partly due to the perceived poor quality of service 
delivered in other institutions.
292-294
 The results of this research show that clinicians view 
this funding structure as problematic particularly when addressing the medical 
management of patients in pain, with individual patients described as needing to be 
persuaded to prioritise, and therefore fund, their treatment. They explain how the treatment 
of pain is often regarded by both patients, and healthcare professionals as an optional ‘add-
on’ luxury. This is in contrast to potentially curative treatments such as cancer 
chemotherapy which are much more likely to be viewed as essential.  
The difficulties in patients funding their own treatment ‘out of pocket’ is highlighted as 
being particularly problematic when considering those suffering from terminal diseases 
such as cancer because these patients have frequently exhausted their financial assets 
through endeavours to cure their underlying condition. Whilst this phenomenon, 
specifically with respect to cancer treatment, is already well described elsewhere,
295
 this 
study shows how clinicians across each different type of healthcare facility describe 
patients’ out of pocket funding of pain treatment as problematic, regardless of the 
underlying cause of the pain or indeed the therapy being offered. For example, clinicians 
working in charity funded palliative care organisations sometimes describe difficulties in 
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being able to provide relatively simple nerve block injections or medications, whilst 
those working in large urban corporate facilities describe how patients are unwilling to pay 
for high end therapies such as implanted electrical devices. To be clear, this study shows 
that although there may be variation in the treatments that are offered to patients in 
different healthcare settings, there is agreement amongst the participants regarding the 
need to persuade patients, who are generally reluctant to finance these treatments, 
regardless of the absolute cost. Poor patients are described as needing to be persuaded to 
pay for relatively cheap treatments, and the wealthy for high-end interventions. 
As I described, scarce resources are both financial and human, but the two are inextricably 
linked. For example, a lack of money directly affects the quantity of human resources 
available in a given institution through restrictions on the salaries that can be paid. There 
is, however, an additional constraint in India, as noted in Chapter 1, of an absolute lack of 
trained medical personnel. This leads to shortages in certain geographical areas because 
clinicians may favour working in urban and private facilities, and it is compounded by a 
‘brain-drain’ wherein healthcare workers frequently elect to work overseas.131 This study 
emphasises the scarcity of trained medical professionals in general and in particular in 
rural areas and some states. The results show how this leads to the provision of sub-
optimal care, especially within the government sector and other over-subscribed services, 
where the time available to spend with each individual patient is severely limited.  
Specifically, the results show that the shortage of manpower is considered to be especially 
problematic within the medical fields related to the treatment of pain. Participants talk of 
the difficulty in recruiting into poorly paid posts in the charitable sector, particularly within 
palliative care, which is often viewed as an unglamorous specialty when compared to 
others where high salaries or the delivery of life saving treatments are possible. Some 
describe a reliance on overseas volunteers to provide certain treatments. Even for those 
working in the private sector and outside of the remit of palliative care, however, there is 
talk of how specialists had faced ridicule from colleagues and taken significant financial 
risks when deciding to leave the relative security of a well-paid post in order to pursue a 
career in the field of pain management. The clinicians in this study add further weight to 
the argument that the treatment of pain is a low priority within the healthcare system when 
they describe how they are required by managers to fit their pain management work, 
around other responsibilities such as the provision of anaesthesia.   
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4.2.2 Diversity 
The study results demonstrate the diversity of healthcare provision in India with respect to 
specialists involved in the treatment of pain (Section 3.4.2). They show that there is a great 
variety in the way in which institutions are funded (Figure 3-11) and that many 
respondents work in more than one institution (Figures 3-12 and 3-13). Some respondents 
working primarily in the charitable sector talk of the need to supplement their income by 
engaging in private work while simultaneously, those working primarily in the private 
sector talk of the desire to carry out unpaid charitable activities. Similarly there is 
considerable variation in the type of care clinicians engage in – whether this be in-patient, 
out-patient or community based (Figures 3-15, 3-16 and 3-17).  
The study also reveals wide variations in clinical practice amongst healthcare workers in 
that they offer different ranges of treatment modalities. However, it also demonstrates 
variations in their conceptualisation of what constitutes an ideal range of treatments. Many 
participants in the study describe a lack of standardised training and inadequate 
professional regulation, confirming other published reports, and they also talk of the 
problems that arise from this non-uniform practice. They explain that the quality of pain 
relief individual patients receive could be improved by implementing clinical guidelines, 
standardising training at a national level, and improving professional regulation. In the 
following section I return to the topic of treatment selection, guidelines and standardised 
training, particularly with respect to the quality of care delivered.  
Diversity of healthcare provision is a universal phenomenon well described within the 
literature, for example, in the field of medical anthropology.
296
 Across the world, 
individuals seek advice regarding their health from numerous disparate groups including 
western medical professionals, locally trained practitioners and family members.
296,297
 As I 
already outlined, in India there is a vast array of trained practitioners working alongside 
allopathic doctors in fields of healthcare known as AYUSH (ayurveda, yoga, unani, 
homeopathy and amchi) and there are also incalculable numbers of untrained 
practitioners.
298
 This diversity can have negative effects on healthcare delivery due to 
variations in service quality and difficulties in coordinating regulation. Patients can also be 
faced with an overwhelming choice of practitioner and indeed my results show that this 
choice can be problematic, particularly when seeking treatment for pain. Factors that affect 
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patient selection of healthcare provider are numerous and complex, particularly in the 
more diverse and unregulated systems often present in low and middle-income 
countries.
299
 A vast literature has arisen on this subject but the key factors to be aware of 
include characteristics of the individual such as age, gender, education level, occupation 
and financial assets; and factors related to the healthcare system such as accessibility, 
acceptability of the provider, cost and perceived quality.
300,301
 
When considering the provision of pain relief in India the circumstances are particularly 
complex due to the multiple areas in which diversity exists. For example allopathic and 
AYUSH practitioners each work in multiple types of institution with funding available 
from government, charitable and private sectors. Within the allopathic community, as 
demonstrated in my results, there is little regulation or standardisation of training and huge 
variation in the clinical treatments offered, and crucially in the normative positions of the 
practitioners. Issues of trust then become pivotal when patients are choosing a medical 
practitioner. For example, interview participants explain that the sheer number of providers 
and the presence of untrustworthy practitioners and practices leads to some patients 
choosing a doctor based simply on previous experience or a personal recommendation 
rather than knowledge of their expertise in the relevant medical field.  They also talk of the 
importance of this system of personal recommendation when growing and maintaining 
referrals to their practices.  
In Section 4.2.1 I outlined the problems within the Indian healthcare system of scarce 
resources – both financial and human, and of how this is particularly problematic within 
the fields specialising in treating pain. In Section 4.2.2 I described the diverse array of 
healthcare providers in the country and the generally low levels of professional regulation. 
The presence of both these factors in combination leads to a very strong market within the 
field of healthcare wherein practitioners are constantly trying to attract custom – from 
patients and through referrals from colleagues. Furthermore, with patients paying for their 
treatment out of pocket and having limited resources do to so, the need to market 
healthcare directly to patients is a key concern for clinicians. Patients themselves are faced 
with a healthcare system in which reputable, affordable practitioners are few and far 
between, and very difficult to identify. In the following sections I discuss how these local 
healthcare system factors influence, and are influenced by, the professionally constructed 
nature of the practice of pain management.  
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4.3 The Medicalisation of Pain and Palliative Care 
4.3.1 Pain as a Medical Problem 
I noted some of the general factors that affect a patient’s decision to access healthcare - 
such as education level, socioeconomic status, accessibility, reputation and cost of the 
provider, but a fundamental factor is also the patient’s underlying beliefs surrounding the 
specific condition they are experiencing. These include ideas about the potential diagnosis 
as well as the perceived benefits of seeking treatment.
300
 This is especially pertinent when 
considering patients seeking treatment for pain, one of the commonest reasons for seeking 
healthcare.
296
 The subjective nature of pain inevitably leads to great variation between 
individuals’ perception of the phenomenon and their interpretation of its meaning.32 
Crucially, the socio-cultural environment also affects whether pain is considered to be 
abnormal or pathological, as opposed to a normal experience of everyday life. Simple 
examples include variations in seeking treatment for dysmenorrhoea (period pain) and the 
pain of childbirth.
302-304
 This social-cultural effect is also known to vary over time, 
particularly in societies that are considered to be undergoing rapid socio-economic 
development.
296
 Furthermore, as I outlined in the introductory chapter, the phenomenon of 
pain existed before the human species evolved and has been subjected to numerous socio-
cultural interpretations, such as those associated with religious and spiritual belief 
systems.
4,5,8
 More recently, following the advent of modern anaesthesia in the 19
th
 century, 
the idea that pain is a medical problem to be fixed has become increasingly prevalent.
5
 
Variations between individuals’ interpretation of painful states (such as period pain and 
childbirth) as being pathological, and the historical changes that have occurred within 
society’s collective interpretation of pain, leads to the conclusion that the medicalisation of 
pain is a socially constructed phenomenon. Furthermore, as I introduced in Section 1.4.1, a 
significant force of influence in this construction process is the medical profession itself. 
Within my study, the results (presented in Section 3.3) demonstrate that the idea of pain as 
a problem to be fixed, is uncontested by the participants. The need to persuade others of 
this fact is also ubiquitous. Although participants clearly describe how other groups across 
society, including patients, doctors, managers and politicians possess alternative 
interpretations of the meaning and management of pain, they describe the need to alter 
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these views and enlighten others with their superior knowledge rather than entertain the 
idea that the medical treatment of pain is only one of several possible paradigms. This is 
very much in line with Freidson’s descriptions of the widespread political dominance of 
the medical profession
176
 and the conclusion that the medical treatment of pain is largely a 
professional construction.  
To be clear, with current western medical technology, many types of pain, typically 
following trauma or surgery and pain of terminal disease, are amenable to treatment and 
are able to be ‘fixed’, whereas in contrast, other long-term or chronic pains are generally 
not cured, although relief may be temporarily or partially achievable. Despite this the study 
participants make little mention of the limitations of currently available medical treatments 
and I only found one explicit comment describing the lack of fully effective treatments for 
all types of pain as a barrier to the improvement of pain management. The participants do 
not discuss the notion that they themselves as medical professionals are by definition partly 
responsible for the professional construction of this medical model. Similarly, they do not 
describe the implications this created phenomenon may ultimately have on the practice of 
pain management. They do, however, raise some interesting themes that result from the 
professionally constructed nature of the model. For example, there is recognition that the 
specific therapies that may be of benefit to those living in India will be different to those in 
the global North. Several cite examples of using particular drug dosing regimes developed 
in countries in the global North that are not tolerated by Indian patients, explaining how 
more medical research is needed in order to solve this problem. Similarly, there is 
acknowledgement that there are differences in the interpretation of pain between different 
population groups. For example, they describe how those who are wealthier and living in 
urban areas are more likely to seek medical advice for chronically painful conditions. 
There is also a change occurring across the generations with increasing impetus to seek 
treatment coming from younger members of society.  
Interestingly, the recent Lancet Commission report not only reinforces this professionally 
constructed notion that pain is a medically fixable problem but also expands on this idea, 
describing a new concept, called ‘severe health-related suffering’ or SHS.3 SHS 
incorporates many other symptoms as well as pain, that are described as requiring medical 
treatment, particularly highlighting differences in access between those in the global South 
and North. The creation of this new metric, and the overwhelming scale of its presence 
Chapter 4 
 
192 
serve to reinforce the call to reduce human suffering through increasing the delivery of 
western medicine at a global level. This is another clear demonstration of the medical 
profession’s political power or economy as described by Freidson and others.174 It also 
relates closely to descriptions of the increasing medicalisation of other conditions, 
including aging and death, previously considered to be a normal part of the human 
experience, that are now deemed to require medical treatment.
179,180
  
One final point to make here is the description by some participants of the need to consider 
the treatment of pain as a human right, echoed in the Lancet Commission report whose 
authors talk of poor opioid access as a “moral failing”.3(p1) As I outlined, it has been argued 
that the very description of humanitarian goals as human rights is problematic.
100
 At first 
glance it may seem like an unarguable act of common sense to describe the relief of human 
suffering with medical analgesics as a human right, in line with the 1948 Universal 
Declaration of Human Rights
92
 and the 1966 International Covenant on Economic, 
Cultural and Social Rights,
38
 that describe respectively the right to health and the right to 
freedom from torture. Some, however, consider these United Nations based declarations to 
be initiatives dominated by countries in the global North
100
 and therefore alienating to 
other regions of the world. This is in line with postcolonial theorists who argue that power 
differentials between nations have remained to a large extent the same as those present in 
the colonial era.
254,255
 Furthermore, by describing a particular cause as a human right there 
is a sense that is becomes sanctified and placed beyond criticism or debate, and this is 
exactly what the participants seem to be doing when describing access to pain relief in 
these terms. The terminology is invoked in order to strengthen their position that others 
need to be made aware of the ‘unarguable fact’ that pain is a phenomenon requiring 
medical treatment, further adding to the political and economic power of the medical 
profession. 
Despite the widespread support for the use of this medical model, I argue that the 
medicalisation of pain is in fact an example of the simplistic reductionist models that are 
criticised for being unrepresentative of the complex social phenomena they aim to 
represent.
5,260,305
 Some authors suggest that the actual use of this model to treat pain can 
cause harm through inadvertently increasing patients’ disability.306 This, largely 
professionally constructed, medical model does not readily incorporate the range and 
complex nature of individual patients’ experiences nor does it fully acknowledge the 
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limitations of western medicine’s ability to cure all types of pain. Furthermore, the 
prevalent and expanding use of the model, exemplified by the Lancet’s newly created SHS, 
implies that with increased scientific research, as called for by several study participants, a 
more effectively functioning medical profession will ultimately rid the world of pain and 
suffering. This perspective is akin to Parson’s much critiqued functionalist approach in 
which doctors act only to improve the lives of their patients,
174
 but it also demonstrates 
how power is wielded by the profession as described by Freidson.
176
 However, this is not 
to say that I consider the medical, professionally constructed, model to be entirely 
redundant, but rather that we need to understand how it is created and modified, its 
assumptions and limitations, and how it functions in the wider dynamic social context. In 
particular we need to consider the dominant role played by the medical profession and how 
its power is wielded in society. I argue that this is best done by adopting an approach, in 
line with Foucault’s social constructionist perspective.174 Through this, we can then 
appreciate not only that one model will not be universally applicable to every clinical and 
social situation but importantly, when the model will be useful, and in doing so use it to its 
fullest potential.  
In the following sections (4.3.2 and 4.4) I discuss some of the practical implications of the 
professional construction of pain as a medical problem namely the creation of medical 
specialties and the selection of different treatment strategies.  
4.3.2 Medical Specialisation 
Practitioners of western medicine are bound together in their profession by their 
specialised knowledge, the growth of which is one of the driving forces behind the creation 
of professional subsections known as specialties.
307
 A result of the conceptualisation of 
pain as a medically fixable problem, and its associated knowledge base, is the creation of 
medical specialties dedicated to treating these patients. Medicine and its subsections, in 
common with other professions, function to control this specialist knowledge base, setting 
entrance and registration criteria, and practice standards, as well as promoting the common 
interests of its members and protecting the group from competition.
296,307,308
 However, as 
described by Abbott in his book, The System of Professions, the boundaries of professional 
group’s sphere of work or ‘jurisdiction’ are constantly changing and contested.309 Each 
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medical speciality has its own knowledge base, professional standards and internal 
structure of hierarchy. Of note there is also a hierarchy between different specialties with 
those focused on particular organs such as the heart and the brain afforded higher status. 
Similarly, those specialising in caring rather than curing sit lower down the status 
hierarchy,
296
 and these would include those with a focus on pain relief. 
As presented in Section 3.5, participants in my study describe the need to create medical 
specialities dedicated to the treatment of pain, with clinicians explaining how the presence 
of organised, officially recognised specialties could improve the provision of pain 
management. They talk of how the creation of specialties would directly promote the 
interest of the group’s membership. They explain how awareness of the need to treat pain 
would be heightened, leading to increased priority being given to this area of medicine. 
This would result in more dedicated clinical posts being created, enabling healthcare 
workers to devote more time to individual patients partly because they would no longer 
need to juggle their time between other clinical commitments such as the delivery of 
anaesthesia.  
Participants also talk of how knowledge would be better controlled by increasing the 
impetus to standardise training and clinical practice, ultimately leading to better quality 
clinical care. This improved quality and reduced corruption would in turn lead to an 
enhanced reputation of this field of medical practice and to increased levels of trust from 
the general public, again, promoting the interests of the specialists themselves. It is also 
important to note, however, the relative lack of effective long-term treatments available 
within western or allopathic medicine to treat chronic pain. Although as I noted above this 
may make the specialty sit lower in the medical hierarchy, with many practitioners 
preferring to work in a field where cure rather than care is possible, it also means that 
patients who receive short-term benefit from a particular treatment are likely to continue to 
return to a practitioner for repeated therapy, ensuring an on-going stream of business.  
These themes relating to the general function of medical specialties and the justification of 
their presence are relatively undisputed within my study findings. The emphasis that 
clinicians in India give to the creation of specialities is likely to be, at least partially, driven 
by the low priority given to the treatment of pain within healthcare and a desire for medical 
practitioners to self-promote. This position is echoed by the recent Lancet Commission 
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report, which specifically describes the need to endorse the practice of palliative care as 
a medical specialty, calling for it to be officially recognised and licensed in every country. 
The professionally constructed nature of medical specialisation means that the creation and 
presence of each medical speciality is not replicated identically across each country of the 
world. Many factors are likely to be significant in this process of evolution such as specific 
qualities of the healthcare system, the professional regulation system and the degree of 
market forces.
310
 When considering the specific case of India, the lack of regulation, the 
range of service providers and the dominance of the private sector are all likely to be 
hugely influential in the process of medical specialisation. In India, two medical specialties 
dedicated to the treatment of pain have begun to emerge over the last 40 years, namely 
palliative medicine and pain medicine. Although they are frequently referred to using other 
names such as palliative care or pain management, for the sake of clarity in this discussion 
I use the terms ‘palliative medicine’ and ‘pain medicine’. These two medical specialties 
are both very much still in their infancy in India, only just beginning to gain national 
official recognition, so in practical terms are really more correctly thought of as ‘proto-
specialities’. Their constituent members are still negotiating the precise details of how 
these two groups should function within the healthcare system and this is very much 
reflected in the results of my study.  
My results show that there is a strong call for both palliative and pain medicine to be 
‘officially’ recognised, by the Medical Council of India (MCI). The MCI being a statutory 
body regulating the education and training of doctors in India which publishes a list of 
institutions, offering recognised postgraduate training courses.
289
 In India, the basic 
medical degree is obtained by doctors trained in allopathic medicine who receive the 
degree of MBBS. Doctors are then eligible to go on to train in a medical specialty and 
obtain a higher degree. Broadly speaking these Indian higher degrees fit into two 
categories: MD or MS (doctor of medicine or master of surgery) programmes, and 
diplomas. These are listed by medical specialty and subspecialty and include the number of 
places or ‘seats’ available to study each course per year. Palliative medicine has recently 
been recognised by the MCI as a specialty, with the first MD students beginning their 
studies at Tata Memorial Hospital, Mumbai in 2012
164
 and an expanding number of 
postgraduate training posts.
311
 In contrast, pain medicine is not listed on the MCI approved 
courses either in its own right or associated with another specialty. On searching the MCI 
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list at the time of writing, there was one institution offering an MD in Palliative 
Medicine (2 seats). In contrast, in anaesthesia, 156 diploma courses were listed (625 seats) 
and 260 MD courses (1604 seats).
289
 This does not include other listed subspecialty 
courses in anaesthesia such as paediatric anaesthesia, cardiac anaesthesia or critical care. 
To complicate matters further, another body, the National Board of Examinations also 
awards postgraduate medical qualifications called Diplomate of National Board (DNB). 
Again, anaesthesia is listed as a speciality of practice but neither pain nor palliative 
medicine is. This lack of official recognition from the MCI as well as being described as 
problematic by the study participants also presents problems when carrying out research in 
this field due to difficulties in defining the study cohort.  
Outwith the official MCI recognition, the medical specialties of pain and palliative 
medicine have continued to evolve in India. The first pain and palliative care clinics were 
founded in major cancer hospitals in the 1980s
312
 and the Indian Association of Palliative 
Care (IAPC) was founded in 1994.
139
 Palliative care delivery has continued to grow across 
the country and this expansion is relatively well described in the literature.
53,118
 Although 
less well documented, the impetus to create an officially recognised specialty of pain 
medicine has also grown since the founding of the national society, the Indian Society for 
Study of Pain (ISSP) in the 1980s.
148
 Despite the lack of MCI recognition, members of the 
ISSP have recently created a group called the Indian Academy of Pain Medicine, as a step 
towards creating their own unified practice guidelines and system of accreditation.
313
 
Various initiatives aiming to move towards a more standardised practice are indeed 
underway within the fields of both pain and palliative medicine
119,314
 and some participants 
describe how voluntary schemes, such as the National Accreditation Scheme for Hospitals 
and Healthcare Providers that require particular pain management services to be delivered, 
have led to improved provision albeit in isolated examples. 
When carrying out this research with respect to these two emergent medical specialties, my 
results show (see Figures 3-2, 3-3 and 3-4) that there is considerable overlap in the 
membership of the societies. Broadly speaking, however, the ISSP is an organisation 
representing pain medicine specialists, whilst the IAPC represents those working in 
palliative medicine, and each has its own national conference. Due to these specialties 
being in their infancy with very few clinicians currently having received MCI approved 
training, these societies and their conferences are likely to be the best representation 
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currently available to study these two groups. Some ambiguity is evident, however, in 
the distinction between the two groups because several participants attended both 
conferences and are members of both societies. 
In contrast to the call for the creation and registration of medical specialities, the details of 
what form these specialties should take, which patients should receive treatment and 
indeed the actual treatments they should be offered, are highly debated. I discuss these 
issues in the remainder of this section and the following section (4.4). 
The key finding from this study relating to the function of the medical specialties is that of 
the overlap between the clinical remit of the two groups, as demonstrated in Figures 3-23 
and 3-24. Although there are a group of attendees at the IAPC conference who only treat 
patients with terminal disease and a significant minority who treat one specific disease 
such as cancer, it is more common for participants, regardless of the conference attended to 
indicate that they treat all types of chronic pain. Of those who indicate that they treat only 
cancer patients, more than half of those who express a preference, state that they would 
like to be treating patients with a wider range of conditions (Figure 3-26). In the 
interviews, those who state that they do not want to treat a wider range of conditions often 
cite reasons such as a lack of resources hindering expansion, rather than the fact that 
patients should not be receiving their care.  
The fact that this early growth of these two specialties in India is occurring at a time when 
palliative care on the international stage is widening its clinical remit is particularly 
pertinent. As I explained, the definition of palliative care is contested both between and 
within countries and indeed the participants in this study do not have entirely consistent 
views, however, the IAPC appears to be encouraging an inclusive interpretation. Their 
website contains a definition of palliative care that includes helping patients with ‘life-
limiting illness’315 – arguably a broader definition than the WHO’s ‘life-threatening’ 
conditions. At the time of writing, a workshop is also advertised on the IAPC website with 
the headline ‘Palliative care for all “All diseases, all stages and all settings.”’315 This is also 
very clearly demonstrated in the Lancet Commission report in which, despite considerable 
effort by the authors to give clarity to the specific medical conditions that are being 
targeted by the Commission, there is a significant degree of ambiguity and indeed 
contradiction in the writing. For example, they state that they “decided not to focus on 
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acute or chronic health conditions that are not life-threatening or life-limiting, including 
chronic, non-malignant pain”3(p11) but they also list amongst the 20 conditions included in 
the SHS metric “injury” and “musculoskeletal disorders”.3(p14) As a practising clinician I 
find it very difficult to see the distinction between these groups, and indeed I struggle to 
think of a condition causing chronic non-malignant pain that is not incorporated in the list 
of 20 conditions described as contributing to SHS.  
It is important to be clear here when considering my study findings, that those who 
consider themselves to be specialists in pain medicine, as opposed to palliative medicine, 
are also treating patients with the same inclusive range of medical conditions. Of note, a 
few participants describe a desire to be less inclusive in the medical conditions they treat, 
due to an enlarging knowledge base that requires further sub-specialisation, for example 
when treating conditions of the spine. Furthermore, not only is debate occurring at a global 
level within palliative medicine, but professionals who consider themselves to be 
specialists in pain medicine are also questioning the nature of their specialty. For example, 
recent scientific advances particularly in imaging techniques have led to greater awareness 
of the physical changes that may be common to some of these conditions and this in turn 
has led to the call for chronic pain itself to be afforded the status of a disease in its own 
right.
182,316,317
 Despite the argument that this re-classification could raise the profile and 
increase research funding into effective treatments, the description of chronic pain as a 
disease is debated.
183
 Interestingly, despite the growth of organisations such as the 
International Association for the Study of Pain, which at the time of writing has, including 
the ISSP, 95 national chapter societies,
318
 pain medicine is not recognised as a specialty in 
its own right, in many countries, including the UK and the USA, often being a subspecialty 
of anaesthesia.
13-15
 
My results also demonstrate a close relationship in India between the fields of anaesthesia 
and those that focus on the treatment of pain. Not only do participants from both 
specialties treat a very overlapping cohort of patients but they have also evolved from the 
parent specialty of anaesthesia, with the majority of practitioners who gave details of their 
higher degree having received their early training in this field, shown in Figure 3-46. 
However there are also some notable differences between the two professional groups. 
When considering the profession of the attendees at the conferences, there is only one 
participant at the ISSP conference who is not a doctor, as shown in Figure 3-19. In contrast 
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nearly half of the IAPC respondents are not doctors, as shown in Figure 3-20, with 
volunteers, social workers, physiotherapists, psychologists and nurses all represented. This 
is also reflected in the membership criteria of each society with all professions and 
volunteers able to join the IAPC whilst only doctors are eligible to take full membership 
status in the ISSP.  
Despite there being significant overlap in the medical conditions that the two specialties 
treat, and in the original training of many clinicians being in anaesthesia, there are striking 
differences in the preferences for different treatment strategies between the two groups. I 
consider this area in more detail in the following section (4.4) but in summary, there is a 
focus within palliative medicine on improving access to opioid medications, and a relative 
lack of attention given to the use of interventional techniques such as nerve blocks. In 
contrast, at the ISSP conference there is a strong predominance of interest in interventional 
treatments, reflected both in the conference programming and in the treatments offered by 
the study participants. This difference in practice and a lack of collaboration between the 
specialities was noted to be a hindrance to improving the provision of pain management. 
This demonstrates one potential, negative consequence resulting from the treatment of pain 
being a professionally constructed phenomenon. 
As a result of the relatively recent evolution of the two specialties in India, participants 
often describe themselves as pioneers in their field and of having to overcome significant 
difficulties when they began their careers (presented in Section 3.9.1). These include 
tolerating unpleasant treatment from unsupportive colleagues and of putting together their 
own training programmes, often incorporating time working overseas and learning clinical 
skills from written materials. They also describe having to make a personal financial 
sacrifice when entering a job either in the charitable sector with low remuneration or in the 
private sector with an initially very small client base. When considering those working 
chiefly in government or charity sectors (although this is not exclusively those working 
within the field of palliative medicine) participants talk of a specific calling and of how 
despite taking a financial salary hit this is more than made for up by the personal 
satisfaction – sometimes even describing this in spiritual or religious terms. Some working 
in palliative medicine explain how the specialty is unglamorous and unpopular. In contrast, 
a few working in pain medicine, talk of the desire to have a better identity when compared 
to playing a supporting role as an anaesthetist to a surgeon.  
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Furthermore, although the two groups of respondents from each conference were not 
selected to enable quantitative, statistically significant comparisons, Figure 3-10 shows the 
differences between the two specialties with respect to the percentage of patients receiving 
their treatment free of care, with the IAPC group tending to treat a larger proportion of 
their patients free of charge. Of course this is not an absolute distinction with many who 
work chiefly in the private sector also undertaking charitable work and those working 
chiefly in the charitable sector working privately to supplement their income.  
These variations in financial structure and clinician motivation add to a wider debate 
surrounding the funding of healthcare across the country as a whole and particularly with 
respect to care delivered in the corporate private sector. During one of the IAPC 
conferences a debate was held called ‘Developing Palliative Medicine is a threat to the 
corporate world of medicine and specialist physician.’ Tying this in with the idea that 
palliative medicine is described as being suitable for all patients at all times, there is a 
suggestion that palliative medicine itself, in the Indian scenario, is actually about providing 
affordable, holistic care, rather than about treating patients with particular medical 
conditions at a particular time in their lives. One particularly clear example of this is the 
highly successful and widely cited model of community based palliative medicine 
originating from the southern Indian state of Kerala, known as the Neighbourhood 
Network in Palliative Care or NNPC.
145
 In the NNPC patients are identified on the basis of 
need rather than following a medical diagnosis. In other words, patients are given care, 
regardless of their underlying disease (as defined by allopathic clinicians) simply if they 
have symptoms that can be treated. Although the degree to which this model can be 
successfully transferred to other geographical regions is debated, even within India,
312,319
 
the local success demonstrates that palliative medicine or palliative care may be 
conceptualised as a social movement capable of revolutionising healthcare, rather than 
simply as a subset of western or allopathic medicine. In this scenario the dominance of the 
medical profession is potentially reduced. The treatment of pain moves away from being 
solely a professional construction and towards a more Foucauldian model of social 
construction, with increased influence from patients and the wider community.  
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4.4 Treatment Selection 
I have demonstrated that the medical specialties of pain and palliative medicine are largely 
professionally constructed phenomena, in part created in response to the increasingly 
widespread belief that pain is a problem to be fixed with medical treatment. A key element 
of many of the functions of medical specialties and indeed a key driver in the processes 
that create them, is the specialist knowledge base that members of the group create and 
control.
307
 I focus in this section (4.4) on the treatments that healthcare workers offer to 
their patients and crucially on the variation in clinicians’ normative positions. Despite a 
clear consensus amongst my research participants on the adoption of the idea that pain 
should be medically treated, I demonstrate how the specifics of what form this treatment 
should take are far more widely contested. Some differences are clearly seen between the 
specialties of pain and palliative medicine, but there are also debates regarding treatment 
selection within each of these two groups.  
The vast majority of the advocacy work and the resulting literature in the field of pain 
treatment, at least at a global level, has been dedicated to improving access to opioid 
medications for patients suffering in the terminal stages of disease, and in particular 
cancer. This work is primarily targeted towards improving access for populations in the 
global South.
59,68,69,73,320
 Many high profile international organisations such as Human 
Rights Watch,
121
 the World Health Organization
1
 and most recently the Lancet
3
 have taken 
up this cause, working alongside internationally focused palliative care groups. However, I 
argue, as have others,
1,166
 that it is also important to consider opioid use in patient groups 
other than those suffering in the terminal stages of disease. This is particularly pertinent in 
India where, as I demonstrated, patients treated under the remit of palliative medicine are 
not always suffering from life-threatening illnesses. Although I touched on the limitation 
of western medicine’s simplistic conceptualisation of pain as a problem to be fixed, the 
complexity of the phenomenon is acknowledge to a certain degree by clinicians working in 
both palliative and pain medicine who describe pain as consisting of social, psychological 
and physical components. Members of both specialities also advocate the use of treatment 
strategies that involve multiple modalities other than opioids in order to address each 
patient’s pain in its entirety. I argue that it is therefore pragmatic to consider the 
availability of a wider range of treatment modalities. In the following sections I discuss the 
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availability of multiple treatment strategies including pharmacological and non-
pharmacological therapies. 
4.4.1 Pharmacological Treatment Availability 
Countries are required to report their annual consumption of strong opioid medications to 
the International Narcotics Control Board. This data, which is regarded as corresponding to 
access levels within each country, are collated and published by the Pain and Policy 
Studies Group (PPSG) at the University of Wisconsin. The latest available data published 
by the PPSG for 2015 ranks India’s per capita morphine usage at 117 out of 144 
countries.
321
 The PPSG has also played a key role in the high profile study, the Global 
Opioid Policy Initiative (GOPI) published in 2013, which details the availability of opioids 
in India, as part of a global project.
59
 The GOPI study data for India concentrates on 
describing availability of several opioid preparations at state level.
2
 Small numbers of key 
informants describe the availability of each medication as categorical data, with a single 
rating given for each medication in each state. The study includes data for every 
preparation of morphine and other strong opioids (oxycodone, methadone and fentanyl) as 
consistently being available either ‘never’ or ‘occasionally’ in each state. This ambitious 
project has created extremely valuable data from many regions of the world, that can be 
used as a tool for comparison between regions, to monitor change over time within a 
region, and more widely as an advocacy tool to improve availability. Indeed the data from 
my study as presented in Figures 3-27 and 3-28 confirm the low availability of opioid 
medications especially when compared to the availability of non-opioid medications (in 
Figures 3-27 and 3-29). Even the cheapest, most readily available strong opioid (injectable 
morphine) is only available ‘always’ for fewer than 50% the questionnaire respondents.  
I argue that whilst the GOPI study data allows for comparison between different groups 
and times, its simplicity is also a potential weakness, as it inevitably fails to capture more 
complex patterns of availability within each region or state. This is also true of the recent 
Lancet Commission report, which depicts opioid access data for each country on a world 
map, but fails to demonstrate differences that occur within each nation. In contrast, my 
study focuses on only one country and therefore allows for more detailed analysis of in-
country variation. My data drawn from multiple participants working in a variety of 
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clinical settings, demonstrate these variations in availability within states and even 
within individual institutions. For example, when injectable morphine, the strong opioid 
preparation with the highest availability is considered for each state represented in the 
study, there is considerable variation within the availability patterns, shown in Figure 3-31. 
No state with more than two respondents reports consistent availability ratings. Similarly 
when considering the availability of weak opioids such as codeine and tramadol, although 
availability is broadly higher than for the strong medications there is still variation within 
states. When considering the availability of codeine, my results in Figure 3-32 show that in 
the state of Bihar codeine is ‘usually’ or ‘always’ available, whereas data from the GOPI 
study describes the medication as ‘never’ available. Whilst this could represent a change in 
availability during the time the two studies were undertaken it is likely that it reflects the 
complex picture of variation in availability. My results also show variations between urban 
and rural availability, and between different healthcare sectors. For example there may be 
much better availability in the well-funded corporate institutions.  
My results also show variation that occurs within individual institutions. For example 
morphine may be available in one department of a hospital, such as in a palliative care or 
oncology department, but not in other areas of the same institution where it could be of 
use, such as in operating theatres or in emergency departments. In practice this means that 
patients suffering from pain that is amenable to treatment with cheap opioid medications 
are only able to receive the treatment if they have pain caused by a particular disease such 
as terminal cancer and are unable to receive it to treat pain following surgery or trauma. 
Whilst some participants in the study do not consider improving the availability of 
morphine to treat pain following surgery or trauma (acute pain) to be a priority, others are 
keen to raise it as a concern.  
The underlying causes of the low accessibility of opioid medications at an international 
and local level are also well described in the literature, largely in relation to use in the field 
of palliative care. These causes, or barriers as they are usually termed, are commonly 
described as falling into three main areas namely: overly complex or stringent legislation, 
low levels of education amongst healthcare workers and wider society, and issues 
surrounding the availability and cost of pharmaceutical preparations.
1,53,73,118,322
 Of note, in 
India the narcotics laws are described as particularly complex with legislation varying 
between states
2
 and there are also widespread reports of poor quality control within the 
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pharmaceutical industry.
161
 The results from this study confirm the presence of each of 
these barriers with participants talking of problems of medication supply and quality, 
complex policies and education deficits, largely but not exclusively with respect to the use 
of opioids within palliative care.  
Data related to the availability of non-opioid analgesics is limited
89
 and there are no large 
scale studies published of availabilities in India that parallel the GOPI and PPSG data. 
There is, however, a body of work relating to improving the availability of all medications 
that are included in the WHO Model List of Essential Medicines
36,90
 and a more recent 
drive to increase the presence of particular non-opioid medications on this list.
63
 Data from 
my study (Figure 3-27) show that although, broadly speaking, non-opioid medications are 
available more often than opioids, none of the medications included in the study are 
available to all respondents all of the time. This therefore includes all of the analgesic 
medications included in the WHO Model List of Essential Medicines (Figure 3-30). The 
Government of India also produces its own country specific list of essential medicines
323
 
which whilst very similar to the WHO list, does contain some differences. Of note, two 
pain medications that are included in the WHO list but not the India specific list, namely 
oral codeine and rectal non-steroidal anti-inflammatories, have relatively low reported 
availability in this study. 
4.4.2 Non-pharmacological Treatments 
Several organisations have published recommended standards for the provision of pain 
management which encompass a wider range of treatments than pharmacological therapy 
alone, such as the IAHPC’s List of Essential Practices in Palliative Care,324 the IASP’s 
Desirable Characteristics of National Pain Strategies,
325
 and local initiatives from the 
IAPC.
119
 However, these lack the detail and specificity of the WHO Model List of Essential 
Medicines. For example, the need to work as a team and to address psychological aspects 
of pain is widely noted but precisely how this should be delivered is not specified in detail. 
Similarly, as I outlined above, published data of treatment modality provision beyond the 
availability of opioids is lacking. In contrast, in this study I included data on the 
availability non-pharmacological treatments. The results as presented in Figure 3-38 show 
that there is generally low availability of all modalities of non-pharmacological therapies. 
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Of those I included, physiotherapy is the most frequently available ‘always’ but even 
this is only true for fewer than 60% of the respondents. None of the treatments are 
available all of the time for all respondents.  
I discussed in the previous section how there are differences in the range of professions 
that are represented at the ISSP and IAPC meetings. As shown in Figure 3-39 many 
respondents from both the ISSP and IAPC groups do not have a multidisciplinary team 
available all of the time. Specifically, only 50% and 65% of ISSP and IAPC respondents 
respectively have a multidisciplinary team available ‘always’ or ‘usually’. However, the 
presence of a wide range of professions at the IAPC meeting does demonstrate a particular 
emphasis from this group on the need to work collaboratively across disciplines. With the 
high numbers of volunteers working in palliative care, some of whom are professionals 
visiting from overseas, it is possible that some patients will receive more holistic care in 
the charitable sector where resources may, in general, be particularly scarce. 
The use of interventional techniques, such as nerve blocks, is particularly notable due to 
the frequency and manner in which participants describe them. When considering this 
category there is a particular difference between the responses from those at the IAPC 
conference and those at the ISSP meeting, as shown in Figure 3-40. All but one ISSP 
respondent state that these interventions are ‘always’ or ‘usually’ available. This is also 
reflected in the contents of the agendas of each conference with a particular predominance 
of discussions on interventional techniques at the ISSP meetings. The difference in 
availabilities of these treatments between the two conferences is especially noteworthy 
when considered in conjunction with the data showing that there is significant overlap in 
the medical conditions of the patients that are being treated by each speciality. A particular 
barrier to increasing the availability of nerve blocks specific to India was also noted in 
relation to the regulation of the use of ultrasound machines, which has occurred in an 
attempt to reduce foetal gender identification. In other countries ultrasound is increasingly 
being used to enhance the accuracy and safety of nerve block techniques. Of note even 
those working in the corporate sector describe how scarce resources prevent them from 
carrying out more sophisticated treatments, as demonstrated by the universally low 
availability of complex interventions (Figure 3-41). 
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4.4.3 Variations in Treatment Selection 
Alongside the differences in the treatment availabilities reported (as discussed in Sections 
4.4.1 and 4.4.2), there is also variation in the treatments that the respondents feel ought to 
be available. In other words the normative positions of clinicians vary. This variation is 
evident in my data when considering both pharmacological and non-pharmacological 
modalities. I argue that a lack of understanding of these differences in normative position, 
of how they arise and in turn affect the practice of pain management, is contributing to 
some of the lack of progress seen in this field at local and global levels. This is directly 
related to the idea that the medical management of pain is a professional construction. 
Although the majority of respondents, as shown in Figures 3-33 and 3-34, wish to be able 
to offer a wider range of treatments, this is not a universal position. Furthermore, my data 
demonstrates variation in the desire of practitioners to increase the availability of opioid 
medications. As shown in Figure 3-35 there is a group, albeit a minority, who despite not 
having morphine and other opioid treatments available all of the time indicate that they do 
not want to have a wider range of treatments available. This is also the case with other 
medications and formulations that are included in the WHO Model List of Essential 
Medicines, as shown in Figure 3-37. I have shown from my data that there are 
discrepancies between Indian clinicians in the degree of acknowledgment that access to 
strong opioids is problematic outside of the palliative care setting. Specifically some 
clinicians do not consider the low levels of opioid available to treat those with injuries in 
emergency departments or following surgery as an issue that needs to be addressed. This is 
in contrast to the position of the WHO which explicitly describes the need to improve the 
treatment of pain in these conditions as a part of its Access to Controlled Medications 
Programme.
1
 Even the Lancet Commission report with its focus on palliative care, notes 
the importance of treating pain following surgery and trauma, and indeed states that 
opioids are often indicated in these scenarios. 
Similarly, there is no universal view regarding the desire to increase the availability of 
non-pharmacological treatments and in particular interventions such as nerve blocks. 
Although the majority of the clinicians in the study have trained in anaesthesia (where 
interventions are a core part of practice) there is a range of opinions regarding the use of 
these treatments. Some respondents at the IAPC conference indicate that they would 
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indeed prefer to perform more interventional procedures and describe the barriers to 
achieving this, such as a lack of education in knowing when such techniques could be 
used, a lack of technical expertise, and a general lack of resources in manpower and 
facilities. Others state that there is little clinical need for such procedures. Some take a 
more utilitarian stance, explaining that although in a world of unlimited healthcare and 
funding they would use interventions, the investment needed to help the few people that 
would benefit would not be a pragmatic use of resources. Some specifically explain how 
they have modified their practice over time and moved towards using nerve blocks less 
frequently as they have gained a deeper understanding of the need for a more holistic 
approach to treatment. Others even talk of the notion that performing interventions is seen 
as an easy way to earn money, referring to ‘block shops’ – clinicians that are motivated to 
perform procedures for personal financial gain. This variation in the use of interventional 
procedures, particularly within palliative care, is also reported in other countries including 
the UK.
326,327
 Furthermore some have stated that in particular settings where access to 
opioids is restricted, interventions may play a particularly important role in pain 
management.
86,328
  
Interestingly in the survey data, when I asked people to name the treatments which they 
would like to be available, although some mention wanting more medication, only two 
people specifically name an opioid – both saying they would like to have fentanyl patches 
available. Many respondents indicate that they would like to have one or more of the non-
pharmacological treatments available. It is possibly that the ordering of the questions with 
this one following directly on from the non-pharmacological availability question meant 
that this topic was more likely to be mentioned due to being at the front of respondents 
minds. Regardless of whether respondents have a stronger preference for increasing the 
availability of pharmacological or non-pharmacological treatments, it is highly likely that 
there is general desire to increase the availability of non-pharmacological treatments.  
Variation in treatment selection amongst clinicians is a well described phenomenon across 
the practice of medicine
190,329
 and is also specifically noted to occur when treating 
pain.
193,194,326,327
 This decision making process is influenced by a combination of factors 
including the characteristics of the patient, the clinician and the healthcare setting
192,195-198
 
and can therefore can be considered to be, at least in part, professionally and socially 
constructed.
330
 To examine this process in more detail, the knowledge drawn upon by each 
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clinician can be considered to be a combination of various different types of knowledge 
including scientific, experiential, social and political.
199,237
 So, in this study when 
considering the use of interventional techniques, participants draw on experiential 
knowledge – they describe how their training in anaesthesia drew them into the field of 
pain management, whereas others explain that they have now moved away from such 
treatments having come to realise that other modalities can be more effective. They 
describe how during their training they drew on scientific knowledge gleaned from 
academic journals, books and conferences. Participants also demonstrate the use social and 
political knowledge when deciding that the financial outlay needed to provide 
interventional treatments would benefit too few patients to be considered practical. The 
more senior clinicians in particular explain how as pioneers in their field they frequently 
had to seek out knowledge themselves, directing their own training without guidance from 
local mentors. It is likely that this will further contribute to the variations seen in the 
current specialist knowledge base and the normative positions of practising clinicians.  
Having demonstrated the contested and professionally constructed themes that arise from 
the results of this study in relation to the conceptualisation of pain as a medical problem, 
the formation and function of medical specialties dedicated to treating pain and the clinical 
strategies employed to manage pain, in the following section I discuss in more detail the 
dynamic social processes that result from these disparate views.  
4.5 Power and the Policy Process 
The huge numbers of patients described as requiring palliative care or suffering with 
chronic pain, and the impact this has on society, has led to the call in recent years for pain 
management and palliative care to be addressed as public health issues.
111,112,331,332
 This 
conceptualisation leads on to the idea that these complex, multi-faceted problems should 
be tackled at a population level, requiring inclusion in national healthcare policy. Indeed in 
2014, the World Health Assembly unanimously adopted a palliative care resolution 
describing the need to incorporate palliative care into national healthcare policies
332,333
 and 
the Lancet Commission report continues this trend. However, critical evaluation of the 
processes involved in this incorporation, particularly with reference to the extensive 
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academic literature base from the social and political sciences is lacking, and is 
therefore the focus of this discussion section.  
To demonstrate the relevance of this approach to this study, I refer to Jan Stjernsward and 
colleagues’ 2007 paper describing the WHO Public Health Model104 (Figure 1-1) as a 
system for guiding the integration of palliative care into a country’s healthcare system. The 
model highlights the need to address four key factors, depicted as education, drug 
availability and implementation, interlinked in a triangle, underlying the umbrella of 
policy. Whilst the authors acknowledge the need to take into account other local factors, 
such as engagement with influential figures and the specifics of each area’s healthcare 
system due to the effects these will have on the policy’s creation and implementation, they 
make little reference to theories from the social and political sciences. Furthermore, they 
do not acknowledge the assumptions and limitations of the components of the model. 
However, the results from my study show that each of the four elements of this model are 
in fact the subject of debate between members of the medical profession practising in 
India. Specifically, there are differences in professional opinions even amongst specialists, 
regarding the manner in which pain management should be delivered to individual patients 
and across the country, with the use of opioid medications being a particularly contentious 
topic. At a fundamental level there is even a lack of uniformity within the medical 
profession and across wider society surrounding the notion that pain is a medical problem 
to be fixed. 
The importance of integrating a social constructionist perspective in to the analysis of the 
policy process is well described,
334,335
 and I discuss the professionally constructed themes, 
highlighted above, that have arisen from my research data with reference to key policy 
theories. Whilst acknowledging that the term ‘policy’ itself is open to interpretation and is 
the subject of numerous, complex definitions,
208
 here I use a broad definition of the word 
as a set of decisions made by those in authority. Hence, I consider local clinical practice 
guidelines, national specialised training standards and healthcare management strategies in 
individual institutions, all to be policies. I explore the stages of the policy process
211
 
(Figure 1-4) in turn, referring to Walt and Gilson’s policy triangle209 (Figure 1-3) as a 
framework to aid analysis.  
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To be clear, the aim of my research is to critically evaluate the practice of clinicians and 
therefore in this discussion I demonstrate the multiple ways in which one group of actors 
affects the dynamic social system that is the policy process, rather than describing a 
complete picture of every actor involved. Focusing on the treatment of pain as a profession 
construction, I show that clinicians act as individuals and as members of larger 
organisations such the Medical Council of India, the WHO, the ISSP, the IAPC, the 
International Association for the Study of Pain and the International Association for 
Hospice and Palliative Care.  
4.5.1 Agenda Setting 
The agenda setting stage of the policy process is concerned with how a particular issue 
gains attention – from both the public and other relevant actors.211 Participants in this study 
describe how pain management is low on the political agenda, being afforded only limited 
priority within the healthcare system. The results also show that clinicians consistently 
describe one of the key barriers to the improvement of pain management to be a lack of 
awareness amongst clinicians, patients, managers and politicians regarding the importance 
of treating pain within the medical setting. They also universally describe pain as a medical 
problem to be fixed. 
This agenda setting stage of the policy process wherein political priorities are formed is 
described by Shiffman and Smith
231
 as being influenced by four elements: actor power, 
ideas, political contexts and issue characteristics. Building on Walt and Gilson’s policy 
triangle this framework highlights the importance of considering how an issue is framed by 
actors, that is, how it is publically depicted,
230
 as well as understanding how power is 
negotiated within the wider socio-political context. With reference to my results, firstly, I 
discuss power and secondly the framing of pain as a medical problem to be fixed. 
In relation to this study and the agenda setting stage, one of the ways in which clinicians or 
actors, describe asserting their power in order to raise attention of the need to treat pain, is 
through exchanging knowledge (presented in Sections 3.8 and 3.9). Implicit here is the 
notion that a superior knowledge base exists within the medical profession that requires 
dissemination to others. Participants in the study identify many different tools that are used 
to perform this knowledge exchange depending on the characteristics of their target 
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audience. For example, they describe exchanging knowledge with other clinicians 
starting at medical and nursing school, and call for the mandatory inclusion of pain 
management in the curricula at an early stage of professional training. They also talk of the 
need to improve specialist education by streamlining national training and delivering CME 
(continuing medical education) programmes to colleagues. While some of this work is 
carried out as individuals, participants also describe how they work through larger 
professional organisations such as the ISSP and IAPC to wield power collectively. They 
also talk of influencing these processes through lobbying professional colleagues such as 
the Medical Council of India (MCI) and international organisations specialising in pain or 
palliative medicine. For example, they explain that if members of the MCI can be 
persuaded of the importance of treating pain then they can potentially ensure pain training 
is compulsory for medical students and that specialist MD programmes are widely 
available across the country.  
Other professional groups are also described in this study as potential targets of influence 
such as politicians who can change national or state level healthcare policy, local managers 
who can alter the distribution of resources within an institution, pharmaceutical companies 
who can control the price and availability of medications and clinical devices, and health 
insurance companies who decide which treatments to fund. Of note, each of these actors 
has some degree of influence in the allocation of scarce resources that are highlighted as 
particularly problematic within the diverse healthcare system of India.  
Participants also describe knowledge exchange strategies targeted towards patients or 
potential patients, such as pain camps, media work and direct marketing campaigns. They 
explain how demand for medical pain treatments and care from specialist physicians will 
increase if the public are more aware of the possible treatment options available and the 
existence of trained clinicians. 
Each of these strategies of knowledge exchange aims to increase the number of patients 
who seek specialist medical attention for the treatment of pain. However, this desire to 
increase demand and the competition that arises between clinicians results in power being 
contested in terms of money and status, as well as knowledge. This competition within the 
profession is widely remarked upon by participants in the study, who describe the need to 
increase the number of referrals they receive from both medical colleagues and directly 
Chapter 4 
 
212 
from patients. The presence of individual private practice where a clinician is paid per 
treatment, as opposed to a fixed system of remuneration, which remains constant 
regardless of the number of patients seen, leads to some individuals attracting patients’ 
custom for their own financial gain, and this study supports the presence of this 
phenomenon through the description of ‘block shops’. A clear demonstration of how 
power may be wielded by clinicians who directly benefit from their own professionally 
constructed description of pain as a medical problem. 
However, the study also demonstrates that the desire to increase referrals is not only or 
always financially driven. There are many examples of participants making enormous 
personal and financial sacrifices in order to provide the very best service they can for 
patients. They talk of working closely with colleagues to complement each other’s skills 
and of how finances are not their motivator. Nonetheless, competition is also not the sole 
preserve of the private sector or those seeking financial gain. Those working in the charity 
and government sectors are also keen to persuade patients to access their services. Without 
patients’ demand, there would be no service and no employment for themselves as 
healthcare workers. Participants working in the charity sector entirely free of charge talk of 
the need to encourage patients to attend. 
To be clear when it comes to the discussion of competition, the need to attract new 
referrals is not simply about encouraging patients to seek medical advice for their pain but 
also about persuading them to choose a doctor trained in a particular medical specialty. So, 
participants in this study explain how there might be a reluctance to refer on to a colleague 
despite them having a more appropriate skill set, to the detriment of the patient.  
As an aside but related to the descriptions of competition, is the issue of corruption. Within 
medical practice in India, corruption in the form of taking extra payments is widely 
reported
133
 and although no one explicitly describes examples of this occurring, they do, on 
occasions, make it clear that they do not take extra money. In doing so, they therefore 
imply that others working in the medical profession do indeed request or at least accept 
additional financial payments. In one hospital I visited signs were clearly displayed 
throughout the institution stating that bribes would not be tolerated. 
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Moving on from descriptions of how the clinicians as actors in the process of agenda 
setting wield their power, I now consider the various ways that the issue of pain treatment 
is framed during this process. An issue can be framed, or conceptualised and publically 
portrayed in many different ways.
336
 In their framework, Shiffman and Smith incorporate 
two categories of frame – ‘internal’ and ‘external’.231 The internal frame relates to the 
depiction of an issue within the group of actors that are initiating the policy process, in this 
case clinicians. In contrast, the external frame relates to the portrayal of the issue to 
external actors, such as patients or managers. A key consistent finding from my study is 
the framing by clinicians of pain as a medical problem to be fixed, demonstrating a 
coherent internal frame within this group. Many of the descriptions of how the profile of 
pain management should be improved relate directly to this framing of pain as a medical 
problem. For example, some describe the need to get their fellow clinicians to consider 
pain a symptom worthy of treatment rather than concentrating on disease modifying or 
curing therapies, as well as the need to educate colleagues on more specific clinical areas 
such the appropriate use of particularly complex treatments. In contrast, I have also shown, 
that the study participants describe other groups in society, even patients and other 
clinicians, as needing to be persuaded of this fact, thereby demonstrating the contested 
nature of this external frame.  
The widespread descriptions in this study of the need to create the medical specialties of 
pain and palliative medicine also directly draw on this framing of pain as a medical 
problem. This relates to encouraging junior doctors to choose pain or palliative medicine 
as a career, and also to maintaining and raising standards of training and practice in the 
field. They talk of the role organisations such as the MCI, as well as politicians can play 
and of how these authority figures can be lobbied from below so that they in turn exert 
more top-down pressure. Some of this work can be taken up or at least supported by the 
professional organisations, the ISSP and IAPC, who then act as intermediaries between 
individual members and larger national or international bodies. Furthermore, they explain 
that by persuading others including clinicians and the MCI of the importance of describing 
pain and palliative medicine as medical specialties, the profile of this area of clinical work 
is raised. In turn, this leads to more authority figures such as managers and politicians 
being persuaded to allocate more of their resource to the field. Crucially in this context, 
participants explain how competition to attract patients to visit a particular healthcare 
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professional is compounded by the relative youth of the specialities and the resultant 
low levels of awareness of their presence.  
When considering descriptions in the study of the need to persuade patients that pain is a 
problem to be fixed there is an acknowledgement of a difference between populations in 
India when compared to the global North. There is both an understanding that things are 
currently different in India - people will tolerate different levels of disability or suffering, 
but also that times are changing, and with increasing prosperity there is increasing demand 
from patients. Participants specifically explain that patients themselves should not tolerate 
pain as they have done in the past. They describe how if patients themselves are persuaded 
of the benefits of seeking treatment for their pain, both they and their families will start to 
demand better levels of treatment availability. This increase in demand from patients will 
in turn influence clinical managers and politicians to increase the provision of services. 
Clinicians therefore demonstrate how they wield power as knowledge, using their 
professionally constructed model to influence other members of society. 
The framing of pain as a treatable medical problem is also at the heart of the calls, 
described in this study and many others,
2,3,53,121
 to alter specific policies that are already in 
place, the most notable being the desire to simplify complex legislation surrounding the 
use of opioid medications. Similarly, although there has been some state level 
implementation
337
 there are calls from within the medical profession and particularly the 
palliative care community
338
 to incorporate the provision of pain and palliative care 
services into national healthcare policy in India.  
4.5.2 Policy Formation  
The descriptions above of how pain is framed by professional practitioners as a medical 
problem and of how this is, in turn, used within the agenda setting process, through 
knowledge exchange, to raise the profile of the work of pain management clinicians, are 
relatively universal within my study findings. For example, the need for nationally 
coordinated specialist training, the need to persuade managers and politicians to fund pain 
management services and the need to encourage patients to seek medical advice for their 
pain. My results also show, however, that the specific detail of the much of the content of 
the knowledge that is exchanged in this process is far more widely contested. This is most 
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clearly demonstrated by the variations in participants’ views regarding treatment 
selection. In this section, I explore the practical relevance of this debated issue in more 
detail using the particular example of clinical practice guidelines (CPGs) drawing on 
theory related to the use of evidenced based medicine (EBM).  
The results of this study show that clinicians consider there to be significant variations in 
the quality of practice in pain management in India, and talk of the need to raise standards 
and improve clinical care by increasing uniformity of practice. Alongside streamlining 
education and training at a national level, one of the strategies they highlight is the need to 
create national CPGs. As I outlined in the opening chapter, however, from a theoretical 
perspective, CPGs are in part professionally constructed, and their creation, which 
specifically includes the incorporation of EBM, can be considered to function as a dynamic 
process involving multiple actors and contests of power.
234,237,238
 In order to analyse this 
process with respect to this study I draw on the framework created by Dobrow and 
colleagues,
241
 introduced in Section 1.4.2, in which they describe three stages of evidence 
utilisation: introduction of evidence (including evidence selection), interpretation of 
evidence and application of evidence. At each stage, various context factors, which can be 
internal, such as the individuals involved and the structure of the process, and external, 
such as the healthcare and political environments, affect the process.  
When considering the creation of pain management guidelines by doctors in India, Dobrow 
and colleagues’ framework can help us understand the various factors affecting this 
process. Whilst some academics have argued that a deeper understanding of this process is 
more fundamental to improving healthcare than simply an increase in the content of the 
evidence base,
206
 participants in my study emphasise the limited locally relevant evidence 
base, with the majority of research being extrapolated from studies carried out in the global 
North. They also describe the barriers that exist to increasing the amount of relevant 
research such as a lack of expertise, time and money.  
Despite essentially having access to the same evidence base, the individual clinicians in 
my study differ in their real world selection of treatments and in their views about what 
ought to be available, that is, their normative positions. For example some argue 
passionately for increased availability of opioid medications whilst others see the lack of 
access to opioids as a reason to look to other modes of treatment. This demonstrates 
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variation in how clinicians select, interpret and apply evidence in their individual 
practice, which is therefore likely to be reproduced during the CPG formation process.  
The study participants also describe some of the factors that are likely to contribute to the 
variations in treatment preference seen in the research. Within Dobrow and colleagues’ 
framework, these can be considered to be internal, individual factors that contribute to 
CPG formation. For example, there is a general lack of consistency in training that 
participants have received in pain management, often creating their own training 
programmes, working overseas or learning from books rather than through direct clinical 
care in India; demonstrating the use of various types of knowledge besides the scientific, 
such as social and experiential. Participants in my study specifically describe a lack of 
training amongst clinicians, in research methods and evaluation.  
Personal subjectivity is specifically described in the literature as affecting the creation of 
CPGs.
236
 In my study, when describing their individual motivation for choosing a career 
working in pain or palliative medicine, several participants describe being particularly 
attracted to certain modes of treatment such as the use of interventional techniques or the 
use of a multidisciplinary, holistic model of care. This personal preference for using a 
particular modality will be very likely therefore, to affect the decision making of each 
clinician in selecting, interpreting and applying scientific evidence.  
Continuing with Dobrow and colleagues’ model, the external healthcare environment of 
the healthcare system in which clinicians operate, will also influence the CPG process. My 
results show the differences in opinion between allopathic practitioners, but there are many 
other professional healthcare providers working in fields such as AYUSH. There are also 
huge variations in the funding of care seen between different allopathic institutions. These 
variations will only increase the difficulties in reaching consensus on the content of              
national CPGs.  
It is also important to appreciate the direct role that financial resources can have on the 
CPG creation process. The role of the pharmaceutical industry in directing the focus of 
medical research is well described.
203
 My study findings show that a lack of funding for 
research is a specific barrier to carrying out this work, which potentially leaves many 
researchers reliant on pharmaceutical and device companies. Furthermore, the presence of 
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financial conflicts of interest is common amongst the authors of CPGs
245
 and a recent 
set of published guidelines for the pharmacological treatment of pain in India includes an 
employee of a pharmaceutical company in the list of authors.
339
  
4.5.3 Policy Implementation 
To continue the concept that clinical guidelines are a form of policy,
340
 the final stage in 
the policy process that I discuss here is implementation. The aim of clinical guidelines is to 
improve quality by ensuring all patients receive the most appropriate treatment from 
appropriately trained individuals in a safe environment. In doing so, variability in practice 
is reduced and unnecessary procedures are not performed. However, when considering 
pain treatments in India, my results show variations in implementation of guidelines as 
well as debate regarding their content. Specifically, my study shows that not only is there 
variation in opinion within the medical professional as to what constitutes ideal practice 
but there is also variation in the pain management services that are provided by different 
healthcare institutions, reflected for example in the different availabilities of particular 
treatments.  
To consider this process of implementation in more detail I refer to Walt and Gilson’s 
policy triangle (Figure 1-3) in which the importance of appreciating the context, as well as 
the power relationships between different actors involved, is highlighted. When 
considering the context of the Indian healthcare system, professional regulation is limited, 
healthcare policy varies between each state, there is a scarcity of resources, and low levels 
of health insurance coverage with most patients paying for treatment out of pocket. In 
addition, my study shows that the training of professionals treating pain in India is variable 
and that clinicians work in a wide range of institutions. Each of these features of the local 
context is likely to contribute to local variation in implementation of national CPGs. 
In the preceding sections I have shown how clinicians themselves wield power during the 
process of agenda setting and in the creation of CPGs, demonstrating a degree of top-down 
influence. Doctors also play a fundamental role and hold significant power during the 
implementation stage.
341
 Therefore, a purely top-down, rational explanatory model of 
implementation, in which policy is enacted precisely as directed by a central decision 
maker, is highly unlikely to be representative when considering the use of CPGs in this 
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particular context, due to its failure to incorporate both the complex power dynamics 
present and the contested nature of the scientific base.
340
 My study shows that through their 
selection of different therapeutic strategies, doctors enact power when treatments are 
actually offered to patients. In doing so, regardless of the content of CPGs, clinicians hold 
significant power when implementing such guidelines, whether or not they are involved in 
the process of creating them. That is, they are enacting power from the bottom-up, working 
as Lipsky described as ‘street-level bureaucrats’.246 In this role, the elite professional status 
of doctors should also be noted, because their decisions are more likely be unchallenged.
249
 
Acting as street-level bureaucrats, my results demonstrate that clinicians’ treatment choices 
frequently differ from those of their colleagues. Furthermore, clinicians in my study also 
talk of influencing the opinions of other actors in the implementation process. They 
explain how this can be achieved through awareness strategies focused on improving 
access to particular treatments. These are aimed at several groups such as other healthcare 
staff, managers, politicians, insurance companies, patients and wider society. In doing so, 
they are also reinforcing their own actions in the implementation process. Similarly, 
participants also talk of strengthening the top-down process of implementation by 
influencing policy makers such as managers and politicians who control the distribution of 
scarce of resources, and by creating their own organisations in the form of professional 
societies to strengthen their position throughout the policy process.  
Finally, but perhaps most pertinently, due to the very low levels of health insurance and the 
fact that the majority of patients pay out of pocket for their treatment, the power of 
individual patients and their families is profoundly important. The results of this study 
confirm this, as participants frequently describe how patients need to be persuaded to pay 
for pain treatments and of the importance of increasing awareness amongst the general 
population. As I highlighted in Chapter 1, pain is a subjective experience and is therefore 
unlike conditions such as high blood pressure or diabetes, which can be measured in an 
objective manner by the healthcare team and treatment advised accordingly. This enhances 
the importance of patients’ judgement of the cost effectiveness of individual treatment 
strategies.  
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4.5.4 Global Power Dynamics 
Throughout Section 4.5 I have shown the multiple ways in which power is negotiated by 
the medical profession in the practice of pain management in India, with particular 
reference to the debates surrounding the organisation of the profession and its specialist 
knowledge base. In this final section I move on to consider the influence of overseas 
medical practice and the role of overseas practitioners as actors. I demonstrated how the 
professionally constructed nature of the medical treatment of pain and key associated 
themes, leads to multiple viewpoints and debated ideas. Therefore when considering the 
wider picture of global healthcare I argue that there is also the need to take a postcolonial 
perspective and appreciate the dominance in the debates of those from the global North. 
Throughout the study, participants talk of how they have been influenced by those working 
in the global North. Many talk of gaining specialist pain training, sometimes even to the 
equivalent of an MD, in countries such as the UK, USA and Australia, and of how this has 
shaped their early careers. Similarly, others explain how they have learned from overseas 
practitioners usually palliative care providers and pioneers in their field at home, who have 
visited India. Many refer to research, publications and guidelines from the global North, 
and celebrate international guest speakers at their conferences. Others talk of how 
volunteers attend their organisations and provide services that would otherwise be 
unavailable to patients. Many participants describe, however, the need to have locally 
created guidelines and modifications to treatment regimes created in the global North, in 
order for them to be appropriate in the Indian context. Others explicitly call for those from 
India to come up with the solutions and changes that are needed, rather than relying on 
external resources. Participants describe the gap being so vast between recommendations 
for ideal practice in the North and the reality that is healthcare in India as to make 
comparison almost futile. 
I described how those in the global North lead the vast majority of initiatives aimed at 
improving pain management on an international scale, and the author list of the Lancet 
Commission’s report confirms this dominance. International groups including the WHO 
explicitly talk of the need to increase the provision of western medical treatments, and the 
Lancet Commission specifically describes the importance of introducing standardised 
teaching curricula and of increased medical specialisation. This serves to enhance the 
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position of Indian allopathic practitioners who are working to raise the profile of pain 
management locally and increase the number of patients receiving treatment through 
influencing medical professionals, managers, politicians and wider society. Indian 
clinicians are in turn reinforcing the dominance of those in the global North and 
encouraging others including patients to do so too. This, I would argue, is a demonstration 
of power being enacted within society in each of the three dimensions I described in the 
opening chapter. First, and most explicitly, western medicine is described as being 
necessary to treat pain, and great effort is being devoted to persuading those living in the 
global South to adopt this view. Secondly, authors and organisations from the global North 
dominate both the descriptions of how these treatments should be delivered and the debates 
that follow, with those in the South given little voice. Finally, power is exerted at its most 
covert level when actors in the global South are persuaded that it is in their best interests to 
support and reinforce this dominant ideology of the North.  
In practice, however, as I have shown with respect to the creation of medical specialties, 
there are in fact a number of difficulties encountered when transferring a model to the 
global South that was conceived in the North. For example, the types of conditions that 
patients are suffering from that are treated under the remit of palliative care remains a topic 
of debate, and is reflected in the range of different models of care delivery present in India, 
from Kerala’s community based Neighbourhood Network in Palliative Care to others run 
along lines that are much more similar to those in the UK.  
Similarly, when considering the specific treatments used to treat pain, the literature is 
dominated by descriptions, largely from those in the global North, of the need to increase 
access to opioid medications for those living in the global South being treated in a 
palliative care setting. Again this is demonstrated in the Lancet Commission report, which 
contains a map of the world with each country re-sized according to the estimated amount 
of morphine available to patients. It shows the US, Canada and Australia as grossly 
swollen landmasses, monopolising the entire picture. Although the aim of the map is to 
demonstrate the low levels of opioids available to those in the global South, it also serves 
as a graphic reflection of the dominance of the North.  
My study, however, demonstrates that the narrow focus of these strategies, while 
commanding an immensely powerful and emotive message, can inadvertently become a 
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weakness, hindering their success. The simplistic descriptions of this field, fail to take 
into account the specific organisational details of local practice, clinicians’ normative 
positions, the treatment of pain outside of palliative care, therapeutic modalities besides 
opioids and perhaps most pertinently of all, global power dynamics. To be clear, while I 
support the aim of the Lancet Commission and other similar initiatives to improve 
appropriate access to opioids across the world, I argue that there are assumptions and 
inconsistencies contained in their work as currently presented that will unfortunately 
reduce its impact.  
4.6 Study Limitations and Reflexivity 
In Chapter 2 I presented the generic limitations of the data collections tools I used in this 
project. Here, in Section 4.6.1, I focus on the more specific issues resulting from this study 
and consider the limitations of my data and the generalisability of my findings. In the 
reflexivity section (4.6.2) I discuss how my own personal socio-cultural position affected 
the research process. 
4.6.1 Study Limitations 
The nature of my data collection means that I recorded a snapshot of clinicians’ practice 
and evaluations, at one particular period. Both these entities, as with any socially situated 
research, are highly likely to be dynamic and to change with time. Furthermore, the 
dynamic nature of such processes also makes it impossible to completely replicate research 
findings.
263
 In this study, however, in order to seek reliability or replicability, I kept a clear 
log of my strategies and decisions regarding planning, data collection and analysis, and 
made these explicit throughout the thesis. Furthermore, as the sole researcher I was able to 
ensure consistency in my methods. 
Throughout the questions in both the interviews and questionnaires I specifically asked 
about the details of how clinicians deliver care on a daily basis. It is impossible to know 
how the participants’ descriptions of their work differ from their actual practice. I argue, 
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however, that is it important to understand how clinicians evaluate their work as well as 
to ascertain accurate data detailing the care that patients receive. 
When collecting the interview and survey data particularly during the conferences, time 
was inevitably a restriction for both participants and me, with many participants having 
multiple commitments during the relatively short time period of the meetings. From a more 
technical perspective, when conducting the interviews, privacy was challenging at times 
with some participants choosing to be interviewed in open public spaces where 
interruptions and background noise were common.  
Moving on to generalisability, that is, the degree to which this study can be applied to 
other settings. Interview data collection was purposively sampled with the aim of including 
key informants working in a variety of clinical and geographical settings. While this 
method ensures inclusivity of specific, targeted groups, the data cannot be used to make 
statistically significant, quantitative comparisons. Similarly, the questionnaire data was a 
convenience sample, which while adding breadth to the interview data, and being the only 
pragmatic way of collecting much of the data presented, it is not, statistically speaking, 
representative of the target population and its constituent groups. As a study of a single 
case, however, the findings here can be generalised in the sense that they add to our 
understanding of theory, a concept known as ‘theoretical generalisation’.277 For example, 
this study demonstrates the value of critically evaluating the practice of clinicians from the 
perspective of a cross-disciplinary academic framework, and the practical application of 
theories from the field of policy studies.  
Moving on from issues of sampling methods, there is also no data to confirm what the 
overall denominator or the target population is, from which my sample is drawn. The 
majority of my primary data was collected at the ISSP and IAPC national conferences but 
it is difficult to know how representative this group is of those working in these fields 
across the country. The number of doctors working in pain management is both unrecorded 
and difficult to define. Arguably all doctors working in a clinical environment with face to 
face patient contact are likely to treat pain at some time or another, although it is also 
highly unlikely that they would describe themselves as having a particular interest or 
expertise in this area. More pertinently, there are other fields of medicine where doctors 
treat a large number of patients with painful conditions, such as neurologists, rehabilitation 
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specialists and rheumatologists. Those attending the ISSP and IAPC conferences are 
clearly likely to have a strong interest in the field of pain management but they are also a 
subset of this group with a strong interest, who are able to spare the time and the money to 
attend, and indeed who feel that this will be of benefit to them. The specific nature of these 
events with a series of didactic lectures and workshops, linked with the ability to network 
with peers is a very standard, widely practiced format within the field of western medicine 
but it may not be everyone’s preferred way of receiving professional education. Given that 
my aim, however, was to engage with those who are practising and leading the field both 
clinically and politically, these national conferences are an efficient and practical way of 
meeting many of these figures where they reliably converge each year.  
Furthermore, with regards to geographical representation, while I recruited participants 
from multiple states and regions, there was variation in the numbers of participants from 
each location, and as I already described it is not possible to identify a detailed regional 
denominator for the sample. The reasons for the high numbers of participants from 
particular states is likely to be multifactorial and include the high number of clinical 
services operating, large urban conurbations and the location of the conferences. Similarly, 
data relating to the proportion of practitioners working in pain management in different 
clinical settings is not available.  
In order to ensure I included data relating to the treatment of pain outside of the remit of 
palliative care, I specifically asked clinicians about how they treated patients suffering 
from chronic (long term pain), acute pain (short term pain following surgery and trauma) 
and even more specifically the pain of labour (childbirth). However, the study yielded 
limited data related to the treatment of acute and labour pain, which is likely to be due to 
the following reasons. Within the Indian context, the management of acute pain and labour 
pain are largely the preserve of anaesthesia and surgical clinicians, rather than those who 
consider themselves to be pain or palliative care specialists. Furthermore, the presence of 
specialist acute pain teams in India is not widespread,
156
 and in contrast to practice in the 
global North, as some participants noted, the provision of analgesia for labour in India is 
far from routine. 
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4.6.2 Reflexivity 
The researcher’s personal attributes impact each stage of the research process which is 
particularly apparent in qualitative research. A clear account of reflexivity is therefore an 
essential part of the process of seeking methodological rigour.
275
  
During my field trips I was introduced to many high profile individuals through clinicians 
whom I knew personally through my professional work as a doctor. This access means I 
recruited several high profile individuals as interview participants. Furthermore, because 
the participants knew that I was a clinician working in pain management their interview 
responses reflect a degree of assumed knowledge on my part – a tacit understanding 
between fellow professionals. Both of these issues, however, whilst imperative to allowing 
me to engage in this work in a way few others would be able to, do inevitably led to a 
degree of bias both in sampling – the individuals introduced to me were partially selected 
or filtered by others, and in the interview responses which were tailored to what the 
participants thought I would be interested in hearing. Clearly, some potential participants 
will have declined the invitation to participate in the research and I cannot know what their 
reasoning was for making this choice. There is the potential, however, for my role as an 
outsider (a non-Indian) to have prevented some from participating. 
While my professional status gave me unique access and enabled me to carry out the 
research, it also informs my academic, cultural and political perspective. I am a physician 
working almost solely in the field of western medicine in the UK, which necessitates me 
having a knowledge base heavily weighted in this field. The study participants and I were 
openly aware of this fact but nevertheless it will have had an effect on the study data and 
indeed on my analysis. As a partial balancing influence to this, I have also taught pain 
management overseas, in Africa, Asia and Europe, and have visited a variety of clinical 
institutions during these trips, which have added to the range of healthcare environments 
that I have experienced.   
While I would not describe this research project as a postcolonial piece of research in 
itself, in the sense that I am not aiming to actively redress a power differential during the 
process of carrying out the project, I am, and therefore the project is, influenced by the 
postcolonial literature. My aim is to deepen our understanding of pain management in 
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India by asking those who are actually involved in delivering this work. This is in 
contrast to describing practice only in relation to an ideal defined by those in the global 
North. A key concept here is that there is a power imbalance with the North dominating the 
process of defining ideals and remedial strategies. An argument follows that because I am 
also from the global North this work inherently perpetuates the power imbalance as I filter 
the data I have collected. Indeed the project is my research, my sample, my questions, my 
data and my analysis. My aim here, however, is to at least start to redress the balance by 
describing the fact that an imbalance actually exists – albeit through description from my 
own privileged perspective. I hope that this work will at least encourage those in the global 
North to acknowledge and evaluate this power imbalance, and open the door to encourage 
more related work from those even better placed to further our understanding of this 
complex field. That said, I would argue that I am uniquely placed to begin this process, 
through my professional status as a clinician working in the UK NHS that has afforded me 
incredibly easy access to the world of pain management in India, in part due to 
relationships with colleagues but also through a common language and tacit understanding. 
Of note, when I presented my early findings at a conference in India, while there was 
widespread encouragement regarding the utility and relevance of the results, one clinician 
said it was a shame that this work had not been carried out by Indian doctors themselves. 
This particular idea is something I have grappled with throughout the project. The idea that 
the voice of the Indian clinicians is unheard and drowned out by the louder, more 
privileged words of practitioners from the global North. That is, practitioners such as me. 
The fact that I then have initiated the research could be argued to further empower the 
dominant North and indeed my own voice. While I acknowledge this viewpoint, I would 
draw attention to the fact that many participants stated that they lack the time, experience 
and resources to carry out such a research project, and are therefore highly unlikely to be 
able to carry out such work in the current climate. Furthermore, I reiterate my hope that 
this project is just a starting point. If further research is subsequently initiated in India and 
if the Northern based international organisations shift even a little to incorporate more 
locally based research then I will consider this project a success. 
Throughout my field notes I commented on the mix of the familiar and the strange, and of 
how these evolved and switched over time. I specifically noted how the conferences I 
attended were a complex mixture of home (the familiar) and abroad (the strange). Despite 
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being many thousands of miles from home, I was able to walk in to the ISSP and IAPC 
conferences, intuitively know where to go, essentially how to behave, and crucially to 
understand almost all of the lecture material due to its familiar format and presentation in 
English. I knew how the meeting would function: as a mixture of small group lectures and 
plenaries, of opening and closing ceremonies, a registration procedure, a conference bag 
and of course the social event. Woven into familiarity, however, was a totally alien world: 
a complex healthcare system to comprehend, an unfamiliar social hierarchy to negotiate, a 
different approach to learning and teaching, not to mention the differences in cuisine and 
hospitality. My dual training as a clinician and social science researcher has positioned me 
optimally to present the complexities of this field of research. 
4.7 Summary 
Despite widespread internationally led efforts to improve the delivery of medical pain 
management, progress has been limited. In this chapter I demonstrated some of the specific 
issues related to the healthcare system in India resulting from my data, that contribute to 
the difficulties in improving service delivery. These include a wide variety of service 
provision, weak regulation and scarce resources. I also demonstrated, however, that much 
of the work directed at improving pain management is based on professionally constructed 
concepts. This includes the fundamental notion that pain is a medical problem to be fixed – 
a foundational concept, which I argue underpins the entire practice of pain and palliative 
medicine. This medical model of pain management and many ideas that follow on from it, 
such as the organisation of medical specialties and their specialised knowledge base, are 
rarely acknowledged within the published literature relating to global pain management as 
being professionally constructed. Furthermore, there are multiple often-disputed ideas 
relating to these issues, for example, the precise nature of how pain should be treated and 
of how the associated medical specialties should function. Even, the appropriateness of 
using a medical model is itself contested, with many individuals not regarding pain as a 
medical problem. This leads to those working in this field universally describing the need 
to raise awareness of the medical treatment of pain.  
In contrast to the medical scientific literature, there is ample discussion within the field of 
policy theory aiming to increase our understanding of the dynamic, social processes that 
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occur when multiple groups negotiate a contested knowledge base. In the setting of this 
study the literature related to agenda setting, policy creation and implementation are 
particularly useful. In this chapter I demonstrated how the medical profession holds and 
negotiates power in the form of knowledge, money and status, with multiple other actors; 
and of how this power fuels these dynamic social processes. Crucially, I demonstrated how 
power is wielded at an international level, and how the dominance of those in the global 
North can potentially adversely affect the effectiveness of initiatives designed to improve 
patients’ access to care.   
I argue that only by acknowledging the professionally constructed nature of the medical 
model upon which much clinical practice is based, and understanding how this model 
functions in society, can we make significant progress in improving the healthcare that 
patients receive. This requires accepting that knowledge will always be contested and that 
its application will take the form of a complex dynamic process of negotiated power 
between multiple actors, each with their own social, cultural and political persuasions.  
 
  
Chapter 5 - CONCLUSIONS 
5.1 Introduction 
Pain is a universal experience that has existed in the animal kingdom since before the 
existence of the human species. It confers a survival advantage, demonstrated in the 
disability and shortened life expectancy of those afflicted with the rare condition of 
congenital insensitivity to pain. Sufferers are unable to sense pain and as a result do not 
remove themselves from injurious situations, and seek medical attention only when 
conditions have progressed in severity.
342
 The diversity of meanings and uses of the word 
‘pain’, listed in the Oxford English Dictionary as both a noun and verb, are extensive and 
includes the description of bodily suffering following physical injury, the experience of 
mental anguish, the description of an irritating situation, the effort taken in carrying out a 
task, and in conjunction with punishment.
343
 Similarly throughout history pain has been the 
subject of multiple cultural and social interpretations.
4,5
 Only recently, within the field of 
western medicine, has pain been conceptualised as a problem to be fixed
5
 with an 
increasing array of ever more technical weaponry. The pharmaceutical and devices 
companies have invested huge sums of money in developing treatments. Medical 
specialties are dedicated to the treatment of pain and their member practitioners utilise 
numerous medical, surgical and psychological therapies. Nevertheless, by using current 
western medical science, doctors remain unable to cure many painful conditions. There is 
still a remarkable dependence on the use of opioid medications - derivatives of opium, a 
naturally occurring substance that has been used to relieve pain for thousands of years.
344
 
Meanwhile the WHO reports that the vast majority of the world’s population are not able 
to access these substances for medical use. I argue therefore that we have to question the 
appropriateness of our current use of a western medical model to treat pain at a global 
level.  
5.2 The Professional Construction of Pain Management 
Throughout this thesis I described the treatment of pain within a medical paradigm as a 
professionally constructed phenomenon and I explained the implications of this 
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conceptualisation. I demonstrated the professionally constructed facets of pain 
management by examining in detail the normative positions and evaluative judgements of 
clinicians practicing in India. I showed, that not only do clinicians describe pain as a 
problem requiring medical attention but also that they describe the limitations that become 
apparent when using this model, such as: ineffective treatments, poor access to effective 
therapies and low levels of knowledge amongst physicians, should be addressed by more 
research, better created and implemented policies, and improved education. That is, they 
describe solutions only in terms of increasing or improving medicalisation and the 
implementation of a medical model, rather than questioning the inherent assumptions of 
the model itself. They do this despite universally describing how others, including 
colleagues and patients, frequently do not prioritise treating pain within a medical 
paradigm. This failure to question the assumptions behind the use of a professionally 
constructed medical model reflects the tendency amongst the members of the medical 
profession to search for technical solutions rather than to consider the wider sociocultural 
context of their work, and indeed the resulting paucity of cross-disciplinary work with 
experts in the fields of social science.
168
 
The participants in this study talk of the need to create and implement policies in order to 
ensure the most appropriate treatments are available to patients and to improve resource 
allocation. These policies are implemented in many areas of clinicians’ work such as in the 
creation of medical specialties, the direct authorship of national clinical practice 
guidelines, advocating for government policy to be modified to improve access to opioids 
and in wider strategic areas addressing financial and workforce resource allocation within 
healthcare. As is described elsewhere in the literature however, the preponderance of these 
clinicians’ descriptions are focused on the content of these polices rather than on the 
complex negotiated processes that exist between the multiple actors involved in the 
creation and implementation of such work.
209
 Furthermore, this study also reveals the 
contentious nature of the specific content of many of the topics which clinicians deem 
appropriate to be included in policies. Despite demonstrating this complexity and the 
presence of a range of views, there remains an assumption that the best way to deal with 
these differing standpoints is to aim for a resolution by finding a definitive answer, through 
increasing research and improving education. That is, the participants tend very much 
towards a positivist perspective. I argue, however, that the professionally constructed 
nature of many of the topics of contention, leads to the existence of different viewpoints 
Chapter 5 
 
230 
from practitioner groups. Rather than trying to eliminate these multiple views, 
therefore, we should be aiming to take a social constructionist approach - understanding 
and embracing each practitioner group, and indeed incorporating views of non-
professionals. I argue that we should be considering the nature of pain management, 
particularly at a global level, to be of such complexity and (at least partially) professionally 
and socially constructed, that when viewed through the lenses of different individuals, 
multiple different perspectives exist. While these perspectives may initially appear 
incompatible, in fact, each may be equally valid and indeed all may be mutually 
compatible. As I outlined, however, the adoption of this approach by the medical 
profession would require a fundamental philosophical shift in ideology for many of its 
members, a group not known for its willingness to embrace uncertainty.
345
 
5.2.1 Two Tales of Opioid Use 
A clear example of the idea that there is more than one mutually compatible point of view 
is the medical use of opioids to treat pain. My study shows that the desire to increase 
opioid availability is not universal amongst clinicians who specialise in treating pain. 
Furthermore, there is variation in opinion as to how opioids should be used within clinical 
institutions and to which patients should have access. I described throughout this work, 
how the majority of discussion related to improving the treatment of pain in India is related 
to improving access to opioids and focuses on patients being treated within the field of 
palliative care. I also demonstrated, however, the broadening remit of palliative care 
globally and within India, to include the treatment of patients suffering from an increasing 
number of medical conditions at ever-earlier stages in their disease. There arises, therefore, 
an inevitable overlap between the clinical remit of the two medical specialties of palliative 
and pain medicine. This overlap, however, and the ambiguous nature of resulting 
terminology further muddy the waters around discussions of increasing opioid availability 
for the treatment of pain. I argue that there is too little acknowledgement within the global 
palliative care literature of the potential problems that may arise from the misuse and 
diversion of opioids as the remit of palliative care widens. This is despite documented 
evidence of opioid diversion and misuse in India.
346
 I also argue that the lack of inclusion 
of these issues in advocacy work will only hinder progress, an example being the 
Worldwide Palliative Care Alliance’s 2016 World Hospice and Palliative Care Day theme 
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‘Living and dying in pain: it doesn’t have to happen’.101 It would appear, that with our 
current abilities and when using a medical model to treat pain, this statement is only true in 
particular situations and when viewed through one particular lens.  
I described in detail in the introductory chapter the variation of global levels of access to 
opioid medications to treat pain, particularly noting the devastating consequences of low 
availabilities in countries of the global South. In other parts of the world, however, 
particularly in North America, an alternative story is being told, a story of opioid overuse, 
which at first glance may seem incompatible with that being told of the South. In 1971, 
President Nixon declared a war on drugs, describing substance abuse as “America's public 
enemy number one”.347 Despite the colossal efforts invested in this conflict in the decades 
that followed Nixon’s statement, reports of the death, destruction and crime arising from 
drug misuse show no signs of abating, and the war on drugs has often been described by 
the media to have failed.
348,349
  
Most recently and particularly pertinent to this thesis is the focus on the rise in misuse of 
prescription drugs and in particularly of opioids prescribed for pain relief. The government 
of the USA has described the problem of addiction and misuse of prescription opioids as 
“the Nation’s fastest growing drug problem”.350(p1) The country’s Centers for Disease 
Control and Prevention estimate that deaths from overdoses of prescription opioids are 
higher than those from heroin and cocaine combined,
351
 and emotive tales of this 
escalating disaster are numerous.
352
 Many, frequently high profile voices, attribute this 
problem of misuse at least in part, to an increase in the prescribing of opioids by the 
medical profession.
81,353
 This viewpoint has been partly fuelled by the case of one 
particular opioid drug called OxyContin, which was ruled in the USA courts to have been 
inappropriately marketed by the pharmaceutical company Purdue Pharma, resulting in a 
$600 million fine, one of the largest ever issued in such a case.
354
 Similarly, in Canada, a 
recent ruling has ordered Purdue Pharma to settle a class-action lawsuit for $20 million.
355
 
Furthermore, there is a suggestion that the increasing tendency to describe pain relief in 
terms of human rights and to focus heavily on assessing and recording patients’ pain has 
further contributed to the problem.
81
 This has led to a call from the American Medical 
Association to stop clinicians from routinely asking patients about their pain.
84
 Although 
this scenario is largely being played out in North America, it is crucial to appreciate the 
dominance of the voice of this part of the world in the arena of global healthcare, 
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particularly when enforced by the USA’s government and its largest medical society. 
Many fear there is the potential for these stories from North America to perpetuate and 
exacerbate some of the causal factors leading to the low availabilities of opioids that are 
present in so much of the global South, which only serves to fuel the global debate.  
I argue, however, that these two seemingly opposite views are in fact mutually compatible, 
but only when a more nuanced scenario is presented, as emerges from this thesis. There are 
some specific controversies in the case of overuse described in the USA. The causal link 
between the rise in overdoses of prescription opioids and the rise in prescriptions of these 
drugs is debated. For example, many of the deaths reported are related to the use of 
multiple medications, not solely to opioids.
79
 When compared to the UK, the USA has a 
particular healthcare model that makes acquiring opioids from multiple prescribers 
relatively easy. This is compounded by the low illicit market cost of prescription opioids in 
comparison to, for example, heroin.
79
 Furthermore, the litigious framework and 
complexities surrounding insurance company funding of healthcare in the USA are also 
described as contributing to the problematic use of opioids.
81
  
Perhaps most importantly of all, the overzealous prescription of opioids described in North 
America, is largely attributed to the treatment of chronic pain that is not associated with 
terminal disease. Although there are some individuals suffering with this type of pain who 
do benefit from the long-term use of opioids, there is little evidence of long term 
effectiveness for the majority.
80
 Medical professionals in the global North are still 
overwhelming in support of the use of opioids to treat pain associated with terminal 
disease and acute pain, with revised guidance on prescribing only called for in relation to 
the treatment of chronic pain that is not associated with terminal disease.
82,83
 I argue 
therefore that it is entirely reasonable for there to be a call for both an increase in the use of 
opioids in some circumstances and a reduction in others. The two positions are not 
incompatible. 
5.2.2 The Funding of Healthcare in India 
Another demonstration of the need to consider the medical treatment of pain as 
professionally constructed is more specific to the Indian scenario. One of the most 
dominant and consistent findings in my study is the description by clinicians of the need to 
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persuade others, including patients, that pain is a medical problem requiring fixing. The 
implication being that others, including many medical professionals do not currently 
consider this to be the case. These individuals are described as needing education and 
access to awareness campaigns. So, while there is generally consensus among the research 
participants they also acknowledge the differing views of other members of their 
profession and wider society. The study participants work in a variety of healthcare 
settings including corporate hospitals, private clinics, government institutions and charity 
organisations. Many, particularly those in palliative care, work for very low levels of 
remuneration, sometimes none. The idea, however, that patients need to be persuaded by 
clinicians of the need to have their pain treated by medical professionals, can be considered 
to be a self-serving notion, and a demonstration of the power the medical profession 
wields. Power is enacted here in potentially its most covert form, wherein the less powerful 
individual is persuaded to be complicit in maintaining their position of subordination by 
believing it to be in their best interests.
221
 
I also explained how much of the scientific knowledge base related to treating pain is 
contested at a global level, resulting in variations in practice preferences of different 
clinicians in this study, for example relating to the use of nerve blocks. This has the 
potential, however, to be particularly problematic in India. As I explained, plurality is an 
integral component of the Indian healthcare system, and it has indeed been described as a 
key facet of the country of India as a whole by Amartya Sen in his book The 
Argumentative Indian.
356
 Within this study, even amongst those working in the private 
sector and outside of palliative care, there is an acknowledgment of the need to address the 
wide variation in practice standards that exist within the field of pain management in India. 
This appears to be compounded by low levels of regulation and a reliance on private 
healthcare providers. The general lack of healthcare coverage across the country leads to a 
huge gap in the market, open to a multitude of practitioners, and the description of pain as 
a medical problem serves to increase the size of this market. 
Interestingly, despite widely reported endemic corruption within the medical 
profession
124,138
 there is little direct acknowledgement of this in my interview and survey 
data. However, I did see reference to it during informal conversations and during visits to 
healthcare institutions. Furthermore there was a very clear demonstration of tensions that 
currently exist between healthcare professionals related to the funding of care by the 
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presence of the debate at an IAPC conference entitled ‘Developing Palliative Medicine 
is a threat to the corporate world of medicine and specialist physician.’ Contained within 
this debate was a wide reaching claim that palliative care could present a revolutionary 
healthcare model, rather than a specific set of specialist treatments provided to patients 
with a limited range of medical conditions.  
To be clear, I consider that it can be in the patients’ best interest to seek medical treatment 
for their pain. There are numerous distressing examples of patients suffering in such severe 
agony from pains that are potentially easily and cheaply treatable, such as the pain of 
terminal cancer, who consider suicide to be their only option.
121
 Attempts to address this 
situation by improving the availability of medications are clearly laudable as is any attempt 
to help relieve another individual’s suffering, but they cannot be easily separated out from 
the interests of the individual doctor. This is likely, however, to be especially relevant 
when considering private practice and in particular the treatment of chronic pain not 
associated with terminal disease, where patients are potentially the clients of practitioners, 
attending for repeated consultations and treatments for many years. There is of course 
therefore the potential for unethical practice. As George Bernard Shaw explains in his The 
Doctor’s Dilemma: preface on doctors, the profession is in danger of acting as the judge, 
the jury and the executioner.
357
  
5.2.3 The Dominance of the Global North 
The final key area I wish to highlight from this research is the dominance in debates of 
concepts originating in the global North. I explained in the opening chapter how 
organisations based in countries of the global North command power and therefore skew 
the debates in the field of global health, these include the WHO, the Lancet, the Institute 
for Health Metrics and Evaluation, the International Association for Hospice and Palliative 
Care, the Worldwide Palliative Care Alliance, the International Association for the Study 
of Pain, the World Institute of Pain, the Pain and Policy Studies Group, and Human Rights 
Watch.  
The idea that pain is a problem to be fixed by western medicine originates, by definition, 
from the global North. In this study I demonstrated how allopathic doctors working in 
India describe the gradual assimilation of this concept into the Indian healthcare system, 
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adopting practices from those working in the global North. This is reinforced by visits 
from overseas practitioners to India, through formal and informal training of Indian 
clinicians overseas, and through academic publications and research, that are again 
dominated by countries in the North. This has occurred despite the failure of western 
medicine to cure many painful conditions particularly those associated with chronic pain 
not associated with terminal disease, and a reliance on opioid medications that have been 
in use since before recorded history. I also demonstrated, in this concluding chapter, how 
reactions to the disastrous problems associated with opioid abuse in the North, blamed at 
least in part on the use of this western medical model, are in danger of overshadowing 
efforts to improve poor access to opioids in the global South, where further devastation and 
loss of life are occurring. This is not to imply that the use of a western medical model to 
treat pain is always unhelpful, but rather that it is only a useful and appropriate model to 
use in particular circumstances for certain patients. Similarly, within the field of global 
palliative care there is a reliance on a western model of care delivery with the widely cited 
WHO models, maps and rankings tied into ideals originating in the global North.   
My research also demonstrates that although there is a distinct influence from the global 
North in the areas of training, education and research, there is also a clear 
acknowledgement from Indian clinicians of the need to modify models of healthcare, that 
have originated in other countries, for use in India. This notion is precisely in step with the 
postcolonial theories of Chakrabarty
257
 who talks of the need to translate rather than 
transfer knowledge from one country to another. I argue, however that in the current state 
of play, dominated and therefore skewed by a Northern perspective that incorporates a 
western medical model of pain and its treatment, ideas are indeed more often transferred 
than translated. This is compounded by a lack of willingness on the part of healthcare 
professionals and wider society to accept the limitations of western medicine, and a 
reluctance to embrace the idea that global pain management could evolve to reveal 
multiple different futures, each held in equally highly regard in their own unique context, 
rather than as a single uniform ideal. 
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5.3 Implications for Further Research 
In this study I focused on critically appraising clinicians’ descriptions of practice and their 
evaluative judgements. I demonstrated the importance of understanding how clinicians 
influence numerous areas of healthcare delivery – both clinical and political, and the value 
of carrying out cross-disciplinary research. The study is intentionally broad by design and 
therefore paves the way for numerous future in-depth projects.  
The research identifies many actors besides doctors who are involved at each stage of the 
clinical and policy processes, and of how the wider social environment impacts these 
systems. Although I demonstrated the complexity of these processes and the role clinicians 
play, future research could focus on gaining a more nuanced understanding of each process 
and the role of other actors. For example, if we wanted to understand in more detail how 
pain management clinical practice guidelines are created in India, a study could include an 
examination of the various actors involved in this process, including doctors, but also 
institutional managers and representatives of pharmaceutical companies, each of whom 
would be operating within a particular socio-cultural context. There are numerous other 
possible areas of research relating to policy processes and pain management, such as 
understanding how government level policies are created and implemented, and how 
clinical guidelines are put into practice. In each case, I argue that future research should be 
aimed at understanding these processes and incorporating a cross-disciplinary perspective, 
rather than concentrating on their content as so much in the published literature has done to 
date. 
On a more specific level, in this thesis, I demonstrated the breadth of treatments that are 
considered to be useful in pain management, beyond opioid medications. Future research 
could target increasing our understanding of the reasons for the observed variations in the 
availability of such treatments. Furthermore, when considering opioid drugs I showed that 
there are a variety of opinions from clinicians regarding the prioritisation of their use, 
particularly with respect to areas of pain management traditionally not included within the 
remit of palliative care. Further research could be dedicated to looking in more depth at the 
treatment of acute pain and chronic pain not associated with terminal disease, and of how 
therapeutic strategies are implemented in these groups of patients.  
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One group of actors that is most notable in their absence from this study are the patients 
themselves. As I explained, the aim of this project is to critically evaluate the practice of 
clinicians, but doctors are ultimately acting to change the lives of patients. Clearly, 
understanding the perspective of patients is of fundamental importance. Further research 
would be useful to examine patients’ conceptualisations of pain – do they fit with the 
western medical model of a problem to fixed or are there alternative paradigms? When and 
how do Indian citizens suffering from pain decide to access medical input, what other 
strategies do they employ, which treatments do they favour and why?  
I used the country of India as a single case of study to deepen our understanding of global 
issues of pain management. Drawing again on the postcolonial theorist, Chakrabarty’s 
concept of multiple futures, I argue that it is important to use future research projects to 
examine in more detail regional differences that occur within India and between other 
countries. In other words, how does the practice of pain management in other countries 
compare and contrast to that observed in India? 
One of the key drivers to this entire research process is the notion that some of the lack of 
progress in improving pain management at a global level has been as a result of limited 
acknowledgment of the assumptions, complexities and contested nature of the issues being 
addressed; issues such as using a western medical model to conceptualise pain, increasing 
opioid availability within the field of palliative care and advocating for alterations to 
healthcare policy. However, demonstrating the presence of these assumptions, 
complexities and controversies is only the first step on the ladder to actually improving the 
rate of progress that is being hindered. As well as advocating for more specific avenues of 
research, there is a fundamental need to engage with other practitioners, particularly those 
key players based in the global North who are working for internationally influential 
organisations. I argue that their assumptions regarding pain and its treatment, and their 
globally dominant position in research and advocacy work, although well intentioned, need 
to be acknowledged and challenged.  
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5.4 Autobiographical Reflection 
In the reflexivity section of the previous chapter I outlined how my own personal 
experiences, cultural and political persuasions have influenced this research project. In this 
section I add a personal reflection on the work in its entirety, having completed the project. 
Ever since spending my elective period as a medical student in the 1990s in southern 
Africa I have been fascinated by the tensions I witnessed that arise when western medicine 
is transferred to countries of the global South. Throughout my career that has followed in 
the NHS I have continued to be involved with overseas projects relating to the treatment of 
pain across resource poor settings, primarily within Africa and Asia. I continue to work in 
the NHS where I have been a full-time consultant in anaesthesia and pain management for 
over ten years treating patients suffering from a range of painful conditions including 
acute, chronic and cancer pain. This combination of work in the UK and overseas, treating 
patients in a clinical setting and working academically in the social sciences, has given me 
a uniquely broad view of the interconnecting issues across many disciplines relating to the 
treatment of pain at a global level. It has also enabled me to be well positioned to gain 
access to my field of study with relative ease. I felt very much at home at medical 
conferences discussing topical issues with fellow members of the medical profession but 
simultaneously able to identify pertinent differences in practice. Inevitably however, there 
is an insider-outsider tension between gaining access to privileged information and yet 
maintaining the ability to notice the uniquely local quotidian. So whilst I was welcomed to 
conferences, invited to visit many clinical institutions and granted numerous interviews, I 
was only able to communicate in English and noted differences between the topics 
discussed on and off the record.  
The literatures of the social sciences and postcolonialism speak to me in particular as they 
address many of my own questions relating to the use of western medicine on a global 
scale, enabling a more critical understanding of these issues. As a medical student I was 
troubled by an awkward feeling of forcing a square peg into a round hole, borne out 
through my own and others’ frustrations with local systems, staff and patients not acting as 
we had been taught that they should. The field of postcolonial studies serves to explain the 
power differentials that remain in the world as a result of the colonial era and as a 
transformative paradigm, to redress this balance of power. This study is not intended to be 
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a transformative postcolonial work in the sense of actively altering power through the 
research process itself, and indeed I acknowledge a degree of conflict here due to my 
privileged voice as a citizen of the global North and sole researcher. Nevertheless, I see 
this work as heavily influenced by postcolonialism, and through this, seek to open the door 
to future transformative research. I aim to increase our understanding of the need to look 
more critically at and beyond current frameworks that are so profoundly dominated by the 
voice of the global North.  
Drawing on theories from anthropology, sociology and policy studies enables us to gain a 
deeper understanding of the wider context of healthcare and crucially its limitations, and I 
argue that it is essential to do so in order to fully realise medicine’s potential. Throughout 
this project, I have been struck by the paucity of cross-disciplinary engagement. Similarly, 
during my own medical training and education, I have been aware of a lack of appreciation 
of the importance of understanding the social context of clinical medicine. This is, 
however, juxtaposed against a daily recognition, by colleagues working in clinical 
environments, of the need to engage with social and political agendas, frequently 
accompanied by frustration, perhaps fuelled in part by a lack of understanding. As doctors 
we are taught relentlessly how to apply a medical model and to fix each problem we 
encounter. Appreciating our limitations and acknowledging that fixes are not always 
possible is counterintuitive to our training and frequently to society’s expectations. I argue, 
however, that there is a moral imperative to engage across society and with candour, 
regarding these limitations.  
Carrying out this research has been a fascinating and profoundly rewarding experience and 
I feel privileged to have witnessed the hard work of a multitude of professionals and 
volunteers who are dedicating their lives to improving pain management in India. I have, 
however, also been struck by how many, including those at the very top of their field, fail 
to engage across academic disciplines and therefore lack insight into their own 
assumptions. Throughout this project I have taken part in many events in the UK and 
overseas aimed at exchanging knowledge and facilitating cross-disciplinary engagement. 
These events have been invaluable not least in demonstrating to me the need to present 
with simplicity and clarity, novel concepts and complex theories to experts in other fields.  
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The scope of this thesis may seem impossibly ambitious, engaging as I have with 
challenging and provocative issues of such overwhelming size as to be considered beyond 
influence, including the world’s opioid crises, the role of corporate healthcare and the 
power relations operating in the field of global health. While I acknowledge that I cannot 
resolve these issues, I have demonstrated that by understanding the impact they have on 
the practice of medicine, we can potentially improve the quality of healthcare provision 
across the world.
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Appendices 
Appendix 1: Oral History Collection Data 
No. of interviews No. of participants 
Single: 59 (38) Interviewed once: 64 (38) 
Paired: 6 (5) Interviewed twice: 5 (5) 
Triplet: 2 (1) Interviewed thrice: 1 (1) 
Total: 67 (44) Total: 70 (44) 
Table A-1 Oral History Collection India Interview Data  
(44 interviews selected for further analysis in brackets) 
Profession No. of participants 
Management 1 
Medicine 38 
Nursing 3 
Non-Health Care 2 
Total 44 
Table A-2 Profession of 44 Oral History Collection India Participants 
Location (Indian state or country) No. of Participants 
Assam 2 
Chandigarh 3 
Gujarat 1 
Karnataka 4 
Kerala 12 
Madhya Pradesh 2 
Maharashtra 3 
New Delhi 3 
Rajasthan 4 
Tamil Nadu 4 
Uttar Pradesh 2 
UK 3 
Undetermined 1 
Total 44 
Table A-3 Location of Work of 44 Oral History Collection India Participants 
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Appendix 2: Interview Guide version 3a 
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Appendix 3: Interview Guide version 3b 
Additional notes added during data collection underlined and italicised 
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Appendix 4: Interview Plan Language Statement 
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Appendix 5: Interview Consent Form 
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Appendix 6: Questionnaire 
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Appendix 7: Questionnaire Plain Language Statement 
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